|
Document And Entity Information (USD $)
In Billions, except Share data, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Feb. 20, 2015
|
Jun. 30, 2014
|
|
| Document And Entity Information [Abstract] | |||
| Entity Registrant Name | SYMETRA FINANCIAL CORPORATION | ||
| Entity Central Index Key | 0001403385 | ||
| Document Type | 10-K | ||
| Document Period End Date | Dec. 31, 2014 | ||
| Amendment Flag | false | ||
| Document Fiscal Year Focus | 2014 | ||
| Document Fiscal Period Focus | FY | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Well-known Seasoned Issuer | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Filer Category | Large Accelerated Filer | ||
| Entity Public Float | $ 1.7 | ||
| Entity Common Stock, Shares Outstanding | 115,833,208 |
| X | ||||||||||
|
- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document. No definition available.
|
| X | ||||||||||
|
- Definition
End date of current fiscal year in the format --MM-DD. No definition available.
|
| X | ||||||||||
|
- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY. No definition available.
|
| X | ||||||||||
|
- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006. No definition available.
|
| X | ||||||||||
|
- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD. No definition available.
|
| X | ||||||||||
|
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other". No definition available.
|
| X | ||||||||||
|
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. No definition available.
|
| X | ||||||||||
|
- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure. No definition available.
|
| X | ||||||||||
|
- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure. No definition available.
|
| X | ||||||||||
|
- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K. No definition available.
|
| X | ||||||||||
|
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. No definition available.
|
| X | ||||||||||
|
- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Investments in limited partnership interests include tax credit investments and investments in private equity funds. The tax credit investments are accounted for under the equity method and recorded at amortized cost. The private equity fund investments are recorded at fair value. No definition available.
|
| X | ||||||||||
|
- Definition
Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of equity securities categorized neither as held-to-maturity nor as trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net amount of deferred policy acquisition costs capitalized on contracts remaining in force as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of deferred tax liability attributable to taxable temporary differences net of deferred tax asset attributable to deductible temporary differences and carryforwards after valuation allowances. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of accrued obligation to policyholders that relates to insured events for long-duration contracts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before allowance of loans made to policy and contract holders using their life insurance contracts' cash value or separate accounts as collateral. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums over and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate carrying amounts, as of the balance sheet date, of assets not separately disclosed in the balance sheet. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Other investments not otherwise specified in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate carrying amount, as of the balance sheet date, of liabilities not separately disclosed in the balance sheet. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Liability as of the balance sheet date to the policyholders for funds held that are returnable under the terms of insurance contracts that were not separately reported. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The liability as of the balance sheet date to the policyholders for deposits held under the terms of insurance contracts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after valuation allowance recoverable including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The fair value of the assets held by the Entity for the benefit of separate account policyholders. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of liability for variable contracts that meet specified criteria that are backed by assets held in separate accounts and carried at the fair value of those assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Fair value of investments in trading equity securities and other forms of trading securities that provide ownership interests. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Consolidated Balance Sheets (Parenthetical) (USD $)
In Millions, except Share data, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Available-for-sale securities: | ||
| Fixed maturities, at amortized cost | $ 23,646.5 | $ 22,261.3 |
| Marketable equity securities, at cost | 112.9 | 129.0 |
| Trading securities: | ||
| Marketable equity securities, at cost | 453.4 | 403.0 |
| Alternative Investments, Fair Value Disclosure | 71.5 | 31.2 |
| Other invested assets at fair value | $ 95.8 | $ 47.8 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Preferred stock, par value (USD per share) | $ 0.01 | $ 0.01 |
| Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
| Preferred stock, shares issued | 0 | 0 |
| Common stock, par value (USD per share) | $ 0.01 | $ 0.01 |
| Common stock, shares authorized | 750,000,000 | 750,000,000 |
| Common stock, shares issued | 124,850,754 | 124,683,023 |
| Common stock, shares outstanding | 115,797,451 | 117,730,757 |
| Treasury stock, shares | 9,053,303 | 6,952,266 |
| X | ||||||||||
|
- Definition
Fair value of investments in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest. Investments include, but are not limited to, investments in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the cost of debt securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the cost of equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments for other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Fair value portion of other assets. No definition available.
|
| X | ||||||||||
|
- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Cost of investments in equity securities and other forms of securities that provide ownership interests classified as trading. No definition available.
|
| X | ||||||||||
|
- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This includes costs incurred during the period associated with normal operations, such as those relating to general administration and those not deferred as related to the acquisition or renewal of insurance contracts. No definition available.
|
| X | ||||||||||
|
- Definition
The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of expense related to deferred policy acquisition costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Income from agency and brokerage operations (includes sales of annuities and supplemental contracts); service charges, commissions, and fees from the sale of insurance and related services; and management fees from separate accounts, deferred annuities, and universal life products. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Interest allocated to policyholders holding contracts under which the insurer must provide a guaranteed yield. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount by which the fair value of an investment in debt and equity securities categorized as Available-for-sale is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of other than temporary impairment (OTTI) on investment in available-for-sale debt security, recognized in other comprehensive loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of other than temporary impairment losses on investments in debt and equity securities categorized as Available-for-sale which have been recognized in earnings during the period. Such impairment losses consist of other than temporary impairments (OTTI) on equity securities, credit losses on investments in debt securities, and when the entity intends to sell an impaired debt security or it is more likely than not that the entity will be required to sell the impaired debt security before recovery of its amortized cost basis. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Consolidated Statements of Comprehensive Income (Loss) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Statement of Comprehensive Income [Abstract] | |||
| Net income | $ 254.4 | $ 220.7 | $ 205.4 |
| Other comprehensive income (loss), net of taxes and reclassification adjustments: | |||
| Changes in unrealized gains (losses) on available-for-sale securities (net of taxes of $212.5, $(465.8) and $213.3) | 394.5 | (865.4) | 396.6 |
| Other-than-temporary impairments on fixed maturities not related to credit losses (net of taxes of $(0.8), $(0.9) and $(2.8)) | (1.4) | (1.6) | (5.3) |
| Impact of net unrealized (gains) losses on deferred policy acquisition costs and deferred sales inducements (net of taxes of $(9.9), $58.3 and $(24.6)) | (18.3) | 108.3 | (45.9) |
| Impact of cash flow hedges (net of taxes of $12.0, $(10.2) and $(0.8)) | 22.2 | (18.9) | (1.5) |
| Other comprehensive income (loss) | 397.0 | (777.6) | 343.9 |
| Total comprehensive income (loss) | $ 651.4 | $ (556.9) | $ 549.3 |
| X | ||||||||||
|
- Definition
The adjustment to deferred policy acquisition costs and deferred sales inducements due to unrealized investment gains or losses recognized in other comprehensive income during the period, net of taxes. No definition available.
|
| X | ||||||||||
|
- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount after tax of other than temporary impairment (OTTI) loss on investment in available-for-sale debt security, recognized in other comprehensive loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Statement of Comprehensive Income [Abstract] | |||
| Changes in unrealized gains (losses) on available-for-sale securities, tax | $ 212.5 | $ (465.8) | $ 213.3 |
| Other-than-temporary impairments on fixed maturities not related to credit losses, tax | (0.8) | (0.9) | (2.8) |
| Impact of net unrealized investment (gains) losses on deferred policy acquisition costs and deferred sales inducements, tax | (9.9) | 58.3 | (24.6) |
| Impact of cash flow hedges, tax | $ 12.0 | $ (10.2) | $ (0.8) |
| X | ||||||||||
|
- Definition
The tax effect on the adjustment to deferred policy acquisition costs and deferred sales inducements due to unrealized investment gains or losses recognized in other comprehensive income during the period. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of tax (expense) benefit of other than temporary impairment (OTTI) on investment in available-for-sale debt security, recognized in other comprehensive loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Consolidated Statements Of Changes In Stockholders' Equity (USD $)
In Millions |
Total
|
Common Stock [Member]
|
Additional Paid In Capital [Member]
|
Treasury Stock [Member]
|
Retained Earnings [Member]
|
Accumulated Other Comprehensive Income [Member]
|
|---|---|---|---|---|---|---|
| Beginning Balance at Dec. 31, 2011 | $ 3,114.9 | $ 1.2 | $ 1,454.6 | $ 0 | $ 631.8 | $ 1,027.3 |
| Net income | 205.4 | 0 | 0 | 0 | 205.4 | 0 |
| Other Comprehensive Income (Loss) | 343.9 | 0 | 0 | 0 | 0 | 343.9 |
| Stock-based compensation | 4.7 | 0 | 4.7 | 0 | 0 | 0 |
| Dividends declared | (38.8) | 0 | 0 | 0 | (38.8) | 0 |
| Ending Balance at Dec. 31, 2012 | 3,630.1 | 1.2 | 1,459.3 | 0 | 798.4 | 1,371.2 |
| Net income | 220.7 | 0 | 0 | 0 | 220.7 | 0 |
| Other Comprehensive Income (Loss) | (777.6) | 0 | 0 | 0 | 0 | (777.6) |
| Stock-based compensation | 5.3 | 0 | 5.3 | 0 | 0 | 0 |
| Shares repurchased | (93.4) | 0 | 0 | (93.4) | 0 | 0 |
| Dividends declared | (43.2) | 0 | 0 | 0 | (43.2) | 0 |
| Ending Balance at Dec. 31, 2013 | 2,941.9 | 1.2 | 1,464.6 | (93.4) | 975.9 | 593.6 |
| Net income | 254.4 | 0 | 0 | 0 | 254.4 | 0 |
| Other Comprehensive Income (Loss) | 397.0 | 0 | 0 | 0 | 0 | 397.0 |
| Stock-based compensation | 4.9 | 0 | 4.9 | 0 | 0 | 0 |
| Shares repurchased | (41.2) | 0 | 0 | (41.2) | 0 | 0 |
| Dividends declared | (196.4) | 0 | 0 | 0 | (196.4) | 0 |
| Ending Balance at Dec. 31, 2014 | $ 3,360.6 | $ 1.2 | $ 1,469.5 | $ (134.6) | $ 1,033.9 | $ 990.6 |
| X | ||||||||||
|
- Definition
Amount of paid and unpaid common stock dividends declared with the form of settlement in cash. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of accrued interest income from investments. As a noncash item, this amount is added back to net income when calculating cash provided by or used in operations using the indirect method. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The increase (decrease) during the reporting period in the balance sheet value of capitalized acquisition costs that are associated with acquiring or renewing insurance contracts, excluding the impact of unrealized investment gains and losses. No definition available.
|
| X | ||||||||||
|
- Definition
The net amount of fees charged to policyholders related to cost of insurance, mortality expense, surrenders and other administrative charges. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method. No definition available.
|
| X | ||||||||||
|
- Definition
The non-cash transaction related to the tax-free and taxable exchange of bonds for other investments. No definition available.
|
| X | ||||||||||
|
- Definition
The present value of the Company's unconditional commitment to provide capital contributions related to its existing investments in limited partnerships. No definition available.
|
| X | ||||||||||
|
- Definition
The cash inflow associated with maturities, calls, paydowns and other repayments of investments. No definition available.
|
| X | ||||||||||
|
- Definition
The cash inflow from proceeds received from the sale of fixed maturities and marketable equity securities No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The increase (decrease) during the reporting period in investment income that has been earned but not yet received in cash. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The change in the future policy benefit reserve balance on the balance sheet. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The increase (decrease) in other insurance liabilities during the period which liabilities are not otherwise defined in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The increase (decrease) during the reporting period in other assets used in operating activities less other operating liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets and liabilities, other noncurrent assets and liabilities, or a combination of other current and noncurrent assets and liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The adjustment required to reconcile net income to cash provided by (used in) operations related to the unpaid portion of interest credited to policy owner accounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of cash paid for interest during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net cash outflow or inflow from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow to reacquire common stock during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Cash outflow for purchase of trading, available-for-sale securities and held-to-maturity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow from the purchase of receivables arising from the mortgage note on real estate. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow associated with other investments held by the entity for investment purposes not otherwise defined in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash inflow from an insurance contract under which the policy holder make a lump sum payment or a series of payments in exchange for periodic payments to the policyholder beginning immediately or at some future date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. No definition available.
|
| X | ||||||||||
|
- Definition
The net cash inflow or outflow from other financing activities. This element is used when there is not a more specific and appropriate element in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash inflow from proceeds from sale of receivables arising from the mortgage note on real estate; includes collections on mortgage notes receivable that are not classified as operating cash flows. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash inflow associated with the sale of other investments not otherwise defined in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow for an insurance contract under which the policy holder make a lump sum payment or a series of payments in exchange for periodic payments to the policyholder beginning immediately or at some future date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Description of Business
|
12 Months Ended |
|---|---|
|
Dec. 31, 2014
|
|
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Organization and Description of Business | 1. Organization and Description of Business Symetra Financial Corporation is a Delaware corporation that, through its subsidiaries, offers products and services that serve the retirement, employment-based benefits and life insurance markets. These products and services are marketed through financial institutions, broker-dealers, benefits consultants, and independent agents and advisors in all states and the District of Columbia. The Company’s principal products include fixed, fixed indexed and variable deferred annuities, single premium immediate annuities, medical stop-loss insurance, limited benefit medical insurance, group life and disability income (DI) insurance, individual life insurance and institutional life insurance including bank-owned life insurance (BOLI) and variable corporate owned life insurance (COLI). The Company also services its block of structured settlement annuities. The accompanying consolidated financial statements include, on a consolidated basis, the accounts of Symetra Financial Corporation and its subsidiaries, which are wholly-owned and collectively referred to as "Symetra" or "the Company." Common and Preferred Stock The Company has 750,000,000 authorized shares of common stock, $0.01 par value per share, and 10,000,000 authorized shares of preferred stock, $0.01 par value per share. The Company’s board of directors has the authority to designate the preferred stock into series and to designate the voting powers, preferences and other rights of the shares of each series without further stockholder approval, as limited by New York Stock Exchange and other regulatory rules. |
| X | ||||||||||
|
- Definition
The entire disclosure for the organization, consolidation and description of business. No definition available.
|
| X | ||||||||||
|
- Details
|
|
Summary Of Significant Accounting Policies
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary Of Significant Accounting Policies | 2. Summary of Significant Accounting Policies Basis of Presentation and Use of Estimates The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (GAAP), including the rules and regulations of the Securities and Exchange Commission (SEC). The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that may affect the amounts reported in the consolidated financial statements and accompanying notes. All significant intercompany transactions and balances have been eliminated. Certain reclassifications have been made to prior year financial information for it to conform to the current period presentation. The most significant estimates include those used to determine the following: valuation of investments carried at fair value; the balance, recoverability and amortization of deferred policy acquisition costs (DAC) and deferred sales inducements (DSI); and the liabilities for funds held under deposit contracts, future policy benefits, and policy and contract claims. The recorded amounts reflect management’s best estimates, though actual results could differ from those estimates. Recognition of Insurance Revenue and Related Benefits The Company’s group insurance policies, which include medical stop-loss, limited benefit medical, and group life and DI, are short duration contracts. Premiums from these products are recognized as revenue when earned over the life of the policy. Policyholder claims are charged to operations as incurred. Traditional individual life insurance products, including term and whole life insurance products, are long-duration contracts, and the associated premiums and benefits are fixed. Premiums from these products are considered earned and recognized as revenue when due. The Company establishes a reserve for future policy benefits associated with earned premiums, resulting in the recognition of profits over the life of the policy. Deposits related to universal life (UL) insurance products and investment-type products are credited to policyholder account balances and reflected as liabilities, rather than as premium income, when received. These UL insurance products include BOLI and single-premium life (SPL) insurance. Investment-type products include fixed deferred annuities, single premium immediate annuities (SPIA), and structured settlements. Revenues from UL insurance and investment type products consist of net investment income on the policyholders’ fund balances, and amounts assessed during the period for cost of insurance, policy administration, and surrender charges. The Company includes the amounts assessed in policy fees, contract charges, and other in the consolidated statements of income. Expenses that are charged to operations for these products include interest credited and claims incurred in excess of related policyholder account balances. Fees for variable products, including variable annuity, variable life, and variable COLI products, include mortality and expense, policy administration and surrender charges. These fees are charged to policyholders’ accounts based upon the daily net assets of the policyholders’ account values and are recognized in policy fees, contract charges, and other in the consolidated statements of income when assessed. Separate Account Assets and Liabilities Separate account balances primarily relate to the Company's variable annuity, variable life, and variable COLI products. Separate account assets are reported at fair value and represent funds that are invested on behalf of the Company’s variable product policyholders. The assets of each separate account are legally segregated and are not subject to claims that arise out of the Company’s other business activities. Investment risks associated with market value changes are borne by the policyholder, except to the extent of guaranteed minimum death benefits (GMDB) made by the Company with respect to certain accounts. Net investment income and realized gains and losses accrue directly to the policyholders and are not included in the Company’s revenues. Separate account liabilities represent the policyholder’s account balance in the separate account. Fees charged to policyholders reduce the account value and the Company includes these fees as revenue in the consolidated statements of income. For variable annuity contracts with GMDB, the Company contractually guarantees death benefits that may exceed the policyholder's account balance. The Company reinsures nearly all of the GMDB risk on its variable annuity contracts. Funds Held Under Deposit Contracts Liabilities for fixed annuity contracts and universal life policies, including BOLI, are computed as deposits net of withdrawals made by the policyholder, plus interest amounts credited based on contract specifications, less contract fees and charges assessed. For SPIAs, including structured settlements, liabilities are based on discounted amounts of estimated future benefits. Future benefits are either fully guaranteed or are contingent on the survivorship of the annuitant. Contingent future benefits are discounted with pricing mortality assumptions, which include provisions for longer life spans over time. The interest rate pattern used to calculate the reserves for SPIAs is set at issue. The interest rates within the pattern vary over time and start with interest rates that prevailed at contract issue. As of December 31, 2014, the weighted-average implied interest rate on the existing book of business was 5.62% and is expected to grade to 6.35% during the next 20 years. Funds held under deposit contracts also include a liability for the embedded derivative related to the Company's fixed indexed annuity (FIA) policies, which is recorded at fair value. See Note 7 for further discussion of the valuation of the embedded derivative. Future Policy Benefits The Company estimates liabilities for future policy benefits for its traditional individual life policies as the present value of expected future policy benefits less future net premiums. The Company selects the net premiums so that the actuarial present value of future benefits equals the actuarial present value of future premiums. The Company sets the interest, mortality, and persistency assumptions in the year of issue and includes a provision for adverse deviation. The provision for adverse deviation is intended to provide coverage for the risk that actual experience may be worse than locked-in best-estimate assumptions. The Company derives mortality assumptions from both company-specific and industry statistics. Future benefits are discounted at interest rates that vary by year of policy issue. These rates are initially set to be consistent with investment rates at the time of issue, and are graded to a lower rate over time. Assumptions are set at the time each product is introduced and are not updated for actual experience unless the total product liability amount is determined to be inadequate to cover future policy benefits. The Company estimates liabilities for future policy benefits for certain group long-term disability policies as the present value of future benefit payments, net of terminations and recoveries, and discounted at interest rates based on investment rates at the time of disability. Policy Loans Policy loans are carried at unpaid principal balances. Policy loans are not granted for amounts in excess of the accumulated cash surrender value of the policy or contract. Investments in Limited Partnerships The Company invests in limited partnerships that generate tax benefits. These partnerships are established to invest in low-income housing and other qualifying purposes, where the primary return on investment is in the form of income tax credits (collectively referred to as "tax credit investments"). The Company's investments are primarily accounted for under the equity method and recorded at amortized cost. Amortization is based on the expected performance of the underlying partnership, with amortization recorded as a reduction to net investment income. When the carrying value of an investment exceeds the total amount of remaining tax benefits, the Company records an impairment loss, which is included in other net realized gains (losses) in the consolidated statements of income. For certain partnerships, the Company provides its investment over time, and the present value of any unfunded commitments is included in the asset balance and recorded in other liabilities. Investments in limited partnerships also include alternative investments (private equity and hedge funds) recorded at fair value. The impact of changes in the fair value of alternative investments is recorded in net investment income. The Company elected the fair value option for these investments, regardless of ownership percentage, to standardize the related accounting and reporting. Variable Interest Entities The Company performs an ongoing qualitative assessment of its involvement with variable interest entities (VIEs). A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, or where investors lack certain characteristics of a controlling financial interest. The Company assesses its contractual, ownership or other interests in a VIE to determine whether it has a variable interest in the entity, and if so, to determine whether the Company has a controlling financial interest and would therefore be considered the primary beneficiary of the VIE. If it is determined the Company is the primary beneficiary of a VIE, the Company includes the assets and liabilities of the VIE in the consolidated financial statements. The limited partnerships that the Company invests in meet the definition of a VIE. Because the Company, as a limited partner, lacks the ability to direct the activities of any of these partnerships, it is not considered the primary beneficiary and therefore has not consolidated them. The maximum exposure to loss in these VIEs was $327.1 and $316.4 as of December 31, 2014 and 2013, respectively. The maximum exposure to loss includes unconditional commitments to provide future capital contributions. In the normal course of business, the Company also makes passive investments in structured securities issued by VIEs. These structured securities primarily include residential and commercial mortgage-backed securities. Because the Company lacks the ability to direct the activities that most significantly impact the economic performance of the VIEs, it is not considered the primary beneficiary and therefore does not consolidate them. The Company’s maximum exposure to loss with respect to these investments is limited to the amortized cost of the Company’s investment, which was $4,569.4 and $4,571.5 as of December 31, 2014 and 2013, respectively. Other Significant Accounting Policies The following table includes significant accounting policies that are described in other notes to the financial statements, including the number of the note.
New Accounting Pronouncements
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for all significant accounting policies of the reporting entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Earnings Per Share
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share | 3. Earnings Per Share Basic earnings per share represents the amount of earnings for the period available to each share of common stock outstanding during the reporting period. Diluted earnings per share represents the amount of earnings for the period available to each share of common stock outstanding during the reporting period, adjusted for the potential issuance of common stock, if dilutive. Participating securities are those for which the instrument holders are entitled to receive any dividends declared on the common stock concurrently with the holders of outstanding shares of common stock, on a one-to-one basis. These securities include restricted stock issued to the Company's employees, as well as the Company's warrants, which were previously exercisable for 18,975,744 common shares. The warrants were held by wholly-owned subsidiaries of White Mountains Insurance Group, Ltd. and Berkshire Hathaway, Inc., both related parties, and were net-share settled on June 20, 2013. Participating securities are included in basic and diluted earnings per share based on the application of the two-class method, for the portion of the period for which the securities were outstanding. Refer to Note 9 for discussion of these instruments. For the years ended December 31, 2014, 2013 and 2012, 2,650,000 of stock options were excluded from the computation of diluted earnings per share, based on the application of the treasury stock method, because they were anti-dilutive. The following table presents information relating to the Company’s calculations of basic and diluted earnings per share:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for earnings per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Investments
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | 4. Investments Available-for-Sale Securities The Company classifies its investments in fixed maturities and certain marketable equity securities as available-for-sale and carries them at fair value. Fixed maturities primarily include bonds, mortgage-backed securities and redeemable preferred stock. See Note 7 for information on the valuation of these securities and additional disclosures regarding fair value measurements. The Company reports net unrealized gains (losses) related to its available-for-sale securities in accumulated other comprehensive income (AOCI) in stockholders’ equity, net of related DAC and DSI adjustments and deferred income taxes. The cost of securities sold is determined using the specific-identification method. The Company reports interest and dividends earned, including prepayment fees or interest-related make whole payments, in net investment income. Interest income for fixed maturities is recognized using the effective yield method. For mortgage-backed securities, the Company recognizes income using a constant effective yield based on anticipated prepayments and the estimated economic life of the securities. Quarterly, the Company compares actual prepayments to anticipated prepayments and recalculates the effective yield to reflect actual payments plus anticipated future payments. The Company includes any resulting adjustment in net investment income in the current period. When the collectibility of interest income for fixed maturities is considered doubtful, any accrued but uncollectible interest is deducted from investment income in the current period. The Company then places the securities on nonaccrual status, and they are not restored to accrual status until all delinquent interest and principal are paid. Trading Securities The Company is invested in common stock and, beginning in 2014, exchange-traded funds (ETFs), which are classified as trading. Changes in the fair value of the Company’s trading portfolio are recorded in net realized gains (losses) in the consolidated statements of income. Dividends earned on trading securities are reported in net investment income. The following tables summarize the Company’s available-for-sale fixed maturities and marketable equity securities.
The Company maintains a diversified portfolio of corporate fixed maturity securities across industries. The following table presents the composition of the Company’s corporate securities portfolio by sector:
The following tables summarize gross unrealized losses and fair values of the Company’s available-for-sale investments. The tables are aggregated by investment category and present separately those securities that have been in a continuous unrealized loss position for less than twelve months and for twelve months or more.
Based on National Association of Insurance Commissioners (NAIC) ratings as of December 31, 2014 and December 31, 2013, the Company held below-investment-grade fixed maturities with fair values of $1,126.6 and $1,267.5, respectively, and amortized costs of $1,111.9 and $1,229.7, respectively. These holdings amounted to 4.4% and 5.5% of the Company’s investments in fixed maturities at fair value as of December 31, 2014 and December 31, 2013, respectively. The following table summarizes the amortized cost and fair value of fixed maturities as of December 31, 2014, by contractual years to maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.
The following table summarizes the Company’s net investment income:
The following table summarizes the Company’s net realized gains (losses):
Other-Than-Temporary Impairments (OTTI) The Company’s review of available-for-sale investment securities for OTTI includes both quantitative and qualitative criteria. Quantitative criteria include the length of time and amount that each security is in an unrealized loss position (i.e., is underwater) and, for fixed maturities, whether expected future cash flows indicate that a credit loss exists. While all securities are monitored for impairment, the Company’s experience indicates that, under normal market conditions, securities for which the cost or amortized cost exceeds fair value by less than 20% do not typically represent a significant risk of impairment and, often, fair values recover over time as the factors that caused the declines improve. If the estimated fair value has declined and remained below cost or amortized cost by 20% or more for at least six months, the Company further analyzes the decrease in fair value to determine whether it is an other-than-temporary decline. To make this determination for each security, the Company considers, among other factors:
For fixed maturities, the Company concludes that an OTTI has occurred if a security is underwater and there is an intent to sell the security or if the present value of expected cash flows is less than the amortized cost of the security (i.e., a credit loss exists). Where a credit loss exists, the Company isolates the portion of the total unrealized loss related to a credit loss, which is recognized in realized gains (losses) on the consolidated statements of income, and the remainder is recorded as a non-credit OTTI through other comprehensive income. In order to determine the amount of the credit loss, the Company calculates the recovery value by discounting its estimate of future cash flows from the security. The discount rate is the original effective yield for corporate securities or current effective yield for mortgage-backed and other structured securities. Determination of Credit-Related OTTI on Corporate Securities To determine the recovery value for a corporate security, the Company performs an analysis including, but not limited to, the following:
Determination of Credit-Related OTTI on Structured Securities To determine the recovery value for a structured security, including residential mortgage-, commercial mortgage- and other asset-backed securities, the Company performs an analysis including, but not limited to, the following:
The largest write-downs recorded through net realized gains (losses) on fixed maturities were related to investments in the following sectors:
The following table presents the severity and duration of the gross unrealized losses on the Company’s underwater available-for-sale fixed maturities, after the recognition of OTTI:
The Company reviewed its available-for-sale fixed maturities with unrealized losses as of December 31, 2014 and 2013 in accordance with its impairment policy and determined, after the recognition of OTTI, that the remaining declines in fair value were temporary. The Company did not intend to sell its underwater securities, and it was not more likely than not that the Company will be required to sell the securities before recovery of cost or amortized cost, which may be maturity. This conclusion is supported by the Company’s spread analyses, cash flow modeling and expected continuation of contractually required principal and interest payments. As of December 31, 2014, there were $0.2 of gross unrealized losses related to available-for-sale marketable equity securities with a total fair value of $0.7 that were underwater by 20% or more. There were no such securities underwater by 20% or more as of December 31, 2013. As of December 31, 2014 and 2013, the Company has evaluated the near-term prospects of its available-for-sale equity securities with unrealized losses in relation to the severity and duration of the impairment. Based on that evaluation, the Company concluded that it had the ability and intent to hold these investments until a recovery of fair value. Changes in the amount of credit-related OTTI recognized in net income where the portion related to other factors was recognized in other comprehensive income (OCI) were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for cash, cash equivalents, investments in debt and equity instruments (including cost and equity investees and related income statement amounts), equity and cost method investments, investments in joint ventures and any other investment. No definition available.
|
|
Mortgage Loans
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mortgage Loans on Real Estate [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mortgage Loans | 5. Mortgage Loans The Company originates and manages a portfolio of mortgage loans which are secured by first-mortgage liens on income-producing commercial real estate, primarily in the retail, industrial and office building sectors. The Company carries its mortgage loans at outstanding principal balances, adjusted for unamortized deferred fees and costs, net of an allowance for loan losses. Loan origination fees and costs are deferred and amortized over the life of the loan. Interest income, including amortization of deferred fees and expenses, is recorded in net investment income. The Company’s mortgage loan portfolio is generally diversified by geographic region, loan size and scheduled maturity. As of December 31, 2014, the three states with the largest concentrations of the Company’s commercial mortgage loans were California, primarily the Los Angeles area, Texas and Washington. Loans in these states comprised 29.1%, 10.8% and 8.4% of the total portfolio, respectively. Loans are underwritten based on loan-to-value (LTV) ratios and debt-service coverage ratios (DSCR) as well as detailed market, property and borrower analyses. The Company’s mortgage loan portfolio is considered a single portfolio segment and class of financing receivables, which is consistent with how the Company assesses and monitors the risk and performance of the portfolio. A large majority of these loans have personal guarantees, and all mortgaged properties are inspected annually. Allowance for Mortgage Loans The allowance for losses on mortgage loans provides for the risk of credit loss inherent in the lending process. The allowance includes a portfolio reserve for probable losses incurred but not specifically identified and, as needed, specific reserves for impaired loans. The allowance for losses on mortgage loans is evaluated at each reporting period and adjustments are recorded when appropriate. To assist in its evaluation of the allowance for loan losses, the Company utilizes the following credit quality indicators to categorize its loans as lower, medium or higher risk:
Loans are specifically evaluated for impairment if the Company considers it probable that amounts due according to the terms of the loan agreement will not be collected, or the loan is modified in a troubled debt restructuring. The Company establishes specific reserves for these loans when the fair value is less than its carrying value. The following table sets forth the Company’s mortgage loans by risk category:
In developing its portfolio reserve for incurred but not specifically identified losses, the Company evaluates loans by risk category and considers its past loan experience, commercial real estate market conditions, and third party data for expected losses on loans with similar LTV ratios and DSCRs. Each loan’s LTV ratio and DSCR is updated annually, primarily during the third quarter. In developing its provision for specifically identified loans, a market valuation on the collateral is performed to determine if a reserve is necessary. The following table summarizes the activity in the Company’s allowance for mortgage loan losses, which includes portfolio and specific reserves:
Non-performing loans, defined generally as those in default, close to being in default or more than 90 days past due, are placed on non-accrual status. As of December 31, 2014, one loan with an outstanding balance of $1.5 was considered non-performing. There were no such loans as of December 31, 2013. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for mortgage loans on real estate, this includes the supplemental information pertaining to each mortgage loan receivable that equals or exceeds three percent of the carrying amount of mortgages. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Derivative Instruments
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Text Block] | 6. Derivative Instruments The Company uses derivative financial instruments to hedge certain portions of its exposure to equity market risk, interest rate risk and foreign currency exchange risk. Derivative financial instruments currently held consist primarily of Standard & Poor’s 500 Index® (S&P 500) options, interest rate swaps, foreign currency swaps and foreign currency forwards. Derivative instruments may be exchange-traded or contracted in the over-the-counter (OTC) market. The Company has established policies for managing its derivatives, including prohibitions on derivatives market-making and other speculative derivatives activities. All of the Company’s derivative financial instruments are individually recognized at fair value as either assets within other invested assets, or liabilities within other liabilities in the consolidated balance sheets. The accounting for changes in the fair value of derivative instruments depends on whether it qualifies and has been designated for hedge accounting. To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and throughout the life of the hedging relationship. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in its fair value are recorded as a component of OCI and reclassified into net income in the same period during which the hedged transaction affects net income. Any hedge ineffectiveness is recorded in the consolidated statements of income within net realized gains (losses). If a derivative instrument does not qualify, or is not designated for hedge accounting, the changes in its fair value are recorded in the consolidated statements of income within net realized gains (losses). The Company prospectively discontinues hedge accounting when: (1) the criteria to qualify for hedge accounting is no longer met (e.g., the derivative is no longer highly effective in offsetting the change in cash flows of a hedged item); (2) the derivative expires, is sold, terminated or exercised; or (3) the derivative is de-designated as a hedging instrument. If it is determined that a derivative no longer qualifies as an effective hedge, the derivative continues to be carried in the consolidated balance sheets at its fair value, with changes in fair value recognized prospectively in income. The Company also issues fixed indexed annuity contracts that contain embedded derivatives, which are recorded at fair value in funds held under deposit contracts in the consolidated balance sheets. Derivative Exposure The following table sets forth the fair value of the Company’s derivative instruments. In the consolidated balance sheets, derivative contracts in an asset position are included in other invested assets, derivative contracts in a liability position are included in other liabilities, and embedded derivative liabilities are included in funds held under deposit contracts.
Equity Market Contracts and Embedded Derivatives The Company uses call options, mainly based on the S&P 500, as part of its equity market risk management strategy. The Company offers a FIA contract that permits the contract holder to allocate all or a portion of their account value to an equity market component, where interest credited to the contract is linked to index performance, subject to caps set by the Company. The contract holders may elect to rebalance index options at renewal dates, typically annually. As of each renewal date, the Company has the opportunity to re-price the indexed component by establishing cap rates, subject to minimum guarantees. The Company transacts in call options that are correlated to the portfolio allocation decisions of the contract holders, such that the Company is economically hedged with respect to equity returns for the current interest term. These derivatives are not designated for hedge accounting. The index-based crediting feature in these contracts is an embedded derivative instrument that is bifurcated from the host contract for measurement purposes, because it possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract. The embedded derivative, which is reported with the host instrument as funds held under deposit contracts in the consolidated balance sheets, is carried at fair value with changes in fair value recognized in net realized gains (losses). Foreign Currency Contracts The Company uses foreign currency swaps and forwards as part of its foreign currency risk management strategy, to reduce risks from changes in currency exchange rates with respect to the Company's investments denominated in foreign currencies. In a foreign currency swap transaction, the Company agrees with other parties to exchange, at specified intervals, one currency for another at a specified rate of exchange. Generally, the notional amount of each currency is exchanged at the maturity of the currency swap by each party. These derivatives qualify and are designated as cash flow hedges, and accumulated gains (losses) are reclassified into income when interest and principal payments on the underlying foreign bonds are received. The Company is invested in foreign currency forwards to hedge exposure related to purchases of foreign denominated equities and fixed maturities. The Company invests in foreign currency forwards to economically hedge its exposure related to foreign currency-denominated fixed maturity purchases until a foreign currency swap is executed. In a foreign currency forward transaction, the Company agrees with other parties to deliver a specified amount of an identified currency at a specified future date. The price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. In general, the Company is selling a foreign currency and receiving U.S. dollars to protect against fluctuations in exchange rates over a short period of time. These derivatives are not designated for hedge accounting. Interest Rate Swaps The Company uses interest rate swaps as part of its interest rate risk management strategy. In an interest rate swap, the Company agrees with other parties to exchange, at specified intervals, the difference between floating-rate and fixed-rate interest amounts calculated by reference to an agreed upon notional principal amount. The Company primarily uses interest rate swaps to synthetically convert variable rate fixed maturities to fixed rate securities. These derivatives qualify and are designated as cash flow hedges, and accumulated gains (losses) are reclassified into income when interest payments on the underlying bonds are received. Collateral Arrangements and Offsetting of Financial Instruments The Company’s derivative contracts are typically governed by an International Swaps and Derivatives Association (ISDA) Master Agreement, except for foreign currency forwards which do not require an ISDA. For each ISDA, the Company and the counterparty have also entered into a credit support annex (CSA) to reduce the risk of counterparty default in derivative transactions by requiring the posting of cash collateral or other financial assets. The CSA requires either party to post collateral when net exposures from all derivative contracts between the parties exceed pre-determined contractual thresholds, which vary by counterparty. The amount of net exposure is the difference between the derivative contract’s fair value and the fair value of the collateral held for such agreements with each counterparty. Collateral amounts required to be posted or received are determined daily based on the net exposure with each counterparty under a master netting agreement. The Company does not offset recognized collateral amounts pledged or received against the fair value amounts recognized for derivative contracts. In the consolidated balance sheets, the Company recognizes cash collateral received in cash and cash equivalents, and the obligation to return cash collateral in other liabilities. Non-cash collateral received is not recognized in the consolidated balance sheets. In the event of default, the counterparty relinquishes claim to the assets pledged as collateral, and the Company recognizes the collateral as its own asset recorded at fair value, or, in the case of cash collateral, derecognizes its obligation to return collateral. The following tables present the potential effect of netting arrangements by counterparty on the Company’s consolidated balance sheets:
(1) Excludes $230.1 of embedded derivatives which have no counterparty.
(1) Excludes $92.1 of embedded derivatives which have no counterparty. Derivatives Designated as Hedges The following table presents the amount of gain (loss) recognized in OCI on derivatives that qualify as cash flow hedges:
See Note 9 for amounts reclassified out of AOCI into net income for the years ended December 31, 2014, 2013 and 2012. The Company expects to reclassify net gains of $6.4 from AOCI into net income in the next 12 months, which includes both discontinued hedges and periodic settlements of active hedges. Actual amounts may vary from this estimate as a result of market conditions. As of December 31, 2014, the maximum term over which the Company is hedging its exposure to the variability in future cash flows is approximately fifteen years. The Company recorded no ineffectiveness for cash flow hedging relationships for the years ended December 31, 2014, 2013 or 2012. Derivatives Not Designated as Hedges The following table shows the effect of derivatives not designated as hedges in the consolidated statements of income, which is recorded in net realized gains (losses):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Fair Value Of Financial Instruments
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Of Financial Instruments | 7. Fair Value of Financial Instruments The Company determines the fair value of its financial instruments based on the fair value hierarchy, which favors the use of observable inputs over the use of unobservable inputs when measuring fair value. The Company has categorized its financial instruments into the three-level hierarchy, which gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The level to which a fair value measurement falls is assigned based on the lowest-level input that is significant to the measurement. The fair value measurements for the Company’s financial instruments are categorized as follows:
The following tables present the fair value of the Company’s financial instruments classified by the valuation hierarchy described above. The financial instruments are separated between those measured at fair value on a recurring basis and those not carried at fair value, but for which disclosure of fair value is required.
Financial Instruments Measured at Fair Value on a Recurring Basis Fixed Maturities The vast majority of the Company’s fixed maturities have been classified as Level 2 measurements. To make this assessment, the Company determines whether the market for a security is active and if significant pricing inputs are observable. The Company predominantly utilizes third party independent pricing services to assist management in determining the fair value of its fixed maturity securities. As of December 31, 2014 and 2013, respectively, pricing services provided prices for 96.0% and 96.6% of the Company’s fixed maturities. As of December 31, 2014, the Company had $929.0 or 3.7%, of its fixed maturities invested in private placement securities. The use of significant observable inputs in determining the fair value of the Company’s investments in private placement securities resulted in the classification of $870.7, or 93.7%, as Level 2 measurements as of December 31, 2014. As of December 31, 2013, the Company had $653.7, or 2.8%, of its fixed maturities invested in private placement securities, of which $635.6, or 97.2%, were classified as Level 2 measurements. Corporate Securities As of December 31, 2014 and 2013, the fair value of the Company’s corporate securities classified as Level 2 measurements was $19,120.9 and $17,324.4, respectively. The following table presents additional information about the composition of the Level 2 corporate securities:
The majority of corporate securities classified as Level 2 measurements are priced by independent pricing services utilizing evaluated pricing models. Because many corporate securities do not trade on a daily basis, evaluated pricing models apply available information through processes such as benchmark curves, benchmarking of like securities, sector groupings and matrix pricing to prepare valuations. The significant inputs for security evaluations include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and other reference data, including market research publications. As of December 31, 2014 and 2013, $770.6, or 4.0%, and $523.5, or 3.0%, respectively, of Level 2 corporate securities were privately placed. These securities were valued using a matrix pricing approach. The significant inputs to the measurement are the base credit spread, treasury yield and expected future cash flows of the security, which are all observable inputs. The base spread is determined based on trades of similar publicly-traded securities, and the expected future cash flows are based on the contractual terms of the security. The valuation approach also incorporates an illiquidity spread, determined based on premiums demanded by investors for privately placed securities. The illiquidity spread is an unobservable input, which ranges from 0 to 60 basis points and is based on the credit quality of the security. The illiquidity spread does not significantly impact the resulting valuation and thus management does not believe it prohibits Level 2 classification. Residential Mortgage-backed Securities As of December 31, 2014 and 2013, the fair value of the Company’s residential mortgage-backed securities (RMBS) classified as Level 2 measurements was $2,921.4 and $2,755.8, respectively. These securities were primarily fixed-rate, with a weighted-average coupon rate of 4.18% and 4.39% as of December 31, 2014 and 2013, respectively. Level 2 RMBS securities are priced by pricing services that utilize evaluated pricing models. Because many RMBS do not trade on a daily basis, evaluated pricing models apply available information through processes such as benchmark curves, benchmarking of like securities, sector groupings and matrix pricing to prepare evaluations. The significant observable inputs for security evaluations include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and other reference data, including market research publications. In addition, the pricing services use models and processes to develop prepayment and interest rate scenarios. The pricing services monitor market indicators, industry and economic events, and their models take into account market convention. Agency securities comprised 87.9% and 89.2% of the Company’s Level 2 RMBS as of December 31, 2014 and 2013, respectively. The following table presents additional information about the composition of the Level 2 non-agency RMBS securities:
As of December 31, 2014 and 2013, the Company’s non-agency Level 2 RMBS had a weighted-average credit enhancement of 9.0% and 8.8%, respectively. As of December 31, 2014 and 2013, $72.8 and $110.3, or 20.6% and 37.0%, respectively, of the Company’s non-agency Level 2 RMBS had an origination or vintage year of 2004 and prior. The underlying collateral in years prior to 2005 is considered higher quality as underwriting standards were more stringent. Commercial Mortgage-backed Securities As of December 31, 2014 and 2013, the fair value of the Company’s commercial mortgage-backed securities (CMBS) classified as Level 2 measurements was $1,331.4 and $1,512.6, respectively. The weighted-average coupon rate on these securities was 4.65% and 4.82% as of December 31, 2014 and 2013, respectively. Level 2 CMBS securities are priced by pricing services that utilize evaluated pricing models. Because many CMBS do not trade on a daily basis, evaluated pricing models apply available information through processes, such as benchmark curves, benchmarking of like securities, sector groupings and matrix pricing to prepare evaluations. The significant observable inputs for security evaluations include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, new issues, monthly payment information and other reference data, including market research publications. The Company’s Level 2 CMBS securities were primarily non-agency securities, which comprised 87.8% and 83.3% of Level 2 CMBS as of December 31, 2014 and 2013, respectively. The non-agency Level 2 CMBS had an estimated weighted-average credit enhancement of 32.8% and 31.4% as of December 31, 2014 and 2013, respectively, and 96.8% and 98.7% were in the most senior tranche as of December 31, 2014 and 2013, respectively. The following table presents additional information about the composition of the underlying collateral of Level 2 non-agency CMBS securities:
Marketable Equity Securities Marketable equity securities are investments in common stock (mainly in publicly traded companies), ETFs, and certain nonredeemable preferred stocks. When the fair values of the Company’s marketable equity securities are based on quoted market prices in active markets for identical assets, they are classified as Level 1 measurements. The fair values of nonredeemable preferred stocks are determined by pricing services utilizing evaluated pricing models and are classified as a Level 2 measurement. These valuations are created based on benchmark curves using industry standard inputs and exchange prices of underlying securities and common stock of the same issuer. Investments in Limited Partnerships Investments in limited partnerships recorded at fair value relate to the Company's alternative investments. The fair value is approximated based upon the Company’s proportionate interest in the underlying partnership or fund’s net asset values (NAV). The Company is generally unable to liquidate these investments during the remaining term of the partnership or fund, which range from three to thirteen years. As such, the Company classifies these securities as a Level 3 measurement. Equity Index Options Equity index options consist primarily of S&P 500 options. As of December 31, 2014, the fair values of these index options were determined using option pricing models. Significant inputs include index implied volatilities, index dividend yields, index prices, a risk-free rate, option term and option strike price. As these inputs are observable, the equity index options are classified as a Level 2 measurement. Separate Accounts Separate account assets are primarily invested in mutual funds with published NAVs, which are classified as a Level 1 measurement. Embedded Derivatives Embedded derivatives relate to the Company’s FIA product, which credits interest to the policyholder’s account balance based on increases in selected indexes, primarily the S&P 500. See Note 6 for further discussion of the embedded derivative. The fair value reflects the excess of the projected benefits based on the indexed fund value over the projected benefits based on the guaranteed fund value. The excess benefits are projected using best estimates for surrenders, mortality and indexed fund interest, and discounted at a risk-free rate plus a spread for nonperformance and policyholder behavior risk. Because the estimates utilize significant unobservable inputs, the Company classifies the embedded derivatives as a Level 3 measurement. Foreign Currency Swaps Foreign currency swaps are valued using an income approach. These swaps are priced utilizing a discounted cash flow model. The significant inputs include the projected cash flows, currency spot rates, swap yield curve and cross currency basis curve. As these inputs are observable, the foreign currency swaps are classified as a Level 2 measurement. Other Financial Instruments Subject to Fair Value Disclosure Requirements Cash and cash equivalents consist of demand bank deposits and short-term highly liquid investments with original maturities of three months or less at the time of purchase. Cash equivalents, which are reported at cost and approximate fair value, were $16.6 and $37.8 as of December 31, 2014 and 2013, respectively. These are classified as a Level 1 measurement. The fair value of the Company’s mortgage loans are measured by discounting the projected future cash flows using the current rate at which the loans would be made to borrowers with similar credit ratings and for the same maturities. Because these estimates utilize significant unobservable inputs, mortgage loans are classified as a Level 3 measurement. The fair value of the Company’s investments in limited partnerships associated with tax credit investments are estimated based on the discounted cash flows over the remaining life of the tax credits, using the original internal rate of return for each investment. As these inputs are considered observable, investments in limited partnerships are classified as a Level 2 measurement. The fair values of funds held under deposit contracts related to investment-type contracts are estimated based on the present value of the discounted cash flows. Cash flows were projected using best estimates for lapses, mortality and expenses, and discounted at a risk-free rate plus a spread for nonperformance and policyholder behavior risk. Because these estimates utilize significant unobservable inputs, the Company classifies funds held under deposit contracts as a Level 3 measurement. The fair value of the Company’s notes payable is determined by an independent pricing service utilizing evaluated pricing models, consistent with how fair value was determined for the majority of its corporate securities. The use of observable inputs resulted in the classification of notes payable as a Level 2 measurement. Rollforward of Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) The following tables present additional information about financial instruments measured at fair value on a recurring basis and for which the Company has utilized significant unobservable inputs (Level 3) to determine fair value for the years ended December 31, 2014 and 2013:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Deferred Policy Acquisition Costs (DAC) and Deferred Sales Inducements (DSI)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Cost Deferred Sales Inducement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Costs (DAC) and Deferred Sales Inducements (DSI) | 8. Deferred Policy Acquisition Costs and Deferred Sales Inducements Deferred Policy Acquisition Costs The Company defers costs that are directly related to the successful acquisition or renewal of insurance contracts. These primarily include commissions, distribution costs directly related to production, third-party underwriting costs and the portion of salaries and benefits directly related to processing successful new and renewal contracts. All other acquisition-related costs, including costs incurred for soliciting potential customers, managing the distribution and underwriting functions, training, administration, unsuccessful acquisition or renewal efforts, market research and product development are not deferrable and are expensed in the period incurred. The Company amortizes deferred acquisition costs for deferred annuity contracts and universal life insurance policies over the lives of the contracts or policies in proportion to the estimated future gross profits. The Company makes assumptions as to lapse rates, mortality experience, maintenance expenses, crediting rates, and investment performance. Actual profits can vary from the estimates and can thereby result in increases or decreases to DAC amortization. The Company regularly evaluates its assumptions and, when necessary, revises the estimated gross profits of these contracts, resulting in assumption and experience unlocking adjustments to DAC amortization. When such estimates are revised, the impact is recorded in the consolidated statements of income. The Company amortizes acquisition costs for traditional individual life insurance policies over the premium paying period of the related policies, using assumptions consistent with those used in computing policy reserves. The Company amortizes acquisition costs for immediate annuities using a constant yield approach. The Company adjusts the unamortized DAC balance for the effect of net unrealized gains and losses on securities and embedded derivatives as if they had been realized as of the balance sheet date. The Company includes the impact of this adjustment, net of tax, in AOCI. The Company also adjusts its unamortized DAC balance for the effect of realized gains and losses including changes in fair value of the embedded derivatives for the Company's FIA policy assets. These adjustments are recognized in net realized gains (losses) in the consolidated statements of income. For some products, policyholders can elect to modify product benefits, features, rights or coverage by exchanging a contract for a new contract; by amendment, endorsement or rider to a contract; or by election of a feature or coverage within a contract. These transactions are known as internal replacements. If the modification substantially changes the original contract, the remaining DAC balance is immediately written off through earnings and any eligible costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC is retained and amortized over the life of the modified contract and any acquisition costs associated with the related modification are expensed as incurred. The following table provides a reconciliation of the beginning and ending balance for DAC:
The Company conducts regular recoverability analyses for its DAC asset balances associated with deferred and immediate annuity, universal life, traditional life, and group life and DI contracts. The Company compares the current DAC asset balances with the estimated present value of future profitability of the underlying business. The DAC asset balances are considered recoverable if the present value of future profits is greater than the current DAC asset balance. As of December 31, 2014 and 2013, all of the DAC asset balances were considered recoverable. Deferred Sales Inducements The Company offers sales inducements on certain deferred annuity contracts and universal life policies. For certain deferred annuity contracts, the inducement entitles the contract holder to an incremental amount of interest that is credited to the account value over a 12- to 60-month period following the initial deposit, depending on the product. The incremental interest causes the initial credited rate to be higher than the contract’s expected ongoing crediting rates for periods after the inducement. For certain universal life policies, the inducement provides an immediate increment to the policyholder’s account value at the issue date or time of deposit. Deferred sales inducements are included in receivables and other assets and amortized into interest credited using the same methodology and assumptions used to amortize DAC. Similar to DAC, the Company amortizes deferred sales inducements for deferred annuity contracts and universal life insurance policies over the lives of the contracts or policies in proportion to the estimated future gross profits. The Company makes assumptions as to lapse rates, mortality experience, maintenance expenses, crediting rates, and investment performance. Actual profits can vary from the estimates and can thereby result in increases or decreases to DSI amortization. The Company regularly evaluates its assumptions and, when necessary, revises the estimated gross profits of these contracts, resulting in assumption and experience unlocking adjustments to DSI amortization. When such estimates are revised, the impact is recorded in the consolidated statements of income. Deferred sales inducement balances are subject to regular recoverability testing to ensure that capitalized amounts do not exceed the present value of estimated gross profits. As of December 31, 2014 and 2013, all of the deferred sales inducement balances were considered recoverable. The Company adjusts the unamortized DSI balance for the effect of net unrealized gains and losses on securities as if they had been realized as of the balance sheet date. The Company includes the impact of this adjustment, net of tax, in AOCI. The Company also adjusts its unamortized DSI balance for the effect of realized gains and losses. These adjustments are recognized in net realized gains (losses) in the consolidated statements of income. The following table provides a reconciliation of the beginning and ending balance for DSI, which is included in receivables and other assets in the consolidated balance sheets. DSI amortization is included in interest credited in the consolidated statements of income.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Text block tag for deferred acquisition cost and deferred sales inducements disclosures. No definition available.
|
|
Stockholders' Equity
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity | 9. Stockholders' Equity The following tables summarize the components of AOCI and the adjustments to OCI for amounts reclassified from AOCI into net income for the years ended December 31, 2014, 2013 and 2012:
Common Stock Outstanding The following table provides a reconciliation of changes in outstanding shares of common stock:
On February 1, 2013, the Company’s board of directors authorized the repurchase, at management’s discretion, of up to 10,000,000 shares of the Company’s outstanding common stock. The authorization was increased to 16,000,000 shares on May 21, 2013. The Company has repurchased 9,053,303 shares under the program as of December 31, 2014. This includes 6,089,999 shares purchased on May 17, 2013 from a related party in a privately negotiated transaction for a total of $81.8. Stock-Based Compensation As of December 31, 2014, the Company had two stock-based compensation plans: the Symetra Financial Corporation Equity Plan, amended and restated on March 5, 2014, (the "Equity Plan") and the Symetra Financial Corporation Employee Stock Purchase Plan, amended and restated on May 11, 2010, (the "Stock Purchase Plan"). The Equity Plan authorizes the Company to issue various types of awards, including restricted stock, stock options, stock appreciation rights, restricted stock units, performance shares, performance units and other types of awards to employees, directors and consultants. A total of 7,830,000 shares are authorized for issuance under the Equity Plan, and 4,074,216 shares are available for future issuance as of December 31, 2014. The Stock Purchase Plan allows eligible employees to purchase shares of the Company’s common stock at a 15% discount from the market price. A total of 870,000 shares are authorized for issuance under this plan. As of December 31, 2014, 328,593 shares are available for future issuance under the Stock Purchase Plan. The Company accounts for stock-based compensation based on the grant-date fair value of the awards. Compensation expense for these awards is recognized over the requisite service period, using the straight-line method. Restricted Shares Restricted shares are valued based on the number of shares granted and the Company’s closing stock price on the grant date. The Company recognizes such compensation cost as expense over the service period (generally three years), net of estimated forfeitures, using the straight-line method. Many factors are considered when estimating forfeitures, including types of awards, employee class and historical experience. The estimation of equity awards that will ultimately vest requires judgment, and to the extent actual results or future estimates differ from current estimates, the Company records a cumulative adjustment in the period that the estimates are revised. Stock-based compensation expense for restricted shares, recognized in other underwriting and operating expenses in the consolidated statements of income, was $3.6, $3.5, and $3.5 for the years ended December 31, 2014, 2013 and 2012, respectively. The related income tax benefit for the years ended December 31, 2014, 2013 and 2012 was $1.3, $1.2 and $1.2, respectively. The following table summarizes the Company’s restricted share activity for the year ended December 31, 2014:
As of December 31, 2014, unrecognized compensation cost for restricted shares was $3.8 and is expected to be recognized over the weighted average of 1.4 years. Stock Options The Company issued 2,950,000 options during the year ended December 31, 2010, that have an exercise price of $26.70. The price reflects a non-discretionary equitable adjustment made, in accordance with the terms of the Company’s Equity Plan, for the special $1.30 cash dividend paid to stockholders during the fourth quarter of 2014. There was no incremental compensation cost recognized as a result of this adjustment. These options vest on June 30, 2017 and expire one year thereafter. The weighted average grant-date fair value of the awards was $2.73 per share. No options have been granted after December 31, 2010. As of December 31, 2014 and 2013, 2,650,000 options were outstanding, none of which were exercisable. The Company measures compensation cost for stock awards at fair value on the grant date and recognizes such cost, net of estimated forfeitures, over the requisite service period (generally seven years). Stock options are valued using the Black-Scholes valuation model. Stock-based compensation expense for stock options was $1.0, $0.9 and $0.5 for the years ended December 31, 2014, 2013 and 2012 respectively, and the related tax benefit was $0.4, $0.3 and $0.2. Outstanding options have a remaining contractual term of 3.5 years and no intrinsic value as of December 31, 2014. As of December 31, 2014, unrecognized compensation cost for stock options was $2.4 and is expected to be recognized over the next 2.5 years. Performance Units During 2014, 2013 and 2012, the Company granted performance units to various members of management under the Equity Plan. The value of each performance unit is determined at the discretion of the Company’s board of directors based on the success of the Company over a three-year period. These are accounted for as liability awards, as the Company intends or is required to settle such awards in cash. The Company recognized $8.0, $6.4 and $4.7 in expense related to performance units granted under the Equity Plan for the years ended December 31, 2014, 2013 and 2012, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Reinsurance
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance | 10. Reinsurance The Company reinsures portions of its insurance risk, primarily in the Individual Life and Benefits segments, in order to spread risk, limit losses and minimize exposure to significant risks. Beginning in 2014, we also utilize inter-company reinsurance agreements to manage our statutory capital position. In the Benefits segment, the Company reinsures portions of risk associated with its group life and DI and medical stop-loss businesses. The Company typically reinsures its group life mortality risk in excess of $0.25 per individual, per line of coverage. For policies issued on or after August 1, 2014, the Company fully retains its short-term disability risk, and for policies issued on or after April 1, 2014, the Company reinsures 75% of its long-term disability risk. The Company reinsures its exposure to medical stop-loss in excess of $1.0 for aggregate policy claims and $1.5 for specific policy claims. The Company also has catastrophic coverage for its group life policies. In the Individual Life segment, the Company reinsures portions of its risk associated with its universal life, term life, BOLI and variable COLI products. Coverage under these reinsurance agreements varies by product, policy issue year and issue age of the insured. For policies issued during 2014, the Company retained face values to $3.0 per policy. For policies issued after November 11, 2014, most of the Company's newly issued fully underwritten term life was 50% reinsured. The Company remains liable to its policyholders to the extent that counterparties to reinsurance contracts do not meet their contractual obligations. Accordingly, the future policy benefit reserves and policy and contract claims liabilities are reported gross of any related reinsurance recoverables, which are reported as assets. The Company reports premiums, benefits, and settlement expenses net of reinsurance in the consolidated statements of income. The Company accounts for reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsured business on bases consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. The following table sets forth net life insurance in force:
The Company evaluates the financial condition of its reinsurers to monitor its exposure to losses from reinsurer insolvencies. As of December 31, 2014, $116.3 or 35.4%, of the reinsurance recoverable was related to one reinsurer. The Company analyzes reinsurance recoverables according to the credit ratings and financial health of its reinsurers and is not aware of its major reinsurers currently experiencing financial difficulties. Of the total amount due from reinsurers as of both December 31, 2014 and 2013, 99.5% were with reinsurers rated A- or higher by A.M. Best. The Company had no write-offs or reserve for uncollectible reinsurance in 2014, 2013 or 2012. Reinsurance recoverables are composed of the following amounts:
The following table sets forth the effect of reinsurance on premiums and policy fees and contract charges. It is disaggregated by accident and health and life insurance products, which are short- and long-duration contracts, respectively.
Ceded reinsurance reduced policyholder benefits and claims by $75.8, $65.2 and $63.9 for the years ended December 31, 2014, 2013 and 2012, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Liability for Unpaid Claims and Claim Adjustment Expenses
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Unpaid Claims and Claim Adjustment Expenses | 11. Liability for Unpaid Claims and Claim Adjustment Expenses Liabilities for policy and contract claims, which primarily represent liabilities for claims under medical stop-loss and individual life policies, are established on the basis of reported losses. The Company also provides for claims incurred but not reported (IBNR). For medical stop-loss policies, this is based on expected loss ratios, claims paying completion patterns and historical experience. If expected loss ratios increase or expected claims paying completion patterns extend, the IBNR claim liability increases. The Company reviews estimates for reported but unpaid claims and IBNR claims quarterly. Any necessary adjustments are reflected in earnings. The following table provides a reconciliation of the beginning and ending liability balances for unpaid claims and claims adjustment expenses. These reserves include policy and contract claims and certain amounts recorded in future policy benefits on the consolidated balance sheets.
For the year ended December 31, 2014, the change in prior year incurred claims was primarily due to favorable claims experience for medical stop-loss. The Company experienced higher than expected claims frequency and severity during 2013 and established its year-end reserves for estimated IBNR based on this experience. The related 2014 claims experience was lower than expected, and the Company released a portion of the reserves. For the year ended December 31, 2013, the change in prior year incurred claims was primarily due to favorable claims experience for medical stop-loss, offset by higher than expected claims on the Company's BOLI product. For the year ended December 31, 2012, the change in prior year incurred claims was primarily due to favorable claims experience for medical stop-loss, primarily related to the business the Company assumed in July 2011. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Notes Payable And Credit Facilities
|
12 Months Ended |
|---|---|
|
Dec. 31, 2014
|
|
| Notes and Loans Payable [Abstract] | |
| Notes Payable And Credit Facilities | 12. Notes Payable and Credit Facilities Senior Notes Due 2016 On March 30, 2006, the Company issued $300.0 of 6.125% senior notes due on April 1, 2016, which were issued at a discount yielding $298.7. Interest on the senior notes is payable semi-annually. The effective interest rate on the senior notes is 6.11%, including the impact of a related terminated cash flow hedge. The senior notes are unsecured senior obligations and are equal in right of payment to all existing and future unsecured senior indebtedness. These notes are redeemable, in whole or in part, at the option of the Company at any time at a redemption price equal to the greater of: (1) 100% of the aggregate principal amount of the notes to be redeemed or (2) the sum of the present value of the remaining scheduled payments of principal and interest on the senior notes, discounted to the redemption date on a semi-annual basis at a prevailing U.S. Treasury rate plus 25 basis points, together in each case with accrued interest payments to the redemption date. Senior Notes Due 2024 On August 4, 2014, the Company issued $250.0 of 4.25% senior notes due on July 15, 2024, which were issued at a discount yielding $249.0. Interest on the notes is payable semi-annually and the effective interest rate of the notes is 4.44%. The notes are general unsecured obligations of the Company and rank equally in right of payment with all existing and future senior indebtedness of the Company, including its senior notes due 2016 and revolving credit facility. The notes are senior in right of payment to the Company's capital efficient notes (CENts). The notes are redeemable, in whole or in part, at the option of the Company on at least 30 but not more than 60 days prior notice, at a redemption price equal to the greater of (i) 100% of the principal amount of the notes or (ii) the present value of the remaining scheduled payments on the redemption date, discounted to the date of redemption using the yield to maturity of a comparable treasury issue plus 30 basis points; plus, in each case, any accrued and unpaid interest. Capital Efficient Notes (CENts) Due 2067 On October 10, 2007, the Company issued $150.0 aggregate principal amount CENts with a scheduled maturity date of October 15, 2037, subject to certain limitations, with a final maturity date of October 15, 2067. The Company issued the CENts at a discount, yielding $149.8. For the initial 10-year period following the original issuance date, to, but not including October 15, 2017, the CENts carry a fixed interest rate of 8.3% payable semi-annually. From October 15, 2017, until the final maturity date of October 15, 2067, interest on the CENts will accrue at a variable annual rate equal to the three-month LIBOR plus 4.18%, payable quarterly. The effective interest rate on the CENts is 9.39%, including the impact of a related terminated cash flow hedge. The Company is required to use commercially reasonable efforts to sell enough qualifying capital securities to permit repayment of the CENts at the scheduled maturity date or on each interest payment date thereafter. Any remaining outstanding principal amount will be due on October 15, 2067. Subject to certain conditions, the Company has the right, on one or more occasions, to defer the payment of interest on the CENts during any period up to 10 years without giving rise to an event of default. Deferred interest will accumulate additional interest at an annual rate equal to the annual interest rate then applicable to the CENts. The CENts are unsecured junior subordinated obligations. The Company can redeem the CENts at its option, in whole or in part, on October 15, 2017, and on each interest payment date thereafter at a redemption price of 100% of the principal amount being redeemed plus accrued but unpaid interest. The Company can redeem the CENts at its option, prior to October 15, 2017, in whole or in part, at a redemption price of 100% of the principal amount being redeemed or, if greater, a make-whole price, plus accrued and unpaid interest. In connection with the offering of the CENts, the Company entered into a replacement capital covenant (RCC) for the benefit of the holders of the senior notes due 2016. Under the terms of the RCC, the Company may not redeem or repay the CENts prior to October 15, 2047 unless the redemption or repayment is financed from the offering of replacement capital securities, as specified in the covenant. The senior notes due 2024 are not entitled to benefit from or otherwise acquire any rights or claims by virtue of the RCC. Revolving Credit Facility On August 28, 2014, the Company entered into a $400.0 senior unsecured revolving credit facility with a syndicate of lending institutions. The facility also provides access to up to an additional $100.0 of financing, subject to the availability of additional commitments from lenders. The facility is set to mature on August 28, 2019 and is available to provide support for working capital, capital expenditures, and other general corporate purposes. Borrowings under the facility will bear interest at a variable annual rate based on adjusted LIBOR or the alternate base rate plus, in each case, an applicable margin. The terms of the facility call for the Company to maintain a debt-to-capitalization ratio, excluding AOCI, not to exceed 35%, and risk-based capital ratios of at least 225% for each material insurance company subsidiary, as well as other customary affirmative covenants. The Company is required to pay facility fees ranging from 0.1% to 0.3%, depending on the Company's ratings from Moody's and S&P, on the daily amount of the commitment. The Company did not borrow under this facility and was in compliance with all covenants as of December 31, 2014. Effective August 28, 2014, concurrently with entry into the unsecured revolving credit agreement referenced above, the Company terminated its prior $300.0 credit agreement, dated December 14, 2011, which was set to mature on December 14, 2015. At termination, the Company had no borrowings outstanding under the credit agreement and was in compliance with all covenants. Surplus Note On December 12, 2014, the Company’s primary insurance subsidiary, Symetra Life Insurance Company, and its newly formed, indirect wholly owned subsidiary, Symetra Reinsurance Corporation (SRC), entered into a 25-year transaction to finance certain non-economic statutory reserves related to a block of universal life insurance policies with secondary guarantees issued by Symetra Life Insurance Company. As part of this transaction, SRC issued a surplus note with no initial principal balance and a maximum capacity of $107.2. As of December 31, 2014, there were no borrowings outstanding under the surplus note. |
| X | ||||||||||
|
- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Income Taxes
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Taxes | 13. Income Taxes Income taxes have been determined using the liability method. The provision for income taxes has two components: amounts currently payable or receivable and deferred income taxes. The deferred income taxes are calculated as the difference between the book and tax bases of the appropriate assets and liabilities and are measured using enacted tax rates. The Company files income tax returns in the U.S. federal and various state jurisdictions. The Company’s federal income tax returns have been examined and closing agreements have been executed with the Internal Revenue Service, or the statute of limitations has expired for all tax periods through December 31, 2009. The Company is not currently subject to any state income tax exams. Differences between income taxes computed by applying the U.S. federal income tax rate of 35% to income from operations before income taxes and the provision for income taxes were as follows:
The tax effects of temporary differences that gave rise to the deferred income tax assets and liabilities were as follows:
As of December 31, 2014, the Company's non-insurance entities have gross federal net operating loss carry-forwards of $81.1, which are reflected in its deferred tax assets. These are due to expire under current law during 2028 through 2034. Deferred tax assets are recognized only to the extent that it is more likely than not that future taxable profits will be available, and a valuation allowance is established where deferred tax assets cannot be recognized. Based on an analysis of the Company’s tax position, management believes that it is more likely than not that the results of future operations will generate sufficient taxable income to enable the Company to utilize all of its deferred tax assets. Accordingly, no valuation allowance for deferred tax assets has been established as of December 31, 2014 and 2013. The Company includes penalties and interest accrued related to unrecognized tax benefits in the calculation of income tax expense. As of December 31, 2014, the Company has no unrecognized tax benefits and does not expect significant changes within the next year. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Commitments And Contingencies
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||
| Commitments And Contingencies | 14. Commitments and Contingencies Operating Leases The Company has office space and certain equipment under leases that expire at various dates through 2025, subject to certain renewal options. The Company accounts for these leases as operating leases. Future minimum lease commitments, including cost escalation clauses, for the next five years and thereafter are as follows:
Other Commitments The Company has a service agreement with a third party service provider to outsource the majority of its information technology infrastructure. Under the original terms of the service agreement, the Company agreed to pay an annual fixed service fee ranging from $10.6 to $11.4 for five years, and the original term of the service agreement expired in July 2014. The Company exercised its extension options in the service agreement for another two years, extending the term through July 2016. During the two-year extension period, the Company agreed to pay an annual fixed service fee of $10.8. The Company incurred service fee expenses of $10.9, $13.4 and $13.6 for the years ended December 31, 2014, 2013 and 2012, respectively, which included the fixed fee as well as a variable fee based on usage. As of December 31, 2014 and 2013, unfunded mortgage loan commitments were $50.7 and $50.5, respectively. The Company had no other material commitments or contingencies as of December 31, 2014 and 2013. Litigation Because of the nature of its business, the Company is subject to legal actions filed or threatened in the ordinary course of its business operations. The Company does not expect that any such litigation, pending or threatened, as of December 31, 2014, will have a material adverse effect on its consolidated financial condition, future operating results or liquidity. |
||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for commitments and contingencies. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Dividends
|
12 Months Ended |
|---|---|
|
Dec. 31, 2014
|
|
| Dividends [Abstract] | |
| Dividends | 15. Dividends The Company’s insurance company subsidiaries are restricted by state regulations as to the aggregate amount of dividends they may pay to their parent company in any consecutive 12-month period without regulatory approval. The aggregate amount of dividends for the current year is determined based on prior year’s statutory limits. Accordingly, Symetra Financial Corporation was eligible to receive dividends from its directly owned insurance company subsidiary, Symetra Life Insurance Company, during 2014 without obtaining regulatory approval, as long as the aggregate dividends paid over 12 months did not exceed $187.0. The total amount of dividends declared to Symetra Financial Corporation by Symetra Life Insurance Company during 2014 was $80.0. In addition, Symetra Financial Corporation received a $45.0 dividend from Symetra Life Insurance Company in January 2014 that was declared in December 2013. Based on state regulations as of December 31, 2014, Symetra Financial Corporation is eligible to receive dividends from Symetra Life Insurance Company during 2015 without obtaining regulatory approval as long as the aggregate dividends paid over the 12 months preceding any dividend payment date in 2015 do not exceed $207.8. Symetra Financial Corporation declared and paid dividends of $1.70 per share during 2014. The total declared and paid dividends included a special dividend of $1.30 per common share for a total payout of $150.7, declared on October 24, 2014. There are no regulatory restrictions on the ability of Symetra Financial Corporation to pay dividends. The declaration and payment of future dividends on common stock will be at the discretion of the Company’s board of directors and will be dependent on, and may be limited by, many factors including the receipt of dividends from the Company’s insurance company subsidiaries, the capital requirements of the Company’s insurance company subsidiaries, the Company’s financial condition and operating results, compliance with covenants of the Company’s revolving credit facility, the Company’s credit and financial strength ratings, and such other factors as the board of directors deems relevant. |
| X | ||||||||||
|
- Definition
The entire disclosure for dividend-related disclosures of the reporting entity. No definition available.
|
| X | ||||||||||
|
- Details
|
|
Statutory-Basis Information
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statutory-Basis Information | 16. Statutory-Basis Information The Company’s insurance company subsidiaries are required to prepare statutory financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile. Statutory accounting practices primarily differ from GAAP by charging policy acquisition costs to expense as incurred and establishing future policy benefit liabilities using different actuarial assumptions, as well as accounting for investments, certain assets and deferred taxes on a different basis. Permitted statutory accounting practices encompass all accounting practices not prescribed and adopted by the NAIC, but which have been specifically allowed by state insurance authorities. The Company’s insurance company subsidiaries have no material permitted accounting practices. The statutory net income and statutory capital and surplus for the Company’s insurance company subsidiaries are as follows:
Each of the insurance company subsidiaries’ state of domicile imposes minimum risk–based capital (RBC) requirements that were developed by the NAIC. The formulas for determining the amount of RBC specify various weighting factors that are applied to the financial balances or various levels of activity based on the perceived degree of risk. Regulatory compliance is determined by a ratio of total adjusted capital, as defined by the NAIC, to company action level RBC, as defined by the NAIC. Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified correction action. As of December 31, 2014 each of the Company’s insurance company subsidiaries exceeded the minimum company action level RBC requirements and maintained risk-based capital ratios in excess of 470% of the company action level. The Company’s insurance company subsidiaries’ minimum statutory capital and surplus necessary to satisfy company action level regulatory requirements in the aggregate was $501.3 at December 31, 2014, of which 95.8% was attributable to Symetra Life Insurance Company. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Definition
The entire disclosure for all statutory-based information of the reporting entity. No definition available.
|
| X | ||||||||||
|
- Details
|
|
Related Parties
|
12 Months Ended |
|---|---|
|
Dec. 31, 2014
|
|
| Related Party Transactions [Abstract] | |
| Related Parties | 17. Related Parties The Company had an investment management agreement with White Mountains Advisors, LLC (WMA), a subsidiary of White Mountains Insurance Group, Ltd. White Mountains Insurance Group, Ltd. is a related party who beneficially owns 20,048,879 shares of the Company’s common stock. This agreement, as amended, provided for investment advisory services related to the Company’s invested assets and portfolio management services. Expenses amounted to $19.0, $16.9 and $16.0 for the years ended December 31, 2014, 2013 and 2012, respectively. As of December 31, 2014 and 2013, amounts due to WMA were $5.1 and $4.3, respectively. Effective January 1, 2015, the Company and WMA entered into a new investment management agreement. Pursuant to the revised agreement, WMA remains the investment advisor on the majority of the Company's investments, including its investment grade fixed maturity portfolio, and certain portfolio management services moved from WMA to the Company. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Segment Information
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Information | 18. Segment Information The Company's operations are managed separately as three divisions, consisting of four business segments based on product groupings, and a fifth reportable segment consisting primarily of unallocated corporate items and surplus investment income. The five segments are Benefits, Deferred Annuities, Income Annuities, Individual Life and Other, described further below. The primary profitability measure that management uses to manage business segment results is pre-tax adjusted operating income (loss). Pre-tax adjusted operating income is defined as income from operations, excluding net realized gains (losses) that are not reflective of the performance of the Company's insurance operations. Excluded gains (losses) are associated with investment sales or disposal, other-than-temporary investment impairments, changes in the fair value of mark-to-market investments and derivative investments (except for certain S&P 500 options discussed below) and changes in the fair value of embedded derivatives related to the Company's FIA product. In the Deferred Annuities segment, certain net gains (losses) related to FIA products sold in the late 1990s are considered related to the performance of insurance operations and included in the pre-tax adjusted operating income. These products credit interest to policyholder accounts based on equity market performance, which is recorded in interest credited. The Company purchases S&P 500 options to economically hedge exposure to this block of business, which are not designated for hedge accounting. Any realized gains from these options are used to meet policyholder obligations. Benefits Division
Retirement Division
Individual Life Division
Non-Operating
The accounting policies of the segments are the same as those described for the Company, except for the method of capital allocation. The Company has an internally developed risk-based capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. This model accounts for the unique and specific nature of the risks inherent in the Company’s segments, and a portion of net investment income on surplus investments, but not the invested assets, is allocated to the segments based on the level of allocated capital. The following tables present selected financial information by segment and reconcile segment pre-tax adjusted operating income (loss) to amounts reported in the consolidated statements of income:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Quarterly Results Of Operations
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quarterly Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quarterly Results Of Operations | 19. Quarterly Results of Operations (Unaudited) The unaudited quarterly results of operations for years ended December 31, 2014 and 2013 are summarized in the table below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Schedule I Summary Of Investments Other Than Investments In Related Parties
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Investments, Other than Investments in Related Parties [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule I Summary of Investments - Other Than Investments in Related Parties | Schedule I Summary of Investments — Other Than Investments in Related Parties As of December 31, 2014 (In millions)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for the schedule applicable to insurance companies summarizing investments held as of the most recent audited balance sheet. At a minimum, such summary is by three major categories of investments including: (1) fixed maturities primarily consisting of bonds, including convertibles and bonds with warrants, and redeemable preferred stocks, (2) equity securities primarily consisting of common stocks and nonredeemable preferred stocks, and (3) other investments including mortgage loans on real estate, real estate held for investment, real estate acquired in satisfaction of debt, policy loans, other long-term investments, and short-term investments not otherwise categorized. The information provided with respect to each item within each category includes: (A) the original cost of equity securities and, as to fixed maturity securities, original cost reduced by repayments and adjusted for amortization of premiums or accrual of discounts, (B) fair value as of the reporting date, and (C) the amount at which the item within each category is shown in the statement of financial position; with respect to (C), if the amount at which shown in the statement of financial position is different from the items original [amortized] cost or fair value, an explanation of the difference may be included herein. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Schedule II Condensed Statement Of Financial Information (Parent Company Only)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Financial Information of Parent Company Only Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule II Condensed Financial Information (Parent Company Only) | Schedule II Condensed Statements of Financial Position (Parent Company Only) (In millions, except share and per share data)
See accompanying notes. Schedule II (continued) Condensed Statements of Comprehensive Income (Loss) (Parent Company Only) (In millions)
See accompanying notes. Schedule II (continued) Condensed Statements of Cash Flows (Parent Company Only) (In millions)
See accompanying notes. Schedule II (continued) Notes to Condensed Financial Statements (Parent Company Only) (In millions) 1. Organization and Presentation The accompanying condensed financial statements present the financial position, results of operations and cash flows for Symetra Financial Corporation (the "Parent Company"). These condensed unconsolidated financial statements should be read in conjunction with the consolidated financial statements of Symetra Financial Corporation and its subsidiaries and the notes thereto (the "Consolidated Financial Statements"). Investments in subsidiaries are accounted for using the equity method of accounting. Additional information about the Parent Company’s accounting policies pertaining to investments, notes payable, commitments and contingencies, and other significant areas are as set forth in Notes 2, 4, 12 and 14 to the consolidated financial statements. 2. Related Parties The Parent Company received cash dividends of $134.5, $219.1 and $85.8 from its subsidiaries for the years ended December 31, 2014, 2013 and 2012, respectively. Cash dividends received in 2014 includes a $45.0 dividend received in January 2014 that was declared in December 2013. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Summary Of Significant Accounting Policies (Policy)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Basis of Presentation, Policy | Basis of Presentation and Use of Estimates The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (GAAP), including the rules and regulations of the Securities and Exchange Commission (SEC). All significant intercompany transactions and balances have been eliminated. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Use of Estimates, Policy | The most significant estimates include those used to determine the following: valuation of investments carried at fair value; the balance, recoverability and amortization of deferred policy acquisition costs (DAC) and deferred sales inducements (DSI); and the liabilities for funds held under deposit contracts, future policy benefits, and policy and contract claims. The recorded amounts reflect management’s best estimates, though actual results could differ from those estimates. The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that may affect the amounts reported in the consolidated financial statements and accompanying notes. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reclassification, Policy | Certain reclassifications have been made to prior year financial information for it to conform to the current period presentation. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recognition of Insurance Revenue and Related Benefits, Policy | Recognition of Insurance Revenue and Related Benefits The Company’s group insurance policies, which include medical stop-loss, limited benefit medical, and group life and DI, are short duration contracts. Premiums from these products are recognized as revenue when earned over the life of the policy. Policyholder claims are charged to operations as incurred. Traditional individual life insurance products, including term and whole life insurance products, are long-duration contracts, and the associated premiums and benefits are fixed. Premiums from these products are considered earned and recognized as revenue when due. The Company establishes a reserve for future policy benefits associated with earned premiums, resulting in the recognition of profits over the life of the policy. Deposits related to universal life (UL) insurance products and investment-type products are credited to policyholder account balances and reflected as liabilities, rather than as premium income, when received. These UL insurance products include BOLI and single-premium life (SPL) insurance. Investment-type products include fixed deferred annuities, single premium immediate annuities (SPIA), and structured settlements. Revenues from UL insurance and investment type products consist of net investment income on the policyholders’ fund balances, and amounts assessed during the period for cost of insurance, policy administration, and surrender charges. The Company includes the amounts assessed in policy fees, contract charges, and other in the consolidated statements of income. Expenses that are charged to operations for these products include interest credited and claims incurred in excess of related policyholder account balances. Fees for variable products, including variable annuity, variable life, and variable COLI products, include mortality and expense, policy administration and surrender charges. These fees are charged to policyholders’ accounts based upon the daily net assets of the policyholders’ account values and are recognized in policy fees, contract charges, and other in the consolidated statements of income when assessed. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Account Assets and Liabilities, Policy | Separate Account Assets and Liabilities Separate account balances primarily relate to the Company's variable annuity, variable life, and variable COLI products. Separate account assets are reported at fair value and represent funds that are invested on behalf of the Company’s variable product policyholders. The assets of each separate account are legally segregated and are not subject to claims that arise out of the Company’s other business activities. Investment risks associated with market value changes are borne by the policyholder, except to the extent of guaranteed minimum death benefits (GMDB) made by the Company with respect to certain accounts. Net investment income and realized gains and losses accrue directly to the policyholders and are not included in the Company’s revenues. Separate account liabilities represent the policyholder’s account balance in the separate account. Fees charged to policyholders reduce the account value and the Company includes these fees as revenue in the consolidated statements of income. For variable annuity contracts with GMDB, the Company contractually guarantees death benefits that may exceed the policyholder's account balance. The Company reinsures nearly all of the GMDB risk on its variable annuity contracts. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Funds Held Under Deposit Contracts, Policy | Funds Held Under Deposit Contracts Liabilities for fixed annuity contracts and universal life policies, including BOLI, are computed as deposits net of withdrawals made by the policyholder, plus interest amounts credited based on contract specifications, less contract fees and charges assessed. For SPIAs, including structured settlements, liabilities are based on discounted amounts of estimated future benefits. Future benefits are either fully guaranteed or are contingent on the survivorship of the annuitant. Contingent future benefits are discounted with pricing mortality assumptions, which include provisions for longer life spans over time. The interest rate pattern used to calculate the reserves for SPIAs is set at issue. The interest rates within the pattern vary over time and start with interest rates that prevailed at contract issue. As of December 31, 2014, the weighted-average implied interest rate on the existing book of business was 5.62% and is expected to grade to 6.35% during the next 20 years. Funds held under deposit contracts also include a liability for the embedded derivative related to the Company's fixed indexed annuity (FIA) policies, which is recorded at fair value. See Note 7 for further discussion of the valuation of the embedded derivative. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Future Policy Benefits, Policy | Future Policy Benefits The Company estimates liabilities for future policy benefits for its traditional individual life policies as the present value of expected future policy benefits less future net premiums. The Company selects the net premiums so that the actuarial present value of future benefits equals the actuarial present value of future premiums. The Company sets the interest, mortality, and persistency assumptions in the year of issue and includes a provision for adverse deviation. The provision for adverse deviation is intended to provide coverage for the risk that actual experience may be worse than locked-in best-estimate assumptions. The Company derives mortality assumptions from both company-specific and industry statistics. Future benefits are discounted at interest rates that vary by year of policy issue. These rates are initially set to be consistent with investment rates at the time of issue, and are graded to a lower rate over time. Assumptions are set at the time each product is introduced and are not updated for actual experience unless the total product liability amount is determined to be inadequate to cover future policy benefits. The Company estimates liabilities for future policy benefits for certain group long-term disability policies as the present value of future benefit payments, net of terminations and recoveries, and discounted at interest rates based on investment rates at the time of disability. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consolidation, Variable Interest Entity, Policy | Variable Interest Entities The Company performs an ongoing qualitative assessment of its involvement with variable interest entities (VIEs). A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, or where investors lack certain characteristics of a controlling financial interest. The Company assesses its contractual, ownership or other interests in a VIE to determine whether it has a variable interest in the entity, and if so, to determine whether the Company has a controlling financial interest and would therefore be considered the primary beneficiary of the VIE. If it is determined the Company is the primary beneficiary of a VIE, the Company includes the assets and liabilities of the VIE in the consolidated financial statements. The limited partnerships that the Company invests in meet the definition of a VIE. Because the Company, as a limited partner, lacks the ability to direct the activities of any of these partnerships, it is not considered the primary beneficiary and therefore has not consolidated them. The maximum exposure to loss in these VIEs was $327.1 and $316.4 as of December 31, 2014 and 2013, respectively. The maximum exposure to loss includes unconditional commitments to provide future capital contributions. In the normal course of business, the Company also makes passive investments in structured securities issued by VIEs. These structured securities primarily include residential and commercial mortgage-backed securities. Because the Company lacks the ability to direct the activities that most significantly impact the economic performance of the VIEs, it is not considered the primary beneficiary and therefore does not consolidate them. The Company’s maximum exposure to loss with respect to these investments is limited to the amortized cost of the Company’s investment, which was $4,569.4 and $4,571.5 as of December 31, 2014 and 2013, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adoption of New Accounting Pronouncements Not yet Adopted, Policy | New Accounting Pronouncements
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share, Policy | Basic earnings per share represents the amount of earnings for the period available to each share of common stock outstanding during the reporting period. Diluted earnings per share represents the amount of earnings for the period available to each share of common stock outstanding during the reporting period, adjusted for the potential issuance of common stock, if dilutive. Participating securities are those for which the instrument holders are entitled to receive any dividends declared on the common stock concurrently with the holders of outstanding shares of common stock, on a one-to-one basis. These securities include restricted stock issued to the Company's employees, as well as the Company's warrants, which were previously exercisable for 18,975,744 common shares. The warrants were held by wholly-owned subsidiaries of White Mountains Insurance Group, Ltd. and Berkshire Hathaway, Inc., both related parties, and were net-share settled on June 20, 2013. Participating securities are included in basic and diluted earnings per share based on the application of the two-class method, for the portion of the period for which the securities were outstanding. Refer to Note 9 for discussion of these instruments. For the years ended December 31, 2014, 2013 and 2012, 2,650,000 of stock options were excluded from the computation of diluted earnings per share, based on the application of the treasury stock method, because they were anti-dilutive. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments, Policy | Policy Loans Policy loans are carried at unpaid principal balances. Policy loans are not granted for amounts in excess of the accumulated cash surrender value of the policy or contract. Investments in Limited Partnerships The Company invests in limited partnerships that generate tax benefits. These partnerships are established to invest in low-income housing and other qualifying purposes, where the primary return on investment is in the form of income tax credits (collectively referred to as "tax credit investments"). The Company's investments are primarily accounted for under the equity method and recorded at amortized cost. Amortization is based on the expected performance of the underlying partnership, with amortization recorded as a reduction to net investment income. When the carrying value of an investment exceeds the total amount of remaining tax benefits, the Company records an impairment loss, which is included in other net realized gains (losses) in the consolidated statements of income. For certain partnerships, the Company provides its investment over time, and the present value of any unfunded commitments is included in the asset balance and recorded in other liabilities. Investments in limited partnerships also include alternative investments (private equity and hedge funds) recorded at fair value. The impact of changes in the fair value of alternative investments is recorded in net investment income. The Company elected the fair value option for these investments, regardless of ownership percentage, to standardize the related accounting and reporting. Available-for-Sale Securities The Company classifies its investments in fixed maturities and certain marketable equity securities as available-for-sale and carries them at fair value. Fixed maturities primarily include bonds, mortgage-backed securities and redeemable preferred stock. See Note 7 for information on the valuation of these securities and additional disclosures regarding fair value measurements. The Company reports net unrealized gains (losses) related to its available-for-sale securities in accumulated other comprehensive income (AOCI) in stockholders’ equity, net of related DAC and DSI adjustments and deferred income taxes. The cost of securities sold is determined using the specific-identification method. The Company reports interest and dividends earned, including prepayment fees or interest-related make whole payments, in net investment income. Interest income for fixed maturities is recognized using the effective yield method. For mortgage-backed securities, the Company recognizes income using a constant effective yield based on anticipated prepayments and the estimated economic life of the securities. Quarterly, the Company compares actual prepayments to anticipated prepayments and recalculates the effective yield to reflect actual payments plus anticipated future payments. The Company includes any resulting adjustment in net investment income in the current period. When the collectibility of interest income for fixed maturities is considered doubtful, any accrued but uncollectible interest is deducted from investment income in the current period. The Company then places the securities on nonaccrual status, and they are not restored to accrual status until all delinquent interest and principal are paid. Trading Securities The Company is invested in common stock and, beginning in 2014, exchange-traded funds (ETFs), which are classified as trading. Changes in the fair value of the Company’s trading portfolio are recorded in net realized gains (losses) in the consolidated statements of income. Dividends earned on trading securities are reported in net investment income. Other-Than-Temporary Impairments (OTTI) The Company’s review of available-for-sale investment securities for OTTI includes both quantitative and qualitative criteria. Quantitative criteria include the length of time and amount that each security is in an unrealized loss position (i.e., is underwater) and, for fixed maturities, whether expected future cash flows indicate that a credit loss exists. While all securities are monitored for impairment, the Company’s experience indicates that, under normal market conditions, securities for which the cost or amortized cost exceeds fair value by less than 20% do not typically represent a significant risk of impairment and, often, fair values recover over time as the factors that caused the declines improve. If the estimated fair value has declined and remained below cost or amortized cost by 20% or more for at least six months, the Company further analyzes the decrease in fair value to determine whether it is an other-than-temporary decline. To make this determination for each security, the Company considers, among other factors:
For fixed maturities, the Company concludes that an OTTI has occurred if a security is underwater and there is an intent to sell the security or if the present value of expected cash flows is less than the amortized cost of the security (i.e., a credit loss exists). Where a credit loss exists, the Company isolates the portion of the total unrealized loss related to a credit loss, which is recognized in realized gains (losses) on the consolidated statements of income, and the remainder is recorded as a non-credit OTTI through other comprehensive income. In order to determine the amount of the credit loss, the Company calculates the recovery value by discounting its estimate of future cash flows from the security. The discount rate is the original effective yield for corporate securities or current effective yield for mortgage-backed and other structured securities. Determination of Credit-Related OTTI on Corporate Securities To determine the recovery value for a corporate security, the Company performs an analysis including, but not limited to, the following:
Determination of Credit-Related OTTI on Structured Securities To determine the recovery value for a structured security, including residential mortgage-, commercial mortgage- and other asset-backed securities, the Company performs an analysis including, but not limited to, the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Loans and Leases Receivable, Nonaccrual Loan and Lease Status, Policy | Non-performing loans, defined generally as those in default, close to being in default or more than 90 days past due, are placed on non-accrual status. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Loans and Leases Receivable, Allowance for Loan Losses Policy | In developing its portfolio reserve for incurred but not specifically identified losses, the Company evaluates loans by risk category and considers its past loan experience, commercial real estate market conditions, and third party data for expected losses on loans with similar LTV ratios and DSCRs. Each loan’s LTV ratio and DSCR is updated annually, primarily during the third quarter. In developing its provision for specifically identified loans, a market valuation on the collateral is performed to determine if a reserve is necessary. The allowance for losses on mortgage loans provides for the risk of credit loss inherent in the lending process. The allowance includes a portfolio reserve for probable losses incurred but not specifically identified and, as needed, specific reserves for impaired loans. The allowance for losses on mortgage loans is evaluated at each reporting period and adjustments are recorded when appropriate. To assist in its evaluation of the allowance for loan losses, the Company utilizes the following credit quality indicators to categorize its loans as lower, medium or higher risk:
Loans are specifically evaluated for impairment if the Company considers it probable that amounts due according to the terms of the loan agreement will not be collected, or the loan is modified in a troubled debt restructuring. The Company establishes specific reserves for these loans when the fair value is less than its carrying value. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivatives, Offsetting Fair Value Amounts, Policy | The Company does not offset recognized collateral amounts pledged or received against the fair value amounts recognized for derivative contracts. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivatives, Policy | The Company uses derivative financial instruments to hedge certain portions of its exposure to equity market risk, interest rate risk and foreign currency exchange risk. Derivative financial instruments currently held consist primarily of Standard & Poor’s 500 Index® (S&P 500) options, interest rate swaps, foreign currency swaps and foreign currency forwards. Derivative instruments may be exchange-traded or contracted in the over-the-counter (OTC) market. The Company has established policies for managing its derivatives, including prohibitions on derivatives market-making and other speculative derivatives activities. All of the Company’s derivative financial instruments are individually recognized at fair value as either assets within other invested assets, or liabilities within other liabilities in the consolidated balance sheets. The accounting for changes in the fair value of derivative instruments depends on whether it qualifies and has been designated for hedge accounting. To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and throughout the life of the hedging relationship. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in its fair value are recorded as a component of OCI and reclassified into net income in the same period during which the hedged transaction affects net income. Any hedge ineffectiveness is recorded in the consolidated statements of income within net realized gains (losses). If a derivative instrument does not qualify, or is not designated for hedge accounting, the changes in its fair value are recorded in the consolidated statements of income within net realized gains (losses). The Company prospectively discontinues hedge accounting when: (1) the criteria to qualify for hedge accounting is no longer met (e.g., the derivative is no longer highly effective in offsetting the change in cash flows of a hedged item); (2) the derivative expires, is sold, terminated or exercised; or (3) the derivative is de-designated as a hedging instrument. If it is determined that a derivative no longer qualifies as an effective hedge, the derivative continues to be carried in the consolidated balance sheets at its fair value, with changes in fair value recognized prospectively in income. The Company also issues fixed indexed annuity contracts that contain embedded derivatives, which are recorded at fair value in funds held under deposit contracts in the consolidated balance sheets. In the consolidated balance sheets, the Company recognizes cash collateral received in cash and cash equivalents, and the obligation to return cash collateral in other liabilities. Non-cash collateral received is not recognized in the consolidated balance sheets. In the event of default, the counterparty relinquishes claim to the assets pledged as collateral, and the Company recognizes the collateral as its own asset recorded at fair value, or, in the case of cash collateral, derecognizes its obligation to return collateral. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value of Financial Instruments, Policy | The Company determines the fair value of its financial instruments based on the fair value hierarchy, which favors the use of observable inputs over the use of unobservable inputs when measuring fair value. The Company has categorized its financial instruments into the three-level hierarchy, which gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The level to which a fair value measurement falls is assigned based on the lowest-level input that is significant to the measurement. The fair value measurements for the Company’s financial instruments are categorized as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and cash equivalents consist of demand bank deposits and short-term highly liquid investments with original maturities of three months or less at the time of purchase. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Transfer, Policy | Transfers into and/or out of Level 3 are reported at the value as of the beginning of the period in which the transfer occurs. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Costs, Policy | The Company conducts regular recoverability analyses for its DAC asset balances associated with deferred and immediate annuity, universal life, traditional life, and group life and DI contracts. The Company compares the current DAC asset balances with the estimated present value of future profitability of the underlying business. The DAC asset balances are considered recoverable if the present value of future profits is greater than the current DAC asset balance. The Company defers costs that are directly related to the successful acquisition or renewal of insurance contracts. These primarily include commissions, distribution costs directly related to production, third-party underwriting costs and the portion of salaries and benefits directly related to processing successful new and renewal contracts. All other acquisition-related costs, including costs incurred for soliciting potential customers, managing the distribution and underwriting functions, training, administration, unsuccessful acquisition or renewal efforts, market research and product development are not deferrable and are expensed in the period incurred. The Company amortizes deferred acquisition costs for deferred annuity contracts and universal life insurance policies over the lives of the contracts or policies in proportion to the estimated future gross profits. The Company makes assumptions as to lapse rates, mortality experience, maintenance expenses, crediting rates, and investment performance. Actual profits can vary from the estimates and can thereby result in increases or decreases to DAC amortization. The Company regularly evaluates its assumptions and, when necessary, revises the estimated gross profits of these contracts, resulting in assumption and experience unlocking adjustments to DAC amortization. When such estimates are revised, the impact is recorded in the consolidated statements of income. The Company amortizes acquisition costs for traditional individual life insurance policies over the premium paying period of the related policies, using assumptions consistent with those used in computing policy reserves. The Company amortizes acquisition costs for immediate annuities using a constant yield approach. The Company adjusts the unamortized DAC balance for the effect of net unrealized gains and losses on securities and embedded derivatives as if they had been realized as of the balance sheet date. The Company includes the impact of this adjustment, net of tax, in AOCI. The Company also adjusts its unamortized DAC balance for the effect of realized gains and losses including changes in fair value of the embedded derivatives for the Company's FIA policy assets. These adjustments are recognized in net realized gains (losses) in the consolidated statements of income. For some products, policyholders can elect to modify product benefits, features, rights or coverage by exchanging a contract for a new contract; by amendment, endorsement or rider to a contract; or by election of a feature or coverage within a contract. These transactions are known as internal replacements. If the modification substantially changes the original contract, the remaining DAC balance is immediately written off through earnings and any eligible costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC is retained and amortized over the life of the modified contract and any acquisition costs associated with the related modification are expensed as incurred. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sales Inducements to Contract Holders, Policy | The Company offers sales inducements on certain deferred annuity contracts and universal life policies. For certain deferred annuity contracts, the inducement entitles the contract holder to an incremental amount of interest that is credited to the account value over a 12- to 60-month period following the initial deposit, depending on the product. The incremental interest causes the initial credited rate to be higher than the contract’s expected ongoing crediting rates for periods after the inducement. For certain universal life policies, the inducement provides an immediate increment to the policyholder’s account value at the issue date or time of deposit. Deferred sales inducements are included in receivables and other assets and amortized into interest credited using the same methodology and assumptions used to amortize DAC. Similar to DAC, the Company amortizes deferred sales inducements for deferred annuity contracts and universal life insurance policies over the lives of the contracts or policies in proportion to the estimated future gross profits. The Company makes assumptions as to lapse rates, mortality experience, maintenance expenses, crediting rates, and investment performance. Actual profits can vary from the estimates and can thereby result in increases or decreases to DSI amortization. The Company regularly evaluates its assumptions and, when necessary, revises the estimated gross profits of these contracts, resulting in assumption and experience unlocking adjustments to DSI amortization. When such estimates are revised, the impact is recorded in the consolidated statements of income. Deferred sales inducement balances are subject to regular recoverability testing to ensure that capitalized amounts do not exceed the present value of estimated gross profits. As of December 31, 2014 and 2013, all of the deferred sales inducement balances were considered recoverable. The Company adjusts the unamortized DSI balance for the effect of net unrealized gains and losses on securities as if they had been realized as of the balance sheet date. The Company includes the impact of this adjustment, net of tax, in AOCI. The Company also adjusts its unamortized DSI balance for the effect of realized gains and losses. These adjustments are recognized in net realized gains (losses) in the consolidated statements of income. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | The Company accounts for stock-based compensation based on the grant-date fair value of the awards. Compensation expense for these awards is recognized over the requisite service period, using the straight-line method. Restricted shares are valued based on the number of shares granted and the Company’s closing stock price on the grant date. The Company recognizes such compensation cost as expense over the service period (generally three years), net of estimated forfeitures, using the straight-line method. Many factors are considered when estimating forfeitures, including types of awards, employee class and historical experience. The estimation of equity awards that will ultimately vest requires judgment, and to the extent actual results or future estimates differ from current estimates, the Company records a cumulative adjustment in the period that the estimates are revised. The Company measures compensation cost for stock awards at fair value on the grant date and recognizes such cost, net of estimated forfeitures, over the requisite service period (generally seven years). Stock options are valued using the Black-Scholes valuation model. The value of each performance unit is determined at the discretion of the Company’s board of directors based on the success of the Company over a three-year period. These are accounted for as liability awards, as the Company intends or is required to settle such awards in cash. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Accounting Policy | The Company remains liable to its policyholders to the extent that counterparties to reinsurance contracts do not meet their contractual obligations. Accordingly, the future policy benefit reserves and policy and contract claims liabilities are reported gross of any related reinsurance recoverables, which are reported as assets. The Company reports premiums, benefits, and settlement expenses net of reinsurance in the consolidated statements of income. The Company accounts for reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsured business on bases consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. The Company reinsures portions of its insurance risk, primarily in the Individual Life and Benefits segments, in order to spread risk, limit losses and minimize exposure to significant risks. Beginning in 2014, we also utilize inter-company reinsurance agreements to manage our statutory capital position. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Unpaid Policy Claims and Claims Adjustment Expense, Policy | Liabilities for policy and contract claims, which primarily represent liabilities for claims under medical stop-loss and individual life policies, are established on the basis of reported losses. The Company also provides for claims incurred but not reported (IBNR). For medical stop-loss policies, this is based on expected loss ratios, claims paying completion patterns and historical experience. If expected loss ratios increase or expected claims paying completion patterns extend, the IBNR claim liability increases. The Company reviews estimates for reported but unpaid claims and IBNR claims quarterly. Any necessary adjustments are reflected in earnings. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax, Policy | Deferred tax assets are recognized only to the extent that it is more likely than not that future taxable profits will be available, and a valuation allowance is established where deferred tax assets cannot be recognized. The Company includes penalties and interest accrued related to unrecognized tax benefits in the calculation of income tax expense. Income taxes have been determined using the liability method. The provision for income taxes has two components: amounts currently payable or receivable and deferred income taxes. The deferred income taxes are calculated as the difference between the book and tax bases of the appropriate assets and liabilities and are measured using enacted tax rates. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting, Policy | The Company's operations are managed separately as three divisions, consisting of four business segments based on product groupings, and a fifth reportable segment consisting primarily of unallocated corporate items and surplus investment income. The five segments are Benefits, Deferred Annuities, Income Annuities, Individual Life and Other, described further below. The primary profitability measure that management uses to manage business segment results is pre-tax adjusted operating income (loss). Pre-tax adjusted operating income is defined as income from operations, excluding net realized gains (losses) that are not reflective of the performance of the Company's insurance operations. Excluded gains (losses) are associated with investment sales or disposal, other-than-temporary investment impairments, changes in the fair value of mark-to-market investments and derivative investments (except for certain S&P 500 options discussed below) and changes in the fair value of embedded derivatives related to the Company's FIA product. In the Deferred Annuities segment, certain net gains (losses) related to FIA products sold in the late 1990s are considered related to the performance of insurance operations and included in the pre-tax adjusted operating income. These products credit interest to policyholder accounts based on equity market performance, which is recorded in interest credited. The Company purchases S&P 500 options to economically hedge exposure to this block of business, which are not designated for hedge accounting. Any realized gains from these options are used to meet policyholder obligations. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). No definition available.
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for offsetting or not offsetting fair value amounts recognized for derivative instruments against such amounts recognized for the right to reclaim cash collateral (a receivable) or the obligation to return cash collateral (a payable) arising from derivative instruments recognized at fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for its derivative instruments and hedging activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for determining the fair value of financial instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for determining when transfers between levels are recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for an insurance entity's net liability for future benefits (for example, death, cash surrender value) to be paid to or on behalf of policyholders, describing the bases, methodologies and components of the reserve, and assumptions regarding estimates of expected investment yields, mortality, morbidity, terminations and expenses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for premium revenue recognition, including the basis for measurement and the timing of recognition of revenue from insurance premiums received from contract holders. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for estimating the allowance for losses on loans and lease receivables. The disclosure may include (a) how the entity determines each element of the allowance, (b) which loans are evaluated individually and which loans are evaluated as a group, (c) how the entity determines both the allocated and unallocated portions of the allowance, (d) how the entity determines the loss factors applied to graded loans in order to develop a general allowance, and (e) what self-correcting mechanism the entity uses to reduce differences between estimated and actual losses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for when a loan ceases to accrue interest or other revenue because the borrower is in financial difficulty. May also describe the treatment of previously earned but uncollected interest income on loans in nonaccrual status, how cash received from borrowers is recorded on loans that are in nonaccrual status, and the policy for resuming accrual of interest. Also includes the policy for charging off uncollectible loans and trade receivables, and the policy for determining past-due or delinquency status (i.e. whether past-due status is based on how recently payments have been received or on contractual terms). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for sales inducements, including the yield enhancement features, such as interest credits and bonuses, given to motivate purchases of insurance products, and description of the nature of the costs deferred and the method for amortizing such deferred costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for segment reporting. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Earnings Per Share (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Earnings Per Share, Basic And Diluted | The following table presents information relating to the Company’s calculations of basic and diluted earnings per share:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Investments (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary Of Available-For-Sale Fixed Maturities And Marketable Equity Securities | The following tables summarize the Company’s available-for-sale fixed maturities and marketable equity securities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedules of Corporate Securities Portfolio by Sector | The following table presents the composition of the Company’s corporate securities portfolio by sector:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary Of Gross Unrealized Losses And Fair Values Of Investments Available-For-Sale | The following tables summarize gross unrealized losses and fair values of the Company’s available-for-sale investments. The tables are aggregated by investment category and present separately those securities that have been in a continuous unrealized loss position for less than twelve months and for twelve months or more.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary Of Contractual Years To Maturity | The following table summarizes the amortized cost and fair value of fixed maturities as of December 31, 2014, by contractual years to maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary Of Net Investment Income | The following table summarizes the Company’s net investment income:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary Of Net Realized Gains (Losses) | The following table summarizes the Company’s net realized gains (losses):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary Of Other Than Temporary Impairment Losses By Industry | The largest write-downs recorded through net realized gains (losses) on fixed maturities were related to investments in the following sectors:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Severity And Duration Of Gross Unrealized Losses On Underwater Available-For-Sale Securities | The following table presents the severity and duration of the gross unrealized losses on the Company’s underwater available-for-sale fixed maturities, after the recognition of OTTI:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Changes In The Amount Of Credit-Related OTTI Recognized In Net Income | Changes in the amount of credit-related OTTI recognized in net income where the portion related to other factors was recognized in other comprehensive income (OCI) were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Definition
Tabular disclosure of the severity and duration of gross unrealized losses on underwater available for sale securities. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of other-than-temporary impairments on fixed maturities recorded during the period, by industry sector. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the amount of other than temporary impairment (OTTI) related to credit losses recognized in earnings including: (a) the beginning balance of the amount related to credit losses on debt securities held by the investor at the beginning of the period for which a portion of an OTTI was recognized in other comprehensive income; (b) additions for the amount related to the credit loss for which an OTTI was not previously recognized; (c) reductions for securities sold during the period (realized); (d) reductions for securities for which the amount previously recognized in other comprehensive income was recognized in earnings because the investor intends to sell the security or more likely than not will be required to sell the security before recovery of its amortized cost basis; (e) additional increases to the amount related to the credit loss for which an OTTI was previously recognized when the investor does not intend to sell the security and it is not more likely than not that the investor will be required to sell the security before recovery of its amortized cost basis; (f) reductions for increases in cash flows expected to be collected that are recognized over the remaining life of the security; and (g) the ending balance of the amount related to credit losses on debt securities held by the entity at the end of the period for which a portion of an OTTI was recognized in other comprehensive income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure of realized gains and losses on investments reported in the statement of income. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. No definition available.
|
| X | ||||||||||
|
- Definition
For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Mortgage Loans (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mortgage Loans on Real Estate [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Mortgage Loans By Risk Category | The following table sets forth the Company’s mortgage loans by risk category:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Allowance For Mortgage Loan Losses | The following table summarizes the activity in the Company’s allowance for mortgage loan losses, which includes portfolio and specific reserves:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Definition
Tabular disclosure of financing receivables (examples of financing receivables include loans, trade accounts receivable and notes receivable) and activity in the allowance for credit losses account. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Derivative Instruments (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] | The following table sets forth the fair value of the Company’s derivative instruments. In the consolidated balance sheets, derivative contracts in an asset position are included in other invested assets, derivative contracts in a liability position are included in other liabilities, and embedded derivative liabilities are included in funds held under deposit contracts.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting Assets [Table Text Block] |
The following tables present the potential effect of netting arrangements by counterparty on the Company’s consolidated balance sheets:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting Liabilities [Table Text Block] |
(1) Excludes $92.1 of embedded derivatives which have no counterparty.
(1) Excludes $230.1 of embedded derivatives which have no counterparty. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments, Gain (Loss) [Table Text Block] | The following table presents the amount of gain (loss) recognized in OCI on derivatives that qualify as cash flow hedges:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivatives Not Designated as Hedges | The following table shows the effect of derivatives not designated as hedges in the consolidated statements of income, which is recorded in net realized gains (losses):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure for other derivative instruments not designated as hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Fair Value Of Financial Instruments (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Assets And Liabilities Accounted For At Fair Value On A Recurring Basis | The following tables present the fair value of the Company’s financial instruments classified by the valuation hierarchy described above. The financial instruments are separated between those measured at fair value on a recurring basis and those not carried at fair value, but for which disclosure of fair value is required.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Additional Information About Composition Of Level 2 Corporate Securities | The following table presents additional information about the composition of the Level 2 corporate securities:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Additional Information About Composition Of Level 2 Non-Agency RMBS Securities | The following table presents additional information about the composition of the Level 2 non-agency RMBS securities:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Additional Information About Composition Of Level Two Cmbs Securities | The following table presents additional information about the composition of the underlying collateral of Level 2 non-agency CMBS securities:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Additional Information About Level 3 Assets and Liabilities Measured At Fair Value On A Recurring Basis | The following tables present additional information about financial instruments measured at fair value on a recurring basis and for which the Company has utilized significant unobservable inputs (Level 3) to determine fair value for the years ended December 31, 2014 and 2013:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Definition
Tabular disclosure of the fair value measurement of assets and liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings are reported in the statement of income; (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of additional information about the composition of underlying collateral of level 2 CMBS securities. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of additional information about the composition of level 2 corporate securities, including significant sectors, weighted-average coupon rate, and weighted-average remaining years to contractual maturity. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of additional information about composition of level 2 non-agency RMBS securities. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Deferred Policy Acquisition Costs (DAC) and Deferred Sales Inducements (DSI) (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Cost Deferred Sales Inducement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Reconciliation For Deferred Policy Acquisition Costs | The following table provides a reconciliation of the beginning and ending balance for DAC:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Reconciliation For Deferred Sales Inducements | The following table provides a reconciliation of the beginning and ending balance for DSI, which is included in receivables and other assets in the consolidated balance sheets. DSI amortization is included in interest credited in the consolidated statements of income.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the movement in deferred policy acquisition costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the change in deferred sales inducements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Stockholders' Equity (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Components and Reclassifications Out Of AOCI | The following tables summarize the components of AOCI and the adjustments to OCI for amounts reclassified from AOCI into net income for the years ended December 31, 2014, 2013 and 2012:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Reconciliation Of Changes In Outstanding Shares Of Common Stock | The following table provides a reconciliation of changes in outstanding shares of common stock:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary Of Restricted Stock Activity | The following table summarizes the Company’s restricted share activity for the year ended December 31, 2014:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss). No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the change in common stock outstanding. No definition available.
|
| X | ||||||||||
|
- Definition
Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. No definition available.
|
|
Reinsurance (Tables)
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Net Life Insurance In Force | The following table sets forth net life insurance in force:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Reinsurance Recoverables | Reinsurance recoverables are composed of the following amounts:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Effect Of Reinsurance on Premiums Policy Fees Contract Charges and Other | The following table sets forth the effect of reinsurance on premiums and policy fees and contract charges. It is disaggregated by accident and health and life insurance products, which are short- and long-duration contracts, respectively.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Definition
Tabular disclosure of the effect of reinsurance on premiums, policy fees and contract charges. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the schedule of net life insurance in force, including amounts assumed from and ceded to other companies. No definition available.
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the schedule of reinsurance recoverables for life insurance and accidental and health insurance. No definition available.
|
| X | ||||||||||
|
- Details
|
|
Liability for Unpaid Claims and Claim Adjustment Expenses (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | The following table provides a reconciliation of the beginning and ending liability balances for unpaid claims and claims adjustment expenses. These reserves include policy and contract claims and certain amounts recorded in future policy benefits on the consolidated balance sheets.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Income Taxes (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Effective Income Tax Rate Reconciliation | Differences between income taxes computed by applying the U.S. federal income tax rate of 35% to income from operations before income taxes and the provision for income taxes were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Deferred Tax Assets and Liabilities | The tax effects of temporary differences that gave rise to the deferred income tax assets and liabilities were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Commitments And Contingencies Commitments And Contingencies (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||
| Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] | Future minimum lease commitments, including cost escalation clauses, for the next five years and thereafter are as follows:
|
||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Statutory-Basis Information (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of statutory net income and statutory capital and surplus [Table Text Block] | The statutory net income and statutory capital and surplus for the Company’s insurance company subsidiaries are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Definition
[Table Text Block] for Schedule of statutory net income and statutory capital and surplus [Table] No definition available.
|
| X | ||||||||||
|
- Details
|
|
Segment Information (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Financial Information By Segment And Reconciliation Of Segment Pre-Tax Adjusted Operating Income (Loss) | The following tables present selected financial information by segment and reconcile segment pre-tax adjusted operating income (loss) to amounts reported in the consolidated statements of income:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Schedule Of Quarterly Results Of Operations (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quarterly Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Quarterly Financial Information | The unaudited quarterly results of operations for years ended December 31, 2014 and 2013 are summarized in the table below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Description of Business Description of Business (Details) (USD $)
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
| Common stock, shares authorized | 750,000,000 | 750,000,000 |
| Common stock, par value | $ 0.01 | $ 0.01 |
| Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
| Preferred stock, par value | $ 0.01 | $ 0.01 |
| X | ||||||||||
|
- Definition
Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Summary Of Significant Accounting Policies Summary Of Significant Accounting Policies (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Amortized cost | $ 23,759.4 | $ 22,390.3 |
| Maximum loss exposure amount related to VIEs | 327.1 | 316.4 |
| Weighted average implied interest rate | 5.62% | |
| Expected weighted-average implied interest rate on SPIAs | 6.35% | |
| Years to grade to expected weighted-average implied interest rate for SPIAs | 20 years | |
|
Mortgage Backed Securities [Member]
|
||
| Amortized cost | $ 4,569.4 | $ 4,571.5 |
| X | ||||||||||
|
- Definition
The expected weighted average implied interest rate on the existing book of business related to single premium immediate annuities (SPIAs) based on the pattern set at contract issuance. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average implied interest rate on the existing book of business related to single premium immediate annuities (SPIAs) used to calculate the reserves. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of time lapsed to reach the expected weighted average implied interest rate on the existing book of business related to single premium immediate annuities (SPIAs). No definition available.
|
| X | ||||||||||
|
- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Earnings Per Share (Details) (USD $)
In Millions, except Share data, unless otherwise specified |
3 Months Ended | 12 Months Ended | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Sep. 30, 2014
|
Jun. 30, 2014
|
Mar. 31, 2014
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|||||||||||
| Earnings Per Share [Abstract] | |||||||||||||||||||||
| Antidilutive securities excluded from computation of earnings per share | 2,650,000 | 2,650,000 | 2,650,000 | ||||||||||||||||||
| Common Shares Attributable To Warrants | 18,975,744 | 18,975,744 | |||||||||||||||||||
| Net income | $ 67.6 | $ 36.0 | $ 71.5 | $ 79.3 | $ 64.4 | $ 45.3 | $ 45.0 | $ 66.0 | $ 254.4 | $ 220.7 | $ 205.4 | ||||||||||
| Weighted-average common shares outstanding — basic | 116,306,640 | 126,609,326 | 138,018,424 | ||||||||||||||||||
| Add: dilutive effect of certain equity instruments | 3,564 | 4,259 | 5,557 | ||||||||||||||||||
| Weighted-average common shares outstanding — diluted | 116,310,204 | 126,613,585 | 138,023,981 | ||||||||||||||||||
| Basic | $ 0.58 | [1] | $ 0.31 | [1] | $ 0.62 | [1] | $ 0.68 | [1] | $ 0.55 | [1] | $ 0.38 | [1] | $ 0.34 | [1] | $ 0.48 | [1] | $ 2.19 | $ 1.74 | $ 1.49 | ||
| Diluted | $ 0.58 | [1] | $ 0.31 | [1] | $ 0.62 | [1] | $ 0.68 | [1] | $ 0.55 | [1] | $ 0.38 | [1] | $ 0.34 | [1] | $ 0.48 | [1] | $ 2.19 | $ 1.74 | $ 1.49 | ||
|
|||||||||||||||||||||
| X | ||||||||||
|
- Definition
Potential common stock securities that are included in weighted average common shares outstanding for the period the securities were outstanding, for purposes of computing basic and diluted earnings per share using the two-class method. No definition available.
|
| X | ||||||||||
|
- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Investments (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Investment [Line Items] | ||
| Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax | $ 1.0 | $ 0.6 |
| Marketable equity securities, available-for-sale | 120.5 | 134.3 |
| Total fixed maturities | 25,379.4 | 23,337.7 |
| Fixed maturities, at amortized cost | 23,646.5 | 22,261.3 |
| Threshold Percentage Used To Determine Significant Risk Of Impairment | 20.00% | |
|
Total Underwater By 20% Or More [Member]
|
||
| Investment [Line Items] | ||
| Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax | 0.2 | 0 |
| Marketable equity securities, available-for-sale | 0.7 | 0 |
| Total fixed maturities | 43.0 | 60.0 |
|
External Credit Rating, Non Investment Grade [Member]
|
||
| Investment [Line Items] | ||
| Total fixed maturities | 1,126.6 | 1,267.5 |
| Fixed maturities, at amortized cost | $ 1,111.9 | $ 1,229.7 |
| Percentage of below-investment grade fixed maturities at fair value | 4.40% | 5.50% |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The percentage of below-investment grade fixed maturities at fair value, based on National Association of Insurance Commissioners ratings. No definition available.
|
| X | ||||||||||
|
- Definition
Based on the unrealized loss relative to amortized cost, the threshold percentage used to determine whether a security has a significant risk of impairment. No definition available.
|
| X | ||||||||||
|
- Definition
This item represents the cost of debt securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of equity securities categorized neither as held-to-maturity nor as trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt securities classified as available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt securities classified as available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the cost of debt securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the cost of equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments for other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of equity securities categorized neither as held-to-maturity nor as trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Investments Investments (Schedule Of Corporate Securities Portfolio By Sector) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Investment [Line Items] | ||
| Fair Value | $ 25,379.4 | $ 23,337.7 |
|
Industrial Sector [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 3,468.3 | 3,237.2 |
| Percentage of Total | 18.10% | 18.70% |
|
Consumer Staples Sector [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 2,861.5 | 2,681.5 |
| Percentage of Total | 14.90% | 15.50% |
|
Consumer Discretionary Sector [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 2,409.3 | 2,184.7 |
| Percentage of Total | 12.60% | 12.60% |
|
Health care [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 2,210.1 | 1,707.8 |
| Percentage of Total | 11.50% | 9.80% |
|
Utilities Sector [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 2,139.6 | 1,917.7 |
| Percentage of Total | 11.10% | 11.10% |
|
Financial Sector [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 2,042.2 | 1,819.2 |
| Percentage of Total | 10.60% | 10.50% |
|
Other Sector [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 4,061.5 | 3,804.3 |
| Percentage of Total | 21.20% | 21.80% |
|
Corporate Securities [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | $ 19,192.5 | $ 17,352.4 |
| Percentage of Total | 100.00% | 100.00% |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Percentage of investments in corporate fixed maturity securities at fair value. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for twelve months or longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for less than twelve months. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for less than twelve months. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for twelve months or longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of investment positions in available-for-sale investments that have been in a continuous unrealized loss position for greater than or equal to a year for which an other-than-temporary impairment (OTTI) has not been recognized in the income statement. No definition available.
|
| X | ||||||||||
|
- Definition
Number of investment positions in available-for-sale investments in a continuous unrealized loss position for less than one year or normal operating cycle, if longer, for which an other-than-temporary impairment (OTTI) has not been recognized in the income statement. No definition available.
|
|
Investments (Summary Of Contractual Years To Maturity) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Amortized Cost | ||
| One year or less | $ 810.9 | |
| Over one year through five years | 5,424.8 | |
| Over five years through ten years | 9,058.0 | |
| Over ten years | 3,783.4 | |
| Cost or Amortized cost | 23,646.5 | 22,261.3 |
| Fair Value | ||
| One year or less | 816.9 | |
| Over one year through five years | 5,836.5 | |
| Over five years through ten years | 9,402.9 | |
| Over ten years | 4,494.7 | |
| Total fixed maturities | 25,379.4 | 23,337.7 |
|
Residential Mortgage-Backed Securities [Member]
|
||
| Amortized Cost | ||
| Cost or Amortized cost | 2,772.0 | 2,678.3 |
| Fair Value | ||
| Total fixed maturities | 2,921.4 | 2,756.0 |
|
Commercial Mortgage-Backed Securities [Member]
|
||
| Amortized Cost | ||
| Cost or Amortized cost | 1,262.6 | 1,436.0 |
| Fair Value | ||
| Total fixed maturities | 1,333.9 | 1,518.4 |
|
Other asset-backed securities [Member]
|
||
| Amortized Cost | ||
| Cost or Amortized cost | 534.8 | |
| Fair Value | ||
| Total fixed maturities | $ 573.1 |
| X | ||||||||||
|
- Definition
This item represents the cost of debt securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after adjustments of available-for-sale debt securities at cost, maturing in the sixth fiscal year through the tenth fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings less cumulative-effect adjustments, and fair value hedge accounting adjustments. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value of available-for-sale debt securities maturing in the sixth fiscal year through the tenth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after adjustments of available-for-sale debt securities at cost, maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings less cumulative-effect adjustments, and fair value hedge accounting adjustments. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value of available-for-sale debt securities maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after adjustments of available-for-sale debt securities at cost, maturing after the tenth fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings less cumulative-effect adjustments, and fair value hedge accounting adjustments. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value of available-for-sale debt securities maturing after the tenth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount after adjustments of available-for-sale debt securities at cost, maturing in the next fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings less cumulative-effect adjustments, and fair value hedge accounting adjustments. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value of available-for-sale debt securities maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Investments (Summary Of Net Investment Income) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Investment [Line Items] | |||
| Total investment income | $ 1,354.2 | $ 1,315.6 | $ 1,303.2 |
| Investment expenses | (33.7) | (30.6) | (28.0) |
| Net investment income | 1,320.5 | 1,285.0 | 1,275.2 |
|
Fixed Maturities [Member]
|
|||
| Investment [Line Items] | |||
| Total investment income | 1,136.7 | 1,117.2 | 1,124.7 |
|
Mortgage Loans [Member]
|
|||
| Investment [Line Items] | |||
| Total investment income | 215.7 | 190.2 | 172.0 |
|
Policy Loans [Member]
|
|||
| Investment [Line Items] | |||
| Total investment income | 3.5 | 3.7 | 3.9 |
|
Other Investments [Member]
|
|||
| Investment [Line Items] | |||
| Total investment income | 4.4 | 4.3 | 5.3 |
|
Marketable Equity Securities, Available-For-Sale Securities [Member]
|
|||
| Investment [Line Items] | |||
| Total investment income | 5.2 | 3.8 | 3.4 |
|
Marketable Equity Securities, Trading [Member]
|
|||
| Investment [Line Items] | |||
| Total investment income | 12.6 | 12.9 | 13.1 |
|
Investment In Limited Partnerships [Member]
|
|||
| Investment [Line Items] | |||
| Total investment income | $ (23.9) | $ (16.5) | $ (19.2) |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The income earned from investments in securities and property, equipment and other capital assets, excluding investment expenses. It includes rent from property and equipment, dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities, excluding investment expenses. It does not include realized gains and losses on investments. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of expenses related to the generation of investment income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Investments (Summary Of Net Realized Gains (Losses)) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
||||||||||
| Investment [Line Items] | ||||||||||||
| Net impairment losses recognized in earnings | $ (14.1) | $ (18.3) | $ (29.0) | |||||||||
| Net realized gains (losses) | 42.4 | 35.6 | 31.1 | |||||||||
| Net realized gain loss other investments | (14.1) | [1] | (4.1) | [1] | (7.8) | [1] | ||||||
| DAC and DSI adjustment | 1.5 | 2.7 | 0.7 | |||||||||
| Gain (loss) on changes in fair value of trading securities | 32.3 | 41.1 | 37.7 | |||||||||
|
Fixed Maturities [Member]
|
||||||||||||
| Investment [Line Items] | ||||||||||||
| Gross gains on sales | 27.6 | 11.7 | 54.3 | |||||||||
| Gross losses on sales | (6.8) | (20.0) | (27.0) | |||||||||
| Net impairment losses recognized in earnings | (14.1) | (18.3) | (29.0) | |||||||||
| Other | (7.4) | [2] | (2.4) | [2] | 3.2 | [2] | ||||||
| Net realized gains (losses) | (0.7) | (29.0) | 1.5 | |||||||||
|
Trading Securities [Member]
|
||||||||||||
| Investment [Line Items] | ||||||||||||
| Net realized gains (losses) | $ 55.7 | [3] | $ 66.0 | [3] | $ 36.7 | [3] | ||||||
|
||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Represents other net gains (losses), which includes calls and redemptions, and changes in fair value of the entity's convertible fixed maturities held as of period end. No definition available.
|
| X | ||||||||||
|
- Definition
The adjustment to the entity's net realized investment gains (losses) for deferred policy acquisition costs and deferred sales inducements. No definition available.
|
| X | ||||||||||
|
- Definition
This item represents the net realized gains (losses) on other investments. No definition available.
|
| X | ||||||||||
|
- Definition
This item represents the gross profit realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the gross loss realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of other than temporary impairment losses on investments in debt and equity securities categorized as Available-for-sale which have been recognized in earnings during the period. Such impairment losses consist of other than temporary impairments (OTTI) on equity securities, credit losses on investments in debt securities, and when the entity intends to sell an impaired debt security or it is more likely than not that the entity will be required to sell the impaired debt security before recovery of its amortized cost basis. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of unrealized holding gain (loss) recognized in the income statement for investments in debt and equity securities and other forms of securities that provide ownership interests classified as trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The percentage of other than temporary impairment charges on investments. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of other than temporary impairment (OTTI) losses on equity securities, OTTI related to credit losses on debt securities, and OTTI losses on debt securities when the entity intends to sell the securities or it is more likely than not that the entity will be required to sell the securities before recovery of its amortized cost basis. Additionally, this item includes OTTI losses recognized during the period on investments accounted for under the cost method of accounting. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of other than temporary impairment losses on investments in debt and equity securities categorized as Available-for-sale which have been recognized in earnings during the period. Such impairment losses consist of other than temporary impairments (OTTI) on equity securities, credit losses on investments in debt securities, and when the entity intends to sell an impaired debt security or it is more likely than not that the entity will be required to sell the impaired debt security before recovery of its amortized cost basis. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Investments (Schedule Of Severity And Duration Of The Gross Unrealized Losses On Securities Available-For-Sale) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Investment [Line Items] | ||
| Fair Value | $ 25,379.4 | $ 23,337.7 |
| Gross Unrealized Losses | (98.2) | (276.2) |
|
Underwater By 20% Or More, Less Than 6 Consecutive Months [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 38.5 | 33.3 |
| Gross Unrealized Losses | (17.3) | (12.3) |
|
Underwater By 20% Or More, 6 Consecutive Months Or More [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 4.5 | 26.7 |
| Gross Unrealized Losses | (2.8) | (18.4) |
|
Total Underwater By 20% Or More [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 43.0 | 60.0 |
| Gross Unrealized Losses | (20.1) | (30.7) |
|
All Other Underwater Fixed Maturities [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 3,168.5 | 5,372.9 |
| Gross Unrealized Losses | (78.1) | (245.5) |
|
Total Underwater Fixed Maturities [Member]
|
||
| Investment [Line Items] | ||
| Fair Value | 3,211.5 | 5,432.9 |
| Gross Unrealized Losses | $ (98.2) | $ (276.2) |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt securities classified as available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Investments (Schedule Of Changes In The Amount Of Credit-Related OTTI Recognized In Net Income) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
||||||
| Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward] | ||||||||
| Balance, beginning of period | $ 23.1 | $ 36.2 | $ 32.5 | |||||
| Increases recognized in the current period: | ||||||||
| For which an OTTI was not previously recognized | 1.1 | 2.9 | 10.0 | |||||
| For which an OTTI was previously recognized | 1.8 | 2.7 | 2.1 | |||||
| Decreases attributable to: | ||||||||
| Securities sold or paid down during the period | (5.8) | (18.7) | (6.9) | |||||
| Previously recognized credit losses on securities impaired during the period due to a change in intent to sell (1) | (0.1) | [1] | 0 | [1] | (1.5) | [1] | ||
| Balance, end of period | $ 20.1 | $ 23.1 | $ 36.2 | |||||
|
||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
This item represents an increase to the cumulative amount of credit losses recognized in earnings for an other than temporary impairment (OTTI) of a debt security held for which a previous OTTI was recognized and the investor does not intend to sell the debt security and it is not more likely than not that the investor will be required to sell the debt security before recovery of its amortized cost basis. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents an increase to the cumulative amount of credit losses recognized in earnings for an other than temporary impairment (OTTI) of a debt security held for which no such other than temporary impairment (OTTI) was previously recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cumulative amount of credit losses recognized in earnings related to debt securities held for which a portion of an other than temporary impairment (OTTI) was recognized in other comprehensive income (a component of shareholders' equity). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents reductions in the amount of cumulative losses recognized in earnings for other than temporary impairments (OTTI) for which a portion of the impairment had been recognized in other comprehensive income (a component of shareholders' equity) due to a change in status of the impaired security because of a change in the entity's intent to either sell the impaired security or it has become more likely than not that the entity will be required to sell the security before recovery of its cost basis. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents reductions in the cumulative amount of credit losses recognized in earnings for an other than temporary impairment (OTTI) of a debt security because of the sale of impaired securities during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Mortgage Loans (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
loans
|
Dec. 31, 2013
loans
|
|
| Mortgage Loans on Real Estate [Line Items] | ||
| Days to consider loans as nonperforming | 90 days | |
| Number of nonperforming loans | 1 | 0 |
| Outstanding principal balance of nonperforming loans | $ 1.5 | |
|
California [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Percentage of mortgage loan portfolio | 29.10% | |
|
Texas [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Percentage of mortgage loan portfolio | 10.80% | |
|
Washington [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Percentage of mortgage loan portfolio | 8.40% | |
|
Risk Level Medium [Member] | Minimum [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Loan to value ratio | 65.00% | |
|
Risk Level Medium [Member] | Maximum [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Loan to value ratio | 80.00% | |
|
Risk Level High [Member] | Minimum [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Loan to value ratio | 65.00% | |
|
Risk Level High [Member] | Maximum [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Loan to value ratio | 80.00% | |
|
Less Than [Member] | Risk Level Low [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Loan to value ratio | 65.00% | |
|
Less Than [Member] | Risk Level Medium [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Loan to value ratio | 65.00% | |
| Debt-service coverage ratio | 150.00% | |
|
Less Than [Member] | Risk Level High [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Debt-service coverage ratio | 150.00% | |
|
Greater Than [Member] | Risk Level Low [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Debt-service coverage ratio | 150.00% | |
|
Greater Than [Member] | Risk Level Medium [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Debt-service coverage ratio | 150.00% | |
|
Greater Than [Member] | Risk Level High [Member]
|
||
| Mortgage Loans on Real Estate [Line Items] | ||
| Loan to value ratio | 80.00% |
| X | ||||||||||
|
- Definition
The number of days after which the entity considers a loan nonperforming and places it on nonaccrual status. No definition available.
|
| X | ||||||||||
|
- Definition
The debt service coverage ratio represents the amount of rental income a property is generating to the amount of mortgage payments due on the property and is used by the entity as an indicator of credit quality. Loan products with high debt service coverage ratio are generally considered higher quality. No definition available.
|
| X | ||||||||||
|
- Definition
Loan-to-value represents the ratio of appraised value of the collateralized assets to the outstanding loan balance borrowed by the debtor and is used by the entity as an indicator of credit quality. Loan products with low loan-to-value ratio are generally considered higher quality. No definition available.
|
| X | ||||||||||
|
- Definition
The number of loans that are nonperforming during the period. No definition available.
|
| X | ||||||||||
|
- Definition
The percentage of the entity's mortgage loan portfolio by geographic region. No definition available.
|
| X | ||||||||||
|
- Definition
Reflects the carrying amount of loans deemed to be questionable as to collection on which no interest is continuing to be recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Mortgage Loans (Mortgage Loans By Risk Category) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
||||||
|---|---|---|---|---|---|---|---|---|
| Mortgage Loans on Real Estate [Line Items] | ||||||||
| Other, Carrying Value | $ (4.4) | [1] | $ (5.9) | [1] | ||||
| Carrying Value | 4,130.1 | 3,541.0 | ||||||
| Reserve on specifically evaluated mortgage loans | 0.2 | 0.2 | ||||||
|
Risk Level Low [Member]
|
||||||||
| Mortgage Loans on Real Estate [Line Items] | ||||||||
| Carrying Value | 2,567.0 | 2,195.1 | ||||||
| % of Total | 62.10% | 61.90% | ||||||
|
Risk Level Medium [Member]
|
||||||||
| Mortgage Loans on Real Estate [Line Items] | ||||||||
| Carrying Value | 994.2 | 843.5 | ||||||
| % of Total | 24.10% | 23.80% | ||||||
|
Risk Level High [Member]
|
||||||||
| Mortgage Loans on Real Estate [Line Items] | ||||||||
| Carrying Value | 571.3 | 506.3 | ||||||
| % of Total | 13.80% | 14.30% | ||||||
|
Credit Quality Indicator Total [Member]
|
||||||||
| Mortgage Loans on Real Estate [Line Items] | ||||||||
| Carrying Value | 4,132.5 | 3,544.9 | ||||||
| % of Total | 100.00% | 100.00% | ||||||
|
Loans Specifically Evaluated For Impairment [Member]
|
||||||||
| Mortgage Loans on Real Estate [Line Items] | ||||||||
| Carrying Value | $ 2.0 | [2] | $ 2.0 | [2] | ||||
|
||||||||
| X | ||||||||||
|
- Definition
Represents the sum of the allowance for loan losses offset by deferred fees and costs for mortgage loans on real estate. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of the entity's mortgage loan portfolio within a specified risk category represented as a percentage of total loans subject to credit quality indicators. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of valuation allowance for financing receivables that are expected to be uncollectible that were individually evaluated for impairment. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The carrying amount of the outstanding balance due under the mortgage loan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Mortgage Loans (Allowance For Mortgage Loan Losses) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Allowance for Mortgage Loan Losses [Roll Forward] | |||
| Allowance at beginning of period | $ 8.1 | $ 7.9 | $ 7.4 |
| Provision for specific loans | 0 | 0.2 | 1.9 |
| Provision for loans not specifically identified | 0 | 0 | 0.8 |
| Charge-offs | 0 | 0 | (2.2) |
| Allowance at end of period | $ 8.1 | $ 8.1 | $ 7.9 |
| X | ||||||||||
|
- Definition
The amount of any write-down or reserves provided in the period on mortgage loans collectively evaluated for impairment. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of any write-down or reserves provided in the period on mortgage loans specifically evaluated for impairment. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of loans and leases that have been written off from both loan receivables and allowance reserve for credit loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of allowance to cover probable credit losses on loans and leases. Includes carryover of or adjustments to the allowance for loan losses in connection with business combinations. Excludes allowance for loans and leases covered under loss sharing agreements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Derivative Instruments (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||
| Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | $ 6.4 | ||
| Maximum Length of Time Hedged in Cash Flow Hedge | 15 years | ||
| Gain (Loss) from ineffective portion of cash flow hedge | $ 0 | $ 0 | $ 0 |
| X | ||||||||||
|
- Definition
The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net gain (loss) recognized in earnings during the reporting period representing the amount of the cash flow hedges' ineffectiveness. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Derivative Instruments (Schedule of Position In Derivative Instruments) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | $ 2,896.6 | $ 1,713.7 |
| Fair Value, Assets | 91.6 | 44.0 |
| Fair Value, Liabilities | 240.8 | 122.5 |
|
Designated as Hedging Instrument [Member]
|
||
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | 797.1 | 537.5 |
| Fair Value, Assets | 20.3 | 4.6 |
| Fair Value, Liabilities | 10.2 | 28.4 |
|
Not Designated as Hedging Instrument [Member]
|
||
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | 2,099.5 | 1,176.2 |
| Fair Value, Assets | 71.3 | 39.4 |
| Fair Value, Liabilities | 230.6 | 94.1 |
|
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]
|
||
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | 158.5 | 97.1 |
| Fair Value, Assets | 5.4 | 4.6 |
| Fair Value, Liabilities | 0 | 0 |
|
Currency Swap [Member] | Designated as Hedging Instrument [Member]
|
||
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | 638.6 | 440.4 |
| Fair Value, Assets | 14.9 | 0 |
| Fair Value, Liabilities | 10.2 | 28.4 |
|
Call Option [Member] | Not Designated as Hedging Instrument [Member]
|
||
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | 2,055.9 | 1,060.9 |
| Fair Value, Assets | 71.0 | 38.8 |
| Fair Value, Liabilities | 0.1 | 1.6 |
|
Foreign Exchange Forward [Member] | Not Designated as Hedging Instrument [Member]
|
||
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | 18.3 | 49.3 |
| Fair Value, Assets | 0.1 | 0.3 |
| Fair Value, Liabilities | 0 | 0.4 |
|
Embedded Derivative Financial Instruments [Member] | Not Designated as Hedging Instrument [Member]
|
||
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | 0 | 0 |
| Fair Value, Assets | 0 | 0 |
| Fair Value, Liabilities | 230.1 | 92.1 |
|
Other Contract [Member] | Not Designated as Hedging Instrument [Member]
|
||
| Derivatives, Fair Value [Line Items] | ||
| Notional Amount | 25.3 | 66.0 |
| Fair Value, Assets | 0.2 | 0.3 |
| Fair Value, Liabilities | $ 0.4 | $ 0 |
| X | ||||||||||
|
- Definition
Aggregate notional amount specified by the derivative(s). Expressed as an absolute value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Derivative Instruments (Schedule of Offsetting Assets) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Offsetting Assets [Line Items] | ||
| Fair Value Presented in the Balance Sheet | $ 91.6 | $ 44.0 |
| Financial Instruments | 0 | 0 |
| Cash Collateral | (83.6) | (27.5) |
| Net Amount | 8.0 | 16.5 |
|
Counterparty A [Member]
|
||
| Offsetting Assets [Line Items] | ||
| Fair Value Presented in the Balance Sheet | 12.0 | 4.4 |
| Financial Instruments | 0 | 0 |
| Cash Collateral | (12.0) | (0.2) |
| Net Amount | 0 | 4.2 |
|
Counterparty B [Member]
|
||
| Offsetting Assets [Line Items] | ||
| Fair Value Presented in the Balance Sheet | 20.2 | 11.0 |
| Financial Instruments | 0 | 0 |
| Cash Collateral | (14.0) | (3.0) |
| Net Amount | 6.2 | 8.0 |
|
Counterparty C [Member]
|
||
| Offsetting Assets [Line Items] | ||
| Fair Value Presented in the Balance Sheet | 12.0 | 17.7 |
| Financial Instruments | 0 | 0 |
| Cash Collateral | (12.0) | (17.4) |
| Net Amount | 0 | 0.3 |
|
Counterparty D [Member]
|
||
| Offsetting Assets [Line Items] | ||
| Fair Value Presented in the Balance Sheet | 14.9 | 9.1 |
| Financial Instruments | 0 | 0 |
| Cash Collateral | (14.9) | (6.9) |
| Net Amount | 0 | 2.2 |
|
Counterparty F [Member]
|
||
| Offsetting Assets [Line Items] | ||
| Fair Value Presented in the Balance Sheet | 24.0 | |
| Financial Instruments | 0 | |
| Cash Collateral | (24.0) | |
| Net Amount | 0 | |
|
Other Counterparty [Member]
|
||
| Offsetting Assets [Line Items] | ||
| Fair Value Presented in the Balance Sheet | 8.5 | 1.8 |
| Financial Instruments | 0 | 0 |
| Cash Collateral | (6.7) | 0 |
| Net Amount | $ 1.8 | $ 1.8 |
| X | ||||||||||
|
- Definition
Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of obligation to return securities collateral under master netting arrangements that have not been offset against derivative assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value, after effects of master netting arrangements, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against an obligation to return collateral. Includes assets not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Derivative Instruments (Schedule of Offsetting Liabilities) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
||||||
|---|---|---|---|---|---|---|---|---|
| Offsetting Liabilities [Line Items] | ||||||||
| Fair Value Presented in the Balance Sheets | $ 10.7 | [1] | $ 30.4 | [2] | ||||
| Financial Instruments | (1.9) | [1] | (2.8) | [2] | ||||
| Cash Collateral | (0.7) | [1] | (0.2) | [2] | ||||
| Net Amount | 8.1 | [1] | 27.4 | [2] | ||||
| Fair Value, Liabilities | 240.8 | 122.5 | ||||||
|
Counterparty A [Member]
|
||||||||
| Offsetting Liabilities [Line Items] | ||||||||
| Fair Value Presented in the Balance Sheets | 1.2 | 5.3 | ||||||
| Financial Instruments | 0 | 0 | ||||||
| Cash Collateral | 0 | 0 | ||||||
| Net Amount | 1.2 | 5.3 | ||||||
|
Counterparty B [Member]
|
||||||||
| Offsetting Liabilities [Line Items] | ||||||||
| Fair Value Presented in the Balance Sheets | 6.7 | 16.9 | ||||||
| Financial Instruments | (1.9) | 0 | ||||||
| Cash Collateral | (0.7) | (0.2) | ||||||
| Net Amount | 4.1 | 16.7 | ||||||
|
Counterparty E [Member]
|
||||||||
| Offsetting Liabilities [Line Items] | ||||||||
| Fair Value Presented in the Balance Sheets | 2.4 | 5.1 | ||||||
| Financial Instruments | 0 | (2.8) | ||||||
| Cash Collateral | 0 | 0 | ||||||
| Net Amount | 2.4 | 2.3 | ||||||
|
Other Counterparty [Member]
|
||||||||
| Offsetting Liabilities [Line Items] | ||||||||
| Fair Value Presented in the Balance Sheets | 0.4 | 3.1 | ||||||
| Financial Instruments | 0 | 0 | ||||||
| Cash Collateral | 0 | 0 | ||||||
| Net Amount | 0.4 | 3.1 | ||||||
|
Not Designated as Hedging Instrument [Member]
|
||||||||
| Offsetting Liabilities [Line Items] | ||||||||
| Fair Value, Liabilities | 230.6 | 94.1 | ||||||
|
Not Designated as Hedging Instrument [Member] | Embedded Derivative Financial Instruments [Member]
|
||||||||
| Offsetting Liabilities [Line Items] | ||||||||
| Fair Value, Liabilities | $ 230.1 | $ 92.1 | ||||||
|
||||||||
| X | ||||||||||
|
- Definition
Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of right to receive securities collateral under master netting arrangements that have not been offset against derivative liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value, after effects of master netting arrangements, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against the right to receive collateral. Includes liabilities not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Derivative Instruments (Schedule of Gains Losses On Cash Flow Hedges) (Details) (Tables) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Derivatives, Fair Value [Line Items] | |||
| Gain (Loss) Recognized in OCI | $ 38.1 | $ (26.8) | $ (0.2) |
|
Interest Rate Swap [Member]
|
|||
| Derivatives, Fair Value [Line Items] | |||
| Gain (Loss) Recognized in OCI | 3.6 | (2.8) | 4.1 |
|
Currency Swap [Member]
|
|||
| Derivatives, Fair Value [Line Items] | |||
| Gain (Loss) Recognized in OCI | $ 34.5 | $ (24.0) | $ (4.3) |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Derivative Instruments (Schedule of Derivatives Not Designated as Hedges Gains Losses) (Details) (Tables) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Derivatives, Fair Value [Line Items] | |||
| Gain (Loss) Recognized in Income | $ (1.5) | $ (2.6) | $ (1.5) |
|
Equity Index Options [Member]
|
|||
| Derivatives, Fair Value [Line Items] | |||
| Gain (Loss) Recognized in Income | 33.4 | 21.4 | 0.4 |
|
Foreign Currency Forwards [Member]
|
|||
| Derivatives, Fair Value [Line Items] | |||
| Gain (Loss) Recognized in Income | 1.3 | 0.9 | (0.4) |
|
Embedded Derivative Financial Instruments [Member]
|
|||
| Derivatives, Fair Value [Line Items] | |||
| Gain (Loss) Recognized in Income | (38.7) | (23.0) | (1.2) |
|
Other Derivatives [Member]
|
|||
| Derivatives, Fair Value [Line Items] | |||
| Gain (Loss) Recognized in Income | $ 2.5 | $ (1.9) | $ (0.3) |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Fair Value Of Financial Instruments (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Percentage of fair value of fixed maturities determined by pricing services | 96.00% | 96.60% |
| Total fixed maturities | $ 25,379.4 | $ 23,337.7 |
| Agency securities as a percentage of Level 2 RMBS | 87.90% | 89.20% |
| Cash equivalents | 16.6 | 37.8 |
|
Maximum [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Investment In Limited Partnerships, Term | 13 | |
| Range of illiquidity adjustments | 0.60% | |
|
Minimum [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Investment In Limited Partnerships, Term | 3 | |
| Range of illiquidity adjustments | 0.00% | |
|
Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 25,233.6 | 23,157.5 |
|
Private Placement [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Private placements as a percentage of fixed maturities | 3.70% | 2.80% |
| Total fixed maturities | 929.0 | 653.7 |
|
Private Placement [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 870.7 | 635.6 |
| Privately Placed Percent Level Two | 93.70% | 97.20% |
|
Commercial Mortgage-Backed Securities [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 1,331.4 | 1,512.6 |
| Weighted Average Coupon Rate | 4.65% | 4.82% |
|
Commercial Mortgage-Backed Securities [Member] | Non Agency Securities [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Weighted-average credit enhancement of securities, percentage | 32.80% | 31.40% |
| Non-agency securities as a percentage of Level 2 CMBS | 87.80% | 83.30% |
| Percentage of non-agency Level 2 CMBS in most senior tranche | 96.80% | 98.70% |
|
Corporate Securities [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 19,120.9 | 17,324.4 |
|
Corporate Securities [Member] | Private Placement [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 770.6 | 523.5 |
| Private placements as a percentage of Level 2 corporate securities | 4.00% | 3.00% |
|
Residential Mortgage-Backed Securities [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 2,921.4 | 2,755.8 |
| Weighted Average Coupon Rate | 4.18% | 4.39% |
|
Residential Mortgage-Backed Securities [Member] | Non Agency Securities [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Weighted-average credit enhancement of securities, percentage | 9.00% | 8.80% |
| Fair value of non-agency Level 2 RMBS originated in 2004 and prior | $ 72.8 | $ 110.3 |
| Percentage of non-agency Level 2 RMBS originated in 2004 and prior | 20.60% | 37.00% |
| X | ||||||||||
|
- Definition
Represents the amount of non-agency Level 2 residential mortgage backed securities that were originated in 2004 or prior (vintage of 2004 or prior). No definition available.
|
| X | ||||||||||
|
- Definition
This represents the percentage of Level 2 corporate fixed maturities that are privately placed securities. No definition available.
|
| X | ||||||||||
|
- Definition
This represents the percentage of fixed maturites for which fair value is determined by third-party pricing services. No definition available.
|
| X | ||||||||||
|
- Definition
Investment In Limited Partnerships, Term No definition available.
|
| X | ||||||||||
|
- Definition
This represents the portion of Level 2 RMBS that are agency securities, as a percentage. No definition available.
|
| X | ||||||||||
|
- Definition
This represents the portion of Level 2 CMBS that are non-agency securities, as a percentage. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the percentage of non-agency Level 2 commercial mortgage backed securities that are in the most senior tranche. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the percentage of non-agency Level 2 residential mortgage backed securities that were originated in 2004 or prior (vintage of 2004 or prior). No definition available.
|
| X | ||||||||||
|
- Definition
This represents the percentage of privately placed securities that are classified as level 2. No definition available.
|
| X | ||||||||||
|
- Definition
This represents the percentage of the fixed maturity portfolio that are invested in private placement securities. No definition available.
|
| X | ||||||||||
|
- Definition
The range (in basis points) of the illiquidity adjustment used to value Level 2 privately placed corporate securities, based on illiquidity spreads observed in transactions involving similar securities. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average coupon rate of the entity's fixed maturity securities. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the weighted-average percentage of the outstanding capital structure that is subordinate in the priority of cash flows and absorbs losses first. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Fair Value Of Financial Instruments (Financial Assets and Liabilities Accounted At Fair Value On Recurring Basis) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | $ 25,379.4 | $ 23,337.7 | ||||||||
| Marketable equity securities, available-for-sale | 120.5 | 134.3 | ||||||||
| Marketable equity securities, trading | 532.0 | 474.4 | ||||||||
| Investments In Limited Partnerships, alternative investments | 309.9 | 296.3 | ||||||||
| Equity index options | 91.6 | 44.0 | ||||||||
| Other invested assets: | 100.5 | 54.1 | ||||||||
| Total investments | 30,634.3 | 27,901.1 | ||||||||
| Separate account assets | 949.8 | 978.4 | ||||||||
| Mortgage loans, net | 4,130.1 | 3,541.0 | ||||||||
| Cash and cash equivalents | 158.8 | 76.0 | 130.8 | 242.3 | ||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 26,602.6 | 24,642.9 | ||||||||
| Notes payable | 697.2 | 449.5 | ||||||||
| Liabilities related to insurance contracts and embedded derivatives excluded from fair value | 6,388.7 | 6,111.6 | ||||||||
|
Level 1 [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0 | ||||||||
| Marketable equity securities, available-for-sale | 62.8 | 77.4 | ||||||||
| Marketable equity securities, trading | 531.6 | 474.1 | ||||||||
| Other | 0.6 | |||||||||
| Separate account assets | 949.8 | 978.4 | ||||||||
| Total assets at fair value | 1,544.8 | 1,530.5 | ||||||||
| Mortgage loans, net | 0 | 0 | ||||||||
| Cash and cash equivalents | 158.8 | 76.0 | ||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Embedded derivatives | 0 | 0 | ||||||||
| Total liabilities at fair value | 0 | 0 | ||||||||
|
Level 1 [Member] | US government and agencies [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0 | ||||||||
|
Level 1 [Member] | State And Political Subdivisions [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0 | ||||||||
|
Level 1 [Member] | Corporate Debt Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0 | ||||||||
|
Level 1 [Member] | Residential Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0 | ||||||||
|
Level 1 [Member] | Commercial Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0 | ||||||||
|
Level 1 [Member] | Other Debt Obligations [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0 | ||||||||
|
Level 1 [Member] | Alternative Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 0 | 0 | ||||||||
|
Level 1 [Member] | Call Option [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Equity index options | 0 | |||||||||
|
Level 1 [Member] | Currency Swap [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Foreign Currency Swaps | 0 | |||||||||
|
Level 1 [Member] | Tax Credit Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 0 | 0 | ||||||||
|
Level 1 [Member] | Deferred Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 0 | [1] | 0 | [2] | ||||||
|
Level 1 [Member] | Income Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 0 | [1] | 0 | [2] | ||||||
|
Level 1 [Member] | Capital Efficient Notes Due2067 [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 0 | 0 | ||||||||
|
Level 1 [Member] | Senior Notes [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 0 | 0 | ||||||||
|
Level 2 [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 25,233.6 | 23,157.5 | ||||||||
| Marketable equity securities, available-for-sale | 57.7 | 56.9 | ||||||||
| Marketable equity securities, trading | 0 | 0 | ||||||||
| Other | 20.7 | |||||||||
| Separate account assets | 0 | 0 | ||||||||
| Total assets at fair value | 25,380.6 | 23,219.6 | ||||||||
| Mortgage loans, net | 0 | 0 | ||||||||
| Cash and cash equivalents | 0 | 0 | ||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Embedded derivatives | 0 | 0 | ||||||||
| Total liabilities at fair value | (10.2) | 0 | ||||||||
|
Level 2 [Member] | US government and agencies [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 409.9 | 327.0 | ||||||||
|
Level 2 [Member] | State And Political Subdivisions [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 829.2 | 751.5 | ||||||||
|
Level 2 [Member] | Corporate Debt Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 19,120.9 | 17,324.4 | ||||||||
|
Level 2 [Member] | Residential Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 2,921.4 | 2,755.8 | ||||||||
|
Level 2 [Member] | Commercial Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 1,331.4 | 1,512.6 | ||||||||
|
Level 2 [Member] | Other Debt Obligations [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 620.8 | 486.2 | ||||||||
|
Level 2 [Member] | Alternative Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 0 | 0 | ||||||||
|
Level 2 [Member] | Call Option [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Equity index options | 68.6 | |||||||||
|
Level 2 [Member] | Currency Swap [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Foreign Currency Swaps | 10.2 | |||||||||
|
Level 2 [Member] | Tax Credit Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 226.6 | 258.0 | ||||||||
|
Level 2 [Member] | Deferred Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 0 | [1] | 0 | [2] | ||||||
|
Level 2 [Member] | Income Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 0 | [1] | 0 | [2] | ||||||
|
Level 2 [Member] | Capital Efficient Notes Due2067 [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 155.6 | 156.2 | ||||||||
|
Level 2 [Member] | Senior Notes [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 569.6 | 319.3 | ||||||||
|
Level 3 [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 145.8 | 180.2 | ||||||||
| Marketable equity securities, available-for-sale | 0 | 0 | ||||||||
| Marketable equity securities, trading | 0.4 | 0.3 | ||||||||
| Other | 3.5 | |||||||||
| Separate account assets | 0 | 0 | ||||||||
| Total assets at fair value | 223.6 | 253.7 | ||||||||
| Mortgage loans, net | 4,375.8 | 3,664.6 | ||||||||
| Cash and cash equivalents | 0 | 0 | ||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Embedded derivatives | (230.1) | 92.1 | ||||||||
| Total liabilities at fair value | (230.1) | 92.1 | ||||||||
|
Level 3 [Member] | US government and agencies [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 17.4 | ||||||||
|
Level 3 [Member] | State And Political Subdivisions [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0 | ||||||||
|
Level 3 [Member] | Corporate Debt Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 71.6 | 28.0 | ||||||||
|
Level 3 [Member] | Residential Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 0 | 0.2 | ||||||||
|
Level 3 [Member] | Commercial Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 2.5 | 5.8 | ||||||||
|
Level 3 [Member] | Other Debt Obligations [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 71.7 | 128.8 | ||||||||
|
Level 3 [Member] | Alternative Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 71.5 | 31.2 | ||||||||
|
Level 3 [Member] | Call Option [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Equity index options | 2.4 | |||||||||
|
Level 3 [Member] | Currency Swap [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Foreign Currency Swaps | 0 | |||||||||
|
Level 3 [Member] | Tax Credit Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 0 | 0 | ||||||||
|
Level 3 [Member] | Deferred Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 14,004.2 | [1] | 11,884.2 | [2] | ||||||
|
Level 3 [Member] | Income Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 8,452.5 | [1] | 7,548.0 | [2] | ||||||
|
Level 3 [Member] | Capital Efficient Notes Due2067 [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 0 | 0 | ||||||||
|
Level 3 [Member] | Senior Notes [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 0 | 0 | ||||||||
|
Carrying Amount [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 25,379.4 | 23,337.7 | ||||||||
| Marketable equity securities, available-for-sale | 120.5 | 134.3 | ||||||||
| Marketable equity securities, trading | 532.0 | 474.4 | ||||||||
| Other | 24.8 | |||||||||
| Other invested assets: | 95.8 | 47.8 | ||||||||
| Total investments | 26,199.2 | 24,025.4 | ||||||||
| Separate account assets | 949.8 | 978.4 | ||||||||
| Total assets at fair value | 27,149.0 | 25,003.8 | ||||||||
| Mortgage loans, net | 4,130.1 | 3,541.0 | ||||||||
| Cash and cash equivalents | 158.8 | 76.0 | ||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Embedded derivatives | (230.1) | 92.1 | ||||||||
| Total liabilities at fair value | (240.3) | 92.1 | ||||||||
|
Carrying Amount [Member] | US government and agencies [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 409.9 | 344.4 | ||||||||
|
Carrying Amount [Member] | State And Political Subdivisions [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 829.2 | 751.5 | ||||||||
|
Carrying Amount [Member] | Corporate Debt Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 19,192.5 | 17,352.4 | ||||||||
|
Carrying Amount [Member] | Residential Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 2,921.4 | 2,756.0 | ||||||||
|
Carrying Amount [Member] | Commercial Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 1,333.9 | 1,518.4 | ||||||||
|
Carrying Amount [Member] | Other Debt Obligations [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 692.5 | 615.0 | ||||||||
|
Carrying Amount [Member] | Alternative Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 71.5 | 31.2 | ||||||||
|
Carrying Amount [Member] | Call Option [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Equity index options | 71.0 | |||||||||
|
Carrying Amount [Member] | Currency Swap [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Foreign Currency Swaps | 10.2 | |||||||||
|
Carrying Amount [Member] | Tax Credit Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 238.4 | 265.1 | ||||||||
|
Carrying Amount [Member] | Deferred Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 13,686.8 | [1] | 12,017.0 | [2] | ||||||
|
Carrying Amount [Member] | Income Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 6,527.1 | [1] | 6,514.3 | [2] | ||||||
|
Carrying Amount [Member] | Capital Efficient Notes Due2067 [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 149.9 | 149.9 | ||||||||
|
Carrying Amount [Member] | Senior Notes [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 547.3 | 299.6 | ||||||||
|
Fair Value [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 25,379.4 | 23,337.7 | ||||||||
| Marketable equity securities, available-for-sale | 120.5 | 134.3 | ||||||||
| Marketable equity securities, trading | 532.0 | 474.4 | ||||||||
| Other | 24.8 | |||||||||
| Other invested assets: | 95.8 | 47.8 | ||||||||
| Total investments | 26,199.2 | 24,025.4 | ||||||||
| Separate account assets | 949.8 | 978.4 | ||||||||
| Total assets at fair value | 27,149.0 | 25,003.8 | ||||||||
| Mortgage loans, net | 4,375.8 | 3,664.6 | ||||||||
| Cash and cash equivalents | 158.8 | 76.0 | ||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Embedded derivatives | (230.1) | 92.1 | ||||||||
| Total liabilities at fair value | (240.3) | 92.1 | ||||||||
|
Fair Value [Member] | US government and agencies [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 409.9 | 344.4 | ||||||||
|
Fair Value [Member] | State And Political Subdivisions [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 829.2 | 751.5 | ||||||||
|
Fair Value [Member] | Corporate Debt Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 19,192.5 | 17,352.4 | ||||||||
|
Fair Value [Member] | Residential Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 2,921.4 | 2,756.0 | ||||||||
|
Fair Value [Member] | Commercial Mortgage-Backed Securities [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 1,333.9 | 1,518.4 | ||||||||
|
Fair Value [Member] | Other Debt Obligations [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Total fixed maturities | 692.5 | 615.0 | ||||||||
|
Fair Value [Member] | Alternative Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 71.5 | 31.2 | ||||||||
|
Fair Value [Member] | Call Option [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Equity index options | 71.0 | |||||||||
|
Fair Value [Member] | Currency Swap [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Foreign Currency Swaps | 10.2 | |||||||||
|
Fair Value [Member] | Tax Credit Investments [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Investments In Limited Partnerships, alternative investments | 226.6 | 258.0 | ||||||||
|
Fair Value [Member] | Deferred Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 14,004.2 | [1] | 11,884.2 | [2] | ||||||
|
Fair Value [Member] | Income Annuities [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Funds held under deposit contracts | 8,452.5 | [1] | 7,548.0 | [2] | ||||||
|
Fair Value [Member] | Capital Efficient Notes Due2067 [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 155.6 | 156.2 | ||||||||
|
Fair Value [Member] | Senior Notes [Member]
|
||||||||||
| Financial Liabilities [Abstract] | ||||||||||
| Notes payable | 569.6 | 319.3 | ||||||||
|
Portion at Fair Value, Fair Value Disclosure [Member] | Level 1 [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Other invested assets: | 0.6 | 0.6 | ||||||||
| Total investments | 595.0 | 552.1 | ||||||||
|
Portion at Fair Value, Fair Value Disclosure [Member] | Level 2 [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Other invested assets: | 89.3 | 5.2 | ||||||||
| Total investments | 25,380.6 | 23,219.6 | ||||||||
|
Portion at Fair Value, Fair Value Disclosure [Member] | Level 3 [Member]
|
||||||||||
| Financial Assets [Abstract] | ||||||||||
| Other invested assets: | 5.9 | 42.0 | ||||||||
| Total investments | $ 223.6 | $ 253.7 | ||||||||
|
||||||||||
| X | ||||||||||
|
- Definition
Investments in limited partnership interests include tax credit investments and investments in private equity funds. The tax credit investments are accounted for under the equity method and recorded at amortized cost. The private equity fund investments are recorded at fair value. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of liabilities related to insurance contracts and embedded derivatives that are excluded from the entity's estimate of the fair values of funds held under deposit contracts related to investment-type contracts. No definition available.
|
| X | ||||||||||
|
- Definition
Other invested assets not separately presented for disclosure. No definition available.
|
| X | ||||||||||
|
- Definition
This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a recurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of equity securities categorized neither as held-to-maturity nor as trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into. No definition available.
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity. No definition available.
|
| X | ||||||||||
|
- Definition
The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Other investments not otherwise specified in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The liability as of the balance sheet date to the policyholders for deposits held under the terms of insurance contracts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The fair value of the assets held by the Entity for the benefit of separate account policyholders. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value of investments in trading equity securities and other forms of trading securities that provide ownership interests. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Fair Value Of Financial Instruments (Additional Information About Composition Of Level 2 Corporate Securities) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | $ 25,379.4 | $ 23,337.7 |
|
Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 25,233.6 | 23,157.5 |
|
Corporate Securities [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 19,192.5 | 17,352.4 |
|
Corporate Securities [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Weighted Average Coupon Rate | 5.30% | 5.60% |
| Weighted-average remaining years to contractual maturity for Level 2 corporate securities | 9 years 1 month 6 days | 9 years 7 months 6 days |
|
Corporate Securities [Member] | Industrial Sector [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 3,468.3 | 3,237.3 |
| Corporate securities, level 2, % of Total | 18.10% | 18.70% |
| Corporate securities, level 2, number of securities | 226 | 223 |
|
Corporate Securities [Member] | Consumer Staples Sector [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 2,855.1 | 2,681.6 |
| Corporate securities, level 2, % of Total | 14.90% | 15.50% |
| Corporate securities, level 2, number of securities | 162 | 159 |
|
Corporate Securities [Member] | Consumer Discretionary Sector [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 2,409.3 | 2,184.7 |
| Corporate securities, level 2, % of Total | 12.60% | 12.60% |
| Corporate securities, level 2, number of securities | 199 | 184 |
|
Corporate Securities [Member] | Utilities Sector [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 2,119.1 | 1,897.9 |
| Corporate securities, level 2, % of Total | 11.10% | 11.00% |
| Corporate securities, level 2, number of securities | 154 | 146 |
|
Corporate Securities [Member] | Health care [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 2,175.4 | 1,699.5 |
| Corporate securities, level 2, % of Total | 11.40% | 9.80% |
| Corporate securities, level 2, number of securities | 122 | 111 |
|
Corporate Securities [Member] | Financial Sector [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | $ 2,032.2 | $ 1,819.2 |
| Corporate securities, level 2, % of Total | 10.60% | 10.50% |
| Corporate securities, level 2, number of securities | 162 | 158 |
| X | ||||||||||
|
- Definition
The number of Level 2 corporate securities possessing certain characteristics. The characteristics are defined in the dimensions associated with this element. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average remaining years to contractual maturity for the entity's corporate securities classified as level 2. No definition available.
|
| X | ||||||||||
|
- Definition
Level 2 corporate securities possessing certain characteristics as a percentage of the Level 2 corporate security portfolio. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average coupon rate of the entity's fixed maturity securities. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Fair Value Of Financial Instruments (Additional Information About Composition Of Level 2 Non-Agency RMBS Securities ) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | $ 25,379.4 | $ 23,337.7 |
|
Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 25,233.6 | 23,157.5 |
|
Level 2 [Member] | Non Agency Residential Mortgage Backed Securities With Super Senior Subordination [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 240.4 | 178.3 |
| % of Total | 67.90% | 59.80% |
|
Residential Mortgage-Backed Securities [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 2,921.4 | 2,756.0 |
|
Residential Mortgage-Backed Securities [Member] | Non Agency Securities [Member] | Level 2 [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 353.8 | 298.3 |
| % of Total | 100.00% | 100.00% |
|
Residential Mortgage-Backed Securities [Member] | Non Agency Securities [Member] | Level 2 [Member] | Standard & Poor's, AAA Rating [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 159.6 | 42.5 |
| % of Total | 45.10% | 14.20% |
|
Residential Mortgage-Backed Securities [Member] | Non Agency Securities [Member] | Level 2 [Member] | Standard Poors Aa Through Bbb Rating [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | 56.1 | 88.0 |
| % of Total | 15.90% | 29.50% |
|
Residential Mortgage-Backed Securities [Member] | Non Agency Securities [Member] | Level 2 [Member] | Standard Poors Bb And Below Rating [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total fixed maturities | $ 138.1 | $ 167.8 |
| % of Total | 39.00% | 56.30% |
| X | ||||||||||
|
- Definition
The amount of non-agency residential mortgage backed securities represented as a percentage of the total non-agency RMBS portfolio. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Fair Value Of Financial Instruments (Additional Information About Composition Of Level Two Cmbs Securities) (Details)
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
|
New York [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Percentage of non-agency Level 2 CMBS collateral | 24.50% | 21.80% |
|
California [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Percentage of non-agency Level 2 CMBS collateral | 10.70% | 11.70% |
|
Florida [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Percentage of non-agency Level 2 CMBS collateral | 7.80% | 7.50% |
|
Texas [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Percentage of non-agency Level 2 CMBS collateral | 7.10% | 7.30% |
|
Office Building [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Percentage of non-agency Level 2 CMBS collateral | 33.40% | 32.60% |
|
Retail Shopping Centers [Member]
|
||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Percentage of non-agency Level 2 CMBS collateral | 29.80% | 31.50% |
| X | ||||||||||
|
- Definition
This represents the percentage of underlying collateral for Level 2 non-agency commercial mortgage backed securities with certain characteristics. No definition available.
|
| X | ||||||||||
|
- Details
|
|
Fair Value Of Financial Instruments (Additional Information About Level 3 Assets and Liabilities Measured At Fair Value On A Recurring Basis) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | $ 253.7 | $ 172.3 | ||||||||||
| Purchases and issues | 83.5 | [1] | 143.3 | [1] | ||||||||
| Sales and settlements | (0.1) | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | (111.3) | [2] | (27.3) | [2] | ||||||||
| Other | (10.6) | [3] | (51.0) | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 3.1 | [4] | 17.4 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 4.2 | (9.3) | ||||||||||
| Realized Gains (Losses) | 1.1 | [4] | 8.3 | [4] | ||||||||
| Ending balance | 223.6 | 253.7 | ||||||||||
| Gross transfers into Level 3 | 27.4 | 6.9 | ||||||||||
| Gross transfers out of Level 3 | (138.7) | (34.2) | ||||||||||
| Financial Liabilities: | ||||||||||||
| Beginning balance | 92.1 | 14.1 | ||||||||||
| Purchases and issues | 100.6 | [1] | 55.2 | [1] | ||||||||
| Sales and settlements | (1.3) | [1] | (0.2) | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | 0 | [2] | 0 | [2] | ||||||||
| Other | 0 | [3] | 0 | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 38.7 | [4] | 23.0 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | 0 | ||||||||||
| Realized Gains (Losses) | 0 | [4] | 0 | [4] | ||||||||
| Ending balance | 230.1 | 92.1 | ||||||||||
|
US government and agencies [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 17.4 | 0 | ||||||||||
| Purchases and issues | 0 | [1] | 18.0 | [1] | ||||||||
| Sales and settlements | 0 | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | (17.4) | [2] | 0 | [2] | ||||||||
| Other | 0 | [3] | 0 | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0 | [4] | 0 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | (0.6) | ||||||||||
| Realized Gains (Losses) | 0 | [4] | 0 | [4] | ||||||||
| Ending balance | 0 | 17.4 | ||||||||||
|
Corporate Debt Securities [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 28.0 | 38.9 | ||||||||||
| Purchases and issues | 41.4 | [1] | 0 | [1] | ||||||||
| Sales and settlements | 0 | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | 0 | [2] | 6.2 | [2] | ||||||||
| Other | (0.7) | [3] | (13.6) | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0 | [4] | 0 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 2.9 | (3.4) | ||||||||||
| Realized Gains (Losses) | 0 | [4] | (0.1) | [4] | ||||||||
| Ending balance | 71.6 | 28.0 | ||||||||||
|
Residential Mortgage-Backed Securities [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 0.2 | 0 | ||||||||||
| Purchases and issues | 0 | [1] | 0 | [1] | ||||||||
| Sales and settlements | (0.1) | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | 0 | [2] | 0.2 | [2] | ||||||||
| Other | (0.2) | [3] | (0.1) | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0 | [4] | 0 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0.1 | 0.1 | ||||||||||
| Realized Gains (Losses) | 0 | [4] | 0 | [4] | ||||||||
| Ending balance | 0 | 0.2 | ||||||||||
|
Commercial Mortgage-Backed Securities [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 5.8 | 18.8 | ||||||||||
| Purchases and issues | 0 | [1] | 0 | [1] | ||||||||
| Sales and settlements | 0 | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | 0 | [2] | 0 | [2] | ||||||||
| Other | (3.3) | [3] | (12.5) | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0 | [4] | 0 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0.1 | (0.5) | ||||||||||
| Realized Gains (Losses) | (0.1) | [4] | 0 | [4] | ||||||||
| Ending balance | 2.5 | 5.8 | ||||||||||
|
Other Debt Obligations [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 128.8 | 73.0 | ||||||||||
| Purchases and issues | 0 | [1] | 91.7 | [1] | ||||||||
| Sales and settlements | 0 | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | (56.9) | [2] | (28.7) | [2] | ||||||||
| Other | (1.3) | [3] | (2.3) | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0 | [4] | 0 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 1.1 | (4.9) | ||||||||||
| Realized Gains (Losses) | 0 | [4] | 0 | [4] | ||||||||
| Ending balance | 71.7 | 128.8 | ||||||||||
|
Marketable Equity Securities, Trading [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 0.3 | 0.2 | ||||||||||
| Purchases and issues | 0 | [1] | 0 | [1] | ||||||||
| Sales and settlements | 0 | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | 0 | [2] | 0 | [2] | ||||||||
| Other | 0.3 | [3] | 0 | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | (0.2) | [4] | 0.1 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | 0 | ||||||||||
| Realized Gains (Losses) | 0 | [4] | 0 | [4] | ||||||||
| Ending balance | 0.4 | 0.3 | ||||||||||
|
Call Option [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 38.8 | |||||||||||
| Purchases and issues | 2.5 | |||||||||||
| Sales and settlements | 0 | |||||||||||
| Transfers In and/or (Out) of Level 3 | (37.0) | |||||||||||
| Other | (1.6) | |||||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0.2 | |||||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | |||||||||||
| Realized Gains (Losses) | (0.5) | |||||||||||
| Ending balance | 2.4 | |||||||||||
|
Embedded derivatives [Member]
|
||||||||||||
| Financial Liabilities: | ||||||||||||
| Beginning balance | 92.1 | 14.1 | ||||||||||
| Purchases and issues | 100.6 | [1] | 55.2 | [1] | ||||||||
| Sales and settlements | (1.3) | [1] | (0.2) | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | 0 | [2] | 0 | [2] | ||||||||
| Other | 0 | [3] | 0 | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 38.7 | [4] | 23.0 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | 0 | ||||||||||
| Realized Gains (Losses) | 0 | [4] | 0 | [4] | ||||||||
| Ending balance | 230.1 | 92.1 | ||||||||||
|
Debt Securities [Member] | Available-for-sale Securities [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 180.2 | 130.7 | ||||||||||
| Purchases and issues | 41.4 | [1] | 109.7 | [1] | ||||||||
| Sales and settlements | (0.1) | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | (74.3) | [2] | (22.3) | [2] | ||||||||
| Other | (5.5) | [3] | (28.5) | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0 | [4] | 0 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 4.2 | (9.3) | ||||||||||
| Realized Gains (Losses) | (0.1) | [4] | (0.1) | [4] | ||||||||
| Ending balance | 145.8 | 180.2 | ||||||||||
|
Available-for-sale Securities [Member] | Equity Securities [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 5.0 | |||||||||||
| Purchases and issues | 0 | [1] | ||||||||||
| Sales and settlements | 0 | [1] | ||||||||||
| Transfers In and/or (Out) of Level 3 | (5.0) | [2] | ||||||||||
| Other | 0 | [3] | ||||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0 | [4] | ||||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | |||||||||||
| Realized Gains (Losses) | 0 | [4] | ||||||||||
| Ending balance | 0 | |||||||||||
|
Investments In Limited Partnerships [Member] | Alternative Investments [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 31.2 | 28.6 | ||||||||||
| Purchases and issues | 37.9 | [1] | 7.5 | [1] | ||||||||
| Sales and settlements | 0 | [1] | 0 | [1] | ||||||||
| Transfers In and/or (Out) of Level 3 | 0 | [2] | 0 | [2] | ||||||||
| Other | (1.4) | [3] | (8.9) | [3] | ||||||||
| Unrealized Gains (Losses) Included in, Net Income | 2.7 | [4] | 2.5 | [4] | ||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | 0 | ||||||||||
| Realized Gains (Losses) | 1.1 | [4] | 1.5 | [4] | ||||||||
| Ending balance | 71.5 | 31.2 | ||||||||||
|
Portion at Fair Value, Fair Value Disclosure [Member] | Other Invested Assets [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 3.2 | |||||||||||
| Purchases and issues | 1.7 | |||||||||||
| Sales and settlements | 0 | |||||||||||
| Transfers In and/or (Out) of Level 3 | 0 | |||||||||||
| Other | (2.4) | |||||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0.4 | |||||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | |||||||||||
| Realized Gains (Losses) | 0.6 | |||||||||||
| Ending balance | 3.5 | |||||||||||
|
Portion at Fair Value, Fair Value Disclosure [Member] | Other Assets [Member]
|
||||||||||||
| Financial Assets: | ||||||||||||
| Beginning balance | 42.0 | 7.8 | ||||||||||
| Purchases and issues | 4.2 | 26.1 | [1] | |||||||||
| Sales and settlements | 0 | 0 | [1] | |||||||||
| Transfers In and/or (Out) of Level 3 | (37.0) | 0 | [2] | |||||||||
| Other | (4.0) | (13.6) | [3] | |||||||||
| Unrealized Gains (Losses) Included in, Net Income | 0.6 | 14.8 | [4] | |||||||||
| Unrealized Gains (Losses) Included in, Other Comprehensive Income | 0 | 0 | ||||||||||
| Realized Gains (Losses) | 0.1 | 6.9 | [4] | |||||||||
| Ending balance | $ 5.9 | $ 42.0 | ||||||||||
|
||||||||||||
| X | ||||||||||
|
- Definition
This item is comprised of transactions, such as pay downs, calls, amortization and redemptions, related to assets measured at fair value and categorized as Level 3 for the period. No definition available.
|
| X | ||||||||||
|
- Definition
This item represents the amount of the total realized gains or losses for the period which are included in the statement of income, related to assets measured at fair value and categorized as Level 3 for the period. No definition available.
|
| X | ||||||||||
|
- Definition
This item is comprised of transactions, such as pay downs, calls, amortization and redemptions, related to liabilities measured at fair value and categorized as Level 3 for the period. No definition available.
|
| X | ||||||||||
|
- Definition
This item represents the amount of the total realized gains or losses for the period which are included in the statement of income, related to liabilities measured at fair value and categorized as Level 3 for the period. No definition available.
|
| X | ||||||||||
|
- Definition
Purchases and issues that have taken place during the period in relation to assets measured at fair value and categorized within Level 3 of the fair value hierarchy. No definition available.
|
| X | ||||||||||
|
- Definition
Sales and settlements that have taken place during the period in relation to assets measured at fair value and categorized within Level 3 of the fair value hierarchy. No definition available.
|
| X | ||||||||||
|
- Definition
Purchases and issues that have taken place during the period in relation to liabilities measured at fair value and categorized within Level 3 of the fair value hierarchy. No definition available.
|
| X | ||||||||||
|
- Definition
Sales and settlements that have taken place during the period in relation to liabilities measured at fair value and categorized within Level 3 of the fair value hierarchy. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of unrealized (holding) gain (loss) which is included in the statement of income (or changes in net assets) related to those assets still held at the reporting date for which fair value is measured on a recurring basis using significant unobservable inputs (Level 3). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of gain (loss) recognized in other comprehensive income (loss) for financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of gain (loss) recognized in other comprehensive income (loss) for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy. No definition available.
|
| X | ||||||||||
|
- Definition
Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Deferred Policy Acquisition Costs (DAC) and Deferred Sales Inducements (DSI) (Schedule Of Reconciliation For Deferred Policy Acquisition Costs) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||
| Unamortized balance at beginning of period | $ 419.9 | $ 367.9 | $ 368.4 |
| Deferral of acquisition costs | 171.4 | 122.3 | 65.2 |
| Adjustments for realized (gains) losses | 0.7 | 2.1 | 0.3 |
| Amortization - excluding unlocking | (67.0) | (61.6) | (62.0) |
| Amortization — impact of assumption and experience unlocking | (11.1) | (10.8) | (4.0) |
| Unamortized balance at end of period | 513.9 | 419.9 | 367.9 |
| Accumulated effect of net unrealized gains | (118.8) | (97.4) | (212.1) |
| Balance at end of period | $ 395.1 | $ 322.5 | $ 155.8 |
| X | ||||||||||
|
- Definition
The adjustment to the unamortized balance of deferred policy acquisition costs related to the accumulated effect of net investment gains or losses on available-for-sale securities. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of adjustment to amortization of deferred policy acquisition costs arising from a revision in estimated gross profit (when such amount serves as the basis for allocating amortization of DAC to reporting periods). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of amortization of deferred policy acquisition costs due to realized investment gains or losses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of other increase (decrease) to amortization expense of deferred policy acquisition cost (DAC). No definition available.
|
| X | ||||||||||
|
- Definition
Net amount of deferred policy acquisition costs capitalized on contracts remaining in force as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total amount of policy acquisition costs capitalized during the income statement period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Carrying (unamortized) amount as of the balance sheet date of deferred policy acquisition costs and value of business acquired (also called present value of future profits). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Deferred Policy Acquisition Costs (DAC) and Deferred Sales Inducements (DSI) (Schedule Of Reconciliation For Deferred Sales Inducements) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Movement in Deferred Sales Inducements [Roll Forward] | |||
| Unamortized balance at beginning of period | $ 154.8 | $ 153.4 | $ 142.0 |
| Capitalizations | 31.4 | 49.5 | 49.7 |
| Adjustments for realized (gains) losses | 0.8 | 0.6 | 0.3 |
| Amortization - excluding unlocking | 42.0 | 41.2 | 36.5 |
| Amortization — impact of assumption and experience unlocking | (8.3) | (7.5) | (2.1) |
| Unamortized balance at end of period | 136.7 | 154.8 | 153.4 |
| Accumulated effect of net unrealized gains | (79.6) | (76.7) | (128.6) |
| Deferred Sales Inducements | $ 57.1 | $ 78.1 | $ 24.8 |
|
Maximum [Member]
|
|||
| Deferred Sales Inducements [Line Items] | |||
| Period over which Incremental Amount of Interest is to be Credited | 60 months | ||
|
Minimum [Member]
|
|||
| Deferred Sales Inducements [Line Items] | |||
| Period over which Incremental Amount of Interest is to be Credited | 12 months | ||
| X | ||||||||||
|
- Definition
Net amount of deferred sales inducements capitalized on contracts remaining in force as of the balance sheet date. This amount consists of capitalized incremental interest provided to certain contract holders and is presented net of the effect of accumulated unrealized gains and losses. No definition available.
|
| X | ||||||||||
|
- Definition
The adjustment to the unamortized balance of deferred sales inducements related to the accumulated effect of net investment gains or losses on available-for-sale securities. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of adjustment to amortization of deferred sales inducement costs arising from a revision in estimated gross profit (when such amount serves as the basis for allocating amortization of DSI to reporting periods). No definition available.
|
| X | ||||||||||
|
- Definition
Amount of deferred sales inducement costs charged to expense in the period, generally in proportion to related revenue earned, estimated gross profits (excluding amounts related to revisions of estimated gross profits), or over the customer relationship or some other period. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The number of months following the initial deposit on certain deferred annuity contracts that the contract holder's account value is to be credited an incremental amount of interest related to deferred sales inducements No definition available.
|
| X | ||||||||||
|
- Definition
The amount of deferred sales inducement costs capitalized during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of any adjustments, including write-offs and the effect of dispositions and internal replacements of contracts, that increases or decreases the gross carrying amount of deferred sales inducements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The unamortized carrying amount of deferred sales inducement costs as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Stockholders' Equity (Narrative) (Details) (USD $)
In Millions, except Share data, unless otherwise specified |
12 Months Ended | 4 Months Ended | 12 Months Ended | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
May 21, 2013
|
Feb. 01, 2013
|
May 17, 2013
Affiliated Entity [Member]
|
Dec. 31, 2014
Equity Plan [Member]
|
Dec. 31, 2014
Stock Purchase Plan [Member]
|
Dec. 31, 2014
Restricted Stock [Member]
|
Dec. 31, 2013
Restricted Stock [Member]
|
Dec. 31, 2012
Restricted Stock [Member]
|
Dec. 31, 2014
Employee Stock Option [Member]
|
Dec. 31, 2013
Employee Stock Option [Member]
|
Dec. 31, 2012
Employee Stock Option [Member]
|
Dec. 31, 2010
Employee Stock Option [Member]
|
Dec. 31, 2014
Special Dividend [Member]
|
Dec. 31, 2014
Performance Shares [Member]
|
Dec. 31, 2013
Performance Shares [Member]
|
Dec. 31, 2012
Performance Shares [Member]
|
|
| Equity [Abstract] | |||||||||||||||||||
| Number of shares authorized to be repurchased | 16,000,000 | 10,000,000 | |||||||||||||||||
| Equity [Line Items] | |||||||||||||||||||
| Number of Shares Authorized | 7,830,000 | 870,000 | |||||||||||||||||
| Stock Repurchase Program Number Of Shares Repurchased | 9,053,303 | 6,089,999 | |||||||||||||||||
| Common stock repurchased, purchase price | $ 41.2 | $ 93.4 | $ 81.8 | ||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 4,074,216 | 328,593 | |||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date | 15.00% | ||||||||||||||||||
| Management Incentive Units Vesting Period | 3 years | ||||||||||||||||||
| Management Incentive Expense In Period | 8.0 | 6.4 | 4.7 | ||||||||||||||||
| Restricted Stock [Abstract] | |||||||||||||||||||
| Employee Service Share-based Compensation, Tax Benefit from Compensation Expense | 1.3 | 1.2 | 1.2 | 0.4 | 0.3 | 0.2 | |||||||||||||
| Allocated Share-based Compensation Expense | 3.6 | 3.5 | 3.5 | 1.0 | 0.9 | 0.5 | |||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 3 years | 7 years | |||||||||||||||||
| Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized | 3.8 | 2.4 | |||||||||||||||||
| Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 1 year 4 months 24 days | 2 years 6 months | |||||||||||||||||
| Stock Options [Abstract] | |||||||||||||||||||
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 26.70 | ||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 2,650,000 | 2,650,000 | |||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 0 | 0 | 0 | 2,950,000 | |||||||||||||||
| Common Stock, Dividends, Per Share, Declared | $ 1.70 | $ 0.34 | $ 0.28 | $ 1.30 | |||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost | 0 | ||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 2.73 | ||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years 6 months | ||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 0 | ||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Represents the expense related to outstanding performance units in period. No definition available.
|
| X | ||||||||||
|
- Definition
Period over which Performance Units granted to management are valued, at the discretion of the Board of Directors based on the success of the company. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of shares repurchased by an entity under an authorized stock repurchase plan. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Unrecognized cost of unvested share-based compensation awards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Discount rate from fair value on purchase date that participants pay for shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
An excess of the fair value of the modified award over the fair value of the award immediately before the modification. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
| X | ||||||||||
|
- Definition
The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan. No definition available.
|
| X | ||||||||||
|
- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Stockholders' Equity (Schedule Of Components and Reclassifications Out Of AOCI) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
||||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||||||
| Beginning Balance | $ 593.6 | |||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | (1,320.5) | (1,285.0) | (1,275.2) | |||||||
| Net realized investment (gains) losses | (42.4) | (35.6) | (31.1) | |||||||
| Total provision (benefit) for income taxes | (45.5) | (53.4) | (64.7) | |||||||
| Other comprehensive income (loss) | 397.0 | (777.6) | 343.9 | |||||||
| Ending Balance | 990.6 | 593.6 | ||||||||
| Other comprehensive income (loss) before reclassifications, available-for-sale securities, tax | 212.0 | (481.1) | 201.1 | |||||||
| Other comprehensive income (loss) before reclassifications, OTTI on fixed maturities, tax | (0.8) | (0.9) | (2.8) | |||||||
| Other comprehensive income (loss) before reclassifications, adjustment for DAC and DSI, tax | (9.4) | 59.2 | (24.4) | |||||||
| Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax | 13.4 | (9.4) | (0.1) | |||||||
| Accumulated Other Comprehensive Income Loss Before Reclassification Adjustments Tax | 215.2 | (432.2) | 173.8 | |||||||
|
Net unrealized gains (losses) on available-for-sale securities [Member]
|
||||||||||
| Accumulated Other Comprehensive Income Loss [Line Items] | ||||||||||
| Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | 393.8 | [1] | (893.6) | [1] | 373.7 | [1] | ||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||||||
| Beginning Balance | 737.8 | 1,610.2 | 1,236.6 | |||||||
| Reclassifications recorded in: | ||||||||||
| Net realized investment (gains) losses | (2.1) | 32.6 | (0.2) | |||||||
| Total provision (benefit) for income taxes | 0.7 | (11.4) | 0.1 | |||||||
| Total reclassifications from AOCI, net of taxes | (1.4) | 21.2 | (0.1) | |||||||
| Other comprehensive income (loss) | 392.4 | (872.4) | 373.6 | |||||||
| Ending Balance | 1,130.2 | 737.8 | 1,610.2 | |||||||
|
Net unrealized gains (losses) on available-for-sale securities [Member] | Interest rate swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | 0 | 0 | 0 | |||||||
|
Net unrealized gains (losses) on available-for-sale securities [Member] | Foreign currency swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | 0 | 0 | ||||||||
|
OTTI on fixed maturities not related to credit losses [Member]
|
||||||||||
| Accumulated Other Comprehensive Income Loss [Line Items] | ||||||||||
| Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | (1.4) | [1],[2] | (1.6) | [1],[2] | (5.3) | [1],[2] | ||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||||||
| Beginning Balance | (14.2) | [2] | (19.6) | [2] | (37.3) | [2] | ||||
| Reclassifications recorded in: | ||||||||||
| Net realized investment (gains) losses | 3.3 | [2] | 10.9 | [2] | 35.3 | [2] | ||||
| Total provision (benefit) for income taxes | (1.2) | [2] | (3.9) | [2] | (12.3) | [2] | ||||
| Total reclassifications from AOCI, net of taxes | 2.1 | [2] | 7.0 | [2] | 23.0 | [2] | ||||
| Other comprehensive income (loss) | 0.7 | [2] | 5.4 | [2] | 17.7 | [2] | ||||
| Ending Balance | (13.5) | [2] | (14.2) | [2] | (19.6) | [2] | ||||
|
OTTI on fixed maturities not related to credit losses [Member] | Interest rate swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | 0 | [2] | 0 | [2] | 0 | [2] | ||||
|
OTTI on fixed maturities not related to credit losses [Member] | Foreign currency swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | 0 | [2] | 0 | [2] | ||||||
|
Adjustment for DAC and DSI [Member]
|
||||||||||
| Accumulated Other Comprehensive Income Loss [Line Items] | ||||||||||
| Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | (17.3) | [1] | 110.1 | [1] | (45.4) | [1] | ||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||||||
| Beginning Balance | (113.1) | (221.4) | (175.5) | |||||||
| Reclassifications recorded in: | ||||||||||
| Net realized investment (gains) losses | (1.5) | (2.7) | (0.7) | |||||||
| Total provision (benefit) for income taxes | 0.5 | 0.9 | 0.2 | |||||||
| Total reclassifications from AOCI, net of taxes | (1.0) | (1.8) | (0.5) | |||||||
| Other comprehensive income (loss) | (18.3) | 108.3 | (45.9) | |||||||
| Ending Balance | (131.4) | (113.1) | (221.4) | |||||||
|
Adjustment for DAC and DSI [Member] | Interest rate swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | 0 | 0 | 0 | |||||||
|
Adjustment for DAC and DSI [Member] | Foreign currency swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | 0 | 0 | ||||||||
|
Net gains (losses) on cash flow hedges [Member]
|
||||||||||
| Accumulated Other Comprehensive Income Loss [Line Items] | ||||||||||
| Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | 24.7 | [1] | (17.4) | [1] | (0.1) | [1] | ||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||||||
| Beginning Balance | (16.9) | 2.0 | 3.5 | |||||||
| Reclassifications recorded in: | ||||||||||
| Net realized investment (gains) losses | 0 | 0 | 0 | |||||||
| Total provision (benefit) for income taxes | 1.4 | 0.8 | 0.7 | |||||||
| Total reclassifications from AOCI, net of taxes | (2.5) | (1.5) | (1.4) | |||||||
| Other comprehensive income (loss) | 22.2 | (18.9) | (1.5) | |||||||
| Ending Balance | 5.3 | (16.9) | 2.0 | |||||||
|
Net gains (losses) on cash flow hedges [Member] | Interest rate swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | (2.5) | (2.2) | (2.1) | |||||||
|
Net gains (losses) on cash flow hedges [Member] | Foreign currency swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | (1.4) | (0.1) | ||||||||
|
Accumulated other comprehensive income [Member]
|
||||||||||
| Accumulated Other Comprehensive Income Loss [Line Items] | ||||||||||
| Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | 399.8 | [1] | (802.5) | [1] | 322.9 | [1] | ||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||||||||||
| Beginning Balance | 593.6 | 1,371.2 | 1,027.3 | |||||||
| Reclassifications recorded in: | ||||||||||
| Net realized investment (gains) losses | (0.3) | 40.8 | 34.4 | |||||||
| Total provision (benefit) for income taxes | 1.4 | (13.6) | (11.3) | |||||||
| Total reclassifications from AOCI, net of taxes | (2.8) | 24.9 | 21.0 | |||||||
| Other comprehensive income (loss) | 397.0 | (777.6) | 343.9 | |||||||
| Ending Balance | 990.6 | 593.6 | 1,371.2 | |||||||
|
Accumulated other comprehensive income [Member] | Interest rate swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | (2.5) | (2.2) | (2.1) | |||||||
|
Accumulated other comprehensive income [Member] | Foreign currency swaps [Member]
|
||||||||||
| Reclassifications recorded in: | ||||||||||
| Net investment income | $ (1.4) | $ (0.1) | ||||||||
|
||||||||||
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit) before reclassification adjustments of accumulated other comprehensive income (loss), recognized in other comprehensive income (loss) during the period. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit) before reclassification adjustments of the adjustments for deferred policy acquisition costs and deferred sales inducements, recognized in other comprehensive income (loss) during the period. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit) before reclassification adjustments of other-than-temporary impairments on investments in available-for-sale debt securities, recognized in other comprehensive income (loss) during the period. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit) before reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities and unrealized holding gain (loss) related to transfers of securities into the available-for-sale category and out of the held-to-maturity category. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax, before reclassification adjustments of other comprehensive income (loss). No definition available.
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax of reclassification adjustments of other comprehensive income (loss). No definition available.
|
| X | ||||||||||
|
- Details
|
|
Stockholders' Equity (Schedule Of Reconciliation Of Changes In Outstanding Shares Of Common Stock) (Details)
|
12 Months Ended | 6 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Jun. 20, 2013
Warrant Settlement [Member]
|
|||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
| Beginning Balance | 117,730,757 | 119,087,677 | 118,637,379 | |||||||
| Common stock issued | 1,790 | [1] | 5,300,569 | [1] | 0 | 5,297,758 | ||||
| Restricted stock issued, net | 195,346 | 254,579 | 379,158 | |||||||
| Employee stock purchase plan shares issued | 110,287 | 133,122 | 141,619 | |||||||
| Common stock repurchased | (2,240,729) | [2] | (7,045,190) | [2] | (70,479) | |||||
| Ending Balance | 115,797,451 | 117,730,757 | 119,087,677 | |||||||
|
||||||||||
| X | ||||||||||
|
- Definition
Number of shares that have been repurchased during the period. No definition available.
|
| X | ||||||||||
|
- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of shares issued during the period as a result of an employee stock purchase plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed. No definition available.
|
| X | ||||||||||
|
- Definition
Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Stockholders' Equity (Summary Of Restricted Stock Activity) (Details) (Restricted Stock [Member], USD $)
|
12 Months Ended |
|---|---|
|
Dec. 31, 2014
|
|
|
Restricted Stock [Member]
|
|
| Number of Shares | |
| Beginning balance | 650,197 |
| Shares granted | 212,202 |
| Shares vested | (369,941) |
| Shares forfeited | (16,856) |
| Ending balance | 475,602 |
| Weighted-Average Fair Value | |
| Beginning balance (USD per share) | $ 11.53 |
| Shares granted (USD per share) | $ 20.33 |
| Shares vested (USD per share) | $ 10.13 |
| Shares forfeited (USD per share) | $ 13.90 |
| Ending balance (USD per share) | $ 16.46 |
| X | ||||||||||
|
- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Reinsurance (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
| Reinsurance recoverables | $ 328.7 | $ 310.8 | |
| Percentage of reinsurance recoverables credit ratings | 99.50% | 99.50% | |
| Ceded reinsurance reduced policyholder benefits and claims | 75.8 | 65.2 | 63.9 |
|
Individual Life [Member] | Maximum [Member]
|
|||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
| Reinsurance Retention Policy, Amount Retained | 3.00 | ||
| Reinsurer reimbursements based on percentage of claims | 50.00% | ||
|
Group life insurance [Member]
|
|||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
| Reinsurance Retention Policy, Amount Retained | 0.25 | ||
|
Long-term disability [Member]
|
|||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 75.00% | ||
|
Single largest reinsurer [Member]
|
|||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
| Reinsurance recoverables | 116.3 | ||
| Percentage of reinsurance with single largest reinsurer | 35.40% | ||
|
Aggregate Policies [Member] | Medical Stop Loss [Member]
|
|||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
| Reinsurance Retention Policy, Amount Retained | 1.00 | ||
|
Specific Policies [Member] | Medical Stop Loss [Member]
|
|||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
| Reinsurance Retention Policy, Amount Retained | $ 1.50 | ||
| X | ||||||||||
|
- Definition
This represents the percentage of the total amount due from reinsurers that relates to highly rated reinsurers, rated A- or higher by A.M.Best. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the amount of the reinsurance recoverable from the Company's single largest reinsurer, as a percentage of total reinsurance. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the amount (as a percentage) of reinsurance recoverables that are covered by coinsurance agreements where the reinsurer reimburses the entity based on a percentage of claims. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of reduction of provision for policy benefits and costs incurred for policies ceded. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount after valuation allowance recoverable including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Stated amount that is the upper retention limit per entity policy. No definition available.
|
| X | ||||||||||
|
- Definition
Percentage of risk reinsured on insurance products per entity policy. No definition available.
|
|
Reinsurance (Schedule Of Net Life Insurance In Force) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|---|---|---|---|
| Reinsurance Disclosures [Abstract] | |||
| Direct life insurance in force | $ 66,931.6 | $ 60,554.7 | $ 55,750.6 |
| Amounts assumed from other companies | 184.8 | 213.2 | 215.5 |
| Amounts ceded to other companies | (22,628.9) | (21,635.5) | (24,153.4) |
| Net life insurance in force | $ 44,487.5 | $ 39,132.4 | $ 31,812.7 |
| Percentage of amount assumed to net | 0.42% | 0.54% | 0.68% |
| Percentage of amount ceded to direct | 33.81% | 35.73% | 43.32% |
| X | ||||||||||
|
- Definition
Life Insurance in Force, Percentage Ceded to Direct No definition available.
|
| X | ||||||||||
|
- Definition
Amount of life insurance issued and outstanding assumed from other entities. Includes, but not limited to, dividends and adjustments to face value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of life insurance issued and outstanding ceded to other entities. Includes, but not limited to, dividends and adjustments to face value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before contracts ceded to other entities and contracts assumed by the entity of life insurance issued and outstanding. Includes, but not limited to, dividends and adjustments to face value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after contracts ceded to other entities and contracts assumed by the entity of life insurance issued and outstanding. Includes, but not limited to, dividends and adjustments to face value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of assumed life insurance issued and outstanding contracts to life insurance issued and outstanding after contracts ceded to other entities and contracts assumed by the entity. Includes, but not limited to, dividends and adjustments to face value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Reinsurance (Schedule Of Reinsurance Recoverables) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | $ 328.7 | $ 310.8 |
|
Life Insurance [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | 248.8 | 240.2 |
|
Life Insurance [Member] | Funds Held Under Deposit Contracts [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | 94.4 | 92.1 |
|
Life Insurance [Member] | Future Policy Benefits [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | 145.6 | 142.9 |
|
Life Insurance [Member] | Policy And Contract Claims [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | 5.0 | 3.7 |
|
Life Insurance [Member] | Paid Claims Expense Allowance And Premium Tax Recoverables [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | 3.8 | 1.5 |
|
Accident and Health Insurance [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | 79.9 | 70.6 |
|
Accident and Health Insurance [Member] | Future Policy Benefits [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | 75.4 | 60.7 |
|
Accident and Health Insurance [Member] | Policy And Contract Claims [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | 3.3 | 4.6 |
|
Accident and Health Insurance [Member] | Paid Claims Expense Allowance And Premium Tax Recoverables [Member]
|
||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||
| Reinsurance recoverables | $ 1.2 | $ 5.3 |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount after valuation allowance recoverable including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Reinsurance (Schedule Of Effect Of Reinsurance on Premiums Policy Fees Contract Charges and Other) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
||||||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||||||||
| Direct Premiums, Total | $ 697.4 | $ 694.3 | $ 653.5 | |||||
| Assumed Premiums, Total | 0 | 0.1 | 16.3 | |||||
| Ceded Premiums, Total | (68.3) | (67.2) | (64.8) | |||||
| Total premiums and other amounts assessed to policyholders | 768.0 | 753.9 | 724.3 | |||||
| Percentage of assumed to total premiums and other amounts assessed to policyholders | 0.00% | 0.01% | 2.25% | |||||
|
Accident and Health Insurance [Member]
|
||||||||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||||||||
| Direct Premiums, Total | 592.6 | 601.9 | 567.1 | |||||
| Ceded Premiums, Total | (30.9) | (29.2) | (23.6) | |||||
|
Life Insurance [Member]
|
||||||||
| Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | ||||||||
| Direct Premiums, Total | 104.8 | 92.4 | 86.4 | |||||
| Ceded Premiums, Total | (37.4) | (38.0) | (41.2) | |||||
| Direct life insurance | 145.0 | 132.3 | 124.7 | |||||
| Ceded life insurance | (6.1) | (5.6) | (5.4) | |||||
| Total policy fees and contract charges | $ 138.9 | [1] | $ 126.7 | [1] | $ 119.3 | [1] | ||
|
||||||||
| X | ||||||||||
|
- Definition
Policy fees and contract charges ceded to other insurers as result of reinsurance arrangements. No definition available.
|
| X | ||||||||||
|
- Definition
Policy fees and contract charges written directly by insurer before adding contracts assumed from other insurers or subtracting any amounts assumed by other insurers. No definition available.
|
| X | ||||||||||
|
- Definition
Amounts assumed from other insurers as a percentage of net total premiums, policy fees and contract charges after subtracting any amounts ceded to another insurer and adding premiums assumed from other insurers. No definition available.
|
| X | ||||||||||
|
- Definition
Represents amounts charged to policyholders other than premiums and recorded in policy fees, contract charges, and other on the consolidated statement of income. This primarily consists of cost of insurance charges. No definition available.
|
| X | ||||||||||
|
- Definition
Net premiums, policy fees and contract charges after subtracting any amounts ceded to another insurer and adding premiums assumed from other insurers. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of earned premiums assumed from other entities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of earned premiums ceded to other entities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums earned. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Liability for Unpaid Claims and Claim Adjustment Expenses (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] | |||
| Balance as of January 1 | $ 234.4 | $ 227.7 | $ 234.6 |
| Less: reinsurance recoverables | 69.2 | 63.7 | 61.8 |
| Net balance as of January 1 | 165.2 | 164.0 | 172.8 |
| Incurred related to insured events of: The current year | 468.1 | 479.5 | 455.3 |
| Incurred related to insured events of: Prior years | (24.5) | (10.4) | (10.4) |
| Total incurred | 443.6 | 469.1 | 444.9 |
| Paid related to insured events of: The current year | 334.2 | 320.0 | 297.4 |
| Paid related to insured events of: Prior years | 118.9 | 147.9 | 156.3 |
| Total paid | 453.1 | 467.9 | 453.7 |
| Net balance as of December 31 | 155.7 | 165.2 | 164.0 |
| Add: reinsurance recoverables | 83.9 | 69.2 | 63.7 |
| Balance as of December 31 | $ 239.6 | $ 234.4 | $ 227.7 |
| X | ||||||||||
|
- Definition
The estimated cost of settling claims under the terms of the underlying insurance policies and assumed and ceded insurance contracts as of the balance sheet date, including an estimate for claims which have been incurred but not reported and the actual and estimated costs of settling claims. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of payments to settle claims incurred in the current period and related claims settlement costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of payments to settle claims incurred in prior periods and related claims settlement costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of expense for claims incurred and costs incurred in the claim settlement process. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of payments to settle insured claims and pay costs incurred in the claims settlement process. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after valuation allowance recoverable under reinsurance contracts for claims and claims adjustments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of expense for claims incurred in the current reporting period and related claims settlement costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of expense for claims incurred in prior reporting periods and related claims settlement costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Notes Payable And Credit Facilities (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended |
|---|---|
|
Dec. 31, 2014
|
|
|
Senior Notes Due2016 [Member]
|
|
| Line of Credit Facility [Line Items] | |
| Debt instruments issuance date | Mar. 30, 2006 |
| Debt instrument principal amount | $ 298.7 |
| Debt instruments value issued | 300.0 |
| Debt instruments fixed interest rate | 6.125% |
| Debt Instrument, Maturity Date | Apr. 01, 2016 |
| Basis spread over reference rate | 0.25% |
| Effective interest rate | 6.11% |
| Debt Instrument, Redemption Price, Percentage | 100.00% |
|
SeniorNotesDue2024 [Member]
|
|
| Line of Credit Facility [Line Items] | |
| Debt instruments issuance date | Aug. 04, 2014 |
| Debt instrument principal amount | 250.0 |
| Debt instruments value issued | 249.0 |
| Debt instruments fixed interest rate | 4.25% |
| Debt Instrument, Maturity Date | Jul. 15, 2024 |
| Basis spread over reference rate | 0.30% |
| Effective interest rate | 4.44% |
| Debt Instrument, Redemption Price, Percentage | 100.00% |
|
Capital Efficient Notes Due2067 [Member]
|
|
| Line of Credit Facility [Line Items] | |
| Debt instruments issuance date | Oct. 10, 2007 |
| Debt instrument principal amount | 150.0 |
| Debt instruments scheduled maturity date | Oct. 15, 2037 |
| Debt instruments final maturity date | Oct. 15, 2067 |
| Debt instruments value issued | 149.8 |
| Initial period of fixed-rate interest, years | 10 years |
| Date upon which the initial period of fixed interest ends | Oct. 15, 2017 |
| Debt instruments fixed interest rate | 8.30% |
| Start date of period of variable rate interest | Oct. 15, 2017 |
| End date of period of variable rate interest | Oct. 15, 2067 |
| Description of variable rate basis | three-month LIBOR |
| Debt Instrument, Basis Spread on Variable Rate | 4.18% |
| Effective interest rate | 9.39% |
| Period of deferral of interest payments | 10 years |
| Earliest redemption date of notes | Oct. 15, 2017 |
| Debt Instrument, Redemption Price, Percentage | 100.00% |
| Date prior to which notes cannot be redeemed without qualifying capital securities | Oct. 15, 2047 |
|
Credit Facility due 2019 [Member]
|
|
| Line of Credit Facility [Line Items] | |
| Line of credit initiation date | Aug. 28, 2014 |
| Line of credit current borrowing capacity | 400.0 |
| Line of credit, additional borrowing capacity | 100.0 |
| Line of credit expiration date | Aug. 28, 2019 |
| Minimum debt to capitalization ratio covenant | 35.00% |
| Minimum risk based capital ratio covenant | 225.00% |
|
Credit Facility due 2015 [Member]
|
|
| Line of Credit Facility [Line Items] | |
| Line of credit current borrowing capacity | 300.0 |
| Line of credit expiration date | Dec. 14, 2015 |
|
Notes Payable, Other Payables [Member]
|
|
| Line of Credit Facility [Line Items] | |
| Debt Instrument, Unused Borrowing Capacity, Amount | $ 107.2 |
|
Minimum [Member] | Credit Facility due 2019 [Member]
|
|
| Line of Credit Facility [Line Items] | |
| Facility fees | 0.10% |
|
Maximum [Member] | Credit Facility due 2019 [Member]
|
|
| Line of Credit Facility [Line Items] | |
| Facility fees | 0.30% |
| X | ||||||||||
|
- Definition
The earliest date on which the company can redeem notes payable at its option, in whole or in part, at a redemption price of 100 percent of the principal amount being redeemed plus accrued but unpaid interest. No definition available.
|
| X | ||||||||||
|
- Definition
The date prior to which the company cannot redeem notes payable at its option, unless such redemption is financed through the offering of replacement capital securities. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the redemption price of the note, expressed as a spread over the relevant reference rate. No definition available.
|
| X | ||||||||||
|
- Definition
The period, subject to certain limitations, up to which the entity has the right to defer the payment of interest without giving rise to the event of default. No definition available.
|
| X | ||||||||||
|
- Definition
Initial period of fixed-rate interest, following the original issuance date. No definition available.
|
| X | ||||||||||
|
- Definition
The date upon which the initial period of fixed-rate interest ends. No definition available.
|
| X | ||||||||||
|
- Definition
Additional borrowing capacity which can be added to the credit facility, subject to availability of financing. No definition available.
|
| X | ||||||||||
|
- Definition
Minimum debt-to-capitalization ratio, excluding AOCI, that the Company is required to maintain. No definition available.
|
| X | ||||||||||
|
- Definition
Minimum Risk-based Capital ratio that the Company's insurance subsidiaries are required to maintain. No definition available.
|
| X | ||||||||||
|
- Definition
The date upon which the period of variable-rate interest ends. No definition available.
|
| X | ||||||||||
|
- Definition
The date upon which the period of variable-rate interest begins. No definition available.
|
| X | ||||||||||
|
- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument. No definition available.
|
| X | ||||||||||
|
- Definition
The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR. No definition available.
|
| X | ||||||||||
|
- Definition
Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Date the debt instrument was issued, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Latest date the outstanding debt instruments are required to be repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Earliest date the outstanding debt instruments are required to be repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage price of original principal amount of debt at which debt can be redeemed by the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Date the credit facility terminates, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Date the credit facility first became available, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility. No definition available.
|
| X | ||||||||||
|
- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Income Taxes (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Income Taxes [Line Items] | |||
| Closed tax years | Dec. 31, 2009 | ||
| U.S. federal income tax rate, rate | 35.00% | 35.00% | 35.00% |
| Gross federal net operating loss carry-forwards attributable to non-life companies | $ 81.1 | ||
| Valuation allowance for deferred tax assets | 0 | 0 | |
| Unrecognized tax benefits | $ 0 | ||
| X | ||||||||||
|
- Definition
Tax years up to and prior that are no longer open to examination under enacted tax laws. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Sep. 30, 2014
|
Jun. 30, 2014
|
Mar. 31, 2014
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Income Tax Disclosure [Abstract] | |||||||||||
| Income from operations before income taxes | $ 85.3 | $ 37.3 | $ 83.2 | $ 94.1 | $ 82.5 | $ 53.2 | $ 55.0 | $ 83.4 | $ 299.9 | $ 274.1 | $ 270.1 |
| Tax provision at U.S. Federal statutory rate | 105.0 | 95.9 | 94.5 | ||||||||
| Tax provision at U.S. Federal statutory rate | 35.00% | 35.00% | 35.00% | ||||||||
| Increase (reduction) in rate resulting from: | |||||||||||
| Tax credit investment credits | (56.8) | (41.2) | (33.5) | ||||||||
| Tax credit investment credits, rate | (18.90%) | (15.00%) | (12.40%) | ||||||||
| Separate account dividend received deduction | (1.4) | (1.2) | (1.1) | ||||||||
| Separate account dividend received deduction, rate | (0.50%) | (0.40%) | (0.40%) | ||||||||
| Adjustment to deferred taxes | 0 | 0 | 4.7 | ||||||||
| Adjustment to deferred taxes, rate | 0.00% | 0.00% | 1.70% | ||||||||
| Other | (1.3) | (0.1) | 0.1 | ||||||||
| Other, rate | (0.40%) | (0.10%) | 0.10% | ||||||||
| Total provision for income taxes | $ 45.5 | $ 53.4 | $ 64.7 | ||||||||
| Provision for income taxes | 15.20% | 19.50% | 24.00% | ||||||||
| X | ||||||||||
|
- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to investment tax credit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to investment tax credit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Income Taxes (Schedule Deferred Income Tax Assets And Liabilities) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
|---|---|---|
| Income Tax Disclosure [Abstract] | ||
| Adjustments to life policy liabilities | $ 323.5 | $ 287.2 |
| Capitalization of policy acquisition costs | 69.9 | 65.5 |
| Non-insurance entity net operating loss | 28.4 | 25.9 |
| Other | 19.2 | 13.3 |
| Total deferred income tax assets | 441.0 | 391.9 |
| Deferred policy acquisition costs | 179.8 | 147.0 |
| Basis adjustment on securities | 124.2 | 123.9 |
| Unrealized gains on investment securities (net of DAC/DSI adjustment: $69.4 and $60.9, respectively) | 532.1 | 319.7 |
| Other | 1.6 | 3.2 |
| Total deferred income tax liabilities | 837.7 | 593.8 |
| Deferred income tax liability, net | 396.7 | 201.9 |
| Tax impact of DAC and DSI adjustment on net unrealized gains | $ 69.4 | $ 60.9 |
| X | ||||||||||
|
- Definition
The tax effect as of the balance sheet date of the amount of the estimated future tax reductions attributable to a difference between the tax basis and the generally accepted accounting principles basis of a company's life policy liabilities. No definition available.
|
| X | ||||||||||
|
- Definition
The tax effect as of the balance sheet date of the amount of the estimated future tax reductions attributable to a difference between the tax basis and the generally accepted accounting principles basis of a company's capitalization of policy acquisition costs. No definition available.
|
| X | ||||||||||
|
- Definition
The tax effect as of the balance sheet date of the cumulative amount of the non-life company net operating loss available to offset future taxable income. No definition available.
|
| X | ||||||||||
|
- Definition
The amount as of the balance sheet date of the estimated future tax effects arising from timing differences on investments in debt and equity securities categorized as trading. No definition available.
|
| X | ||||||||||
|
- Definition
The amount as of the balance sheet date of the estimated future tax effects arising from unrealized gains on investments in debt and equity securities categorized as anything other than held-to-maturity or trading. No definition available.
|
| X | ||||||||||
|
- Definition
The tax impact of the adjustment to accumulated net unrealized investment (gains) losses for deferred acquisition costs and deferred sales inducements. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of deferred tax liability attributable to taxable temporary differences. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences not separately disclosed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of deferred tax liability attributable to taxable temporary differences net of deferred tax asset attributable to deductible temporary differences and carryforwards after valuation allowances. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount as of the balance sheet date of the estimated future tax effects attributable to policy acquisition costs being expensed for tax purposes but capitalized in conformity with generally accepted accounting principles, which will reverse in future periods when amortization of such capitalized costs cannot be deducted for tax purposes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of deferred tax liability attributable to taxable temporary differences not separately disclosed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Commitments And Contingencies Commitments And Contingencies (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Loss Contingencies [Line Items] | |||
| Unfunded mortgage loan commitments | $ 50.7 | $ 50.5 | |
|
Information Technology Outsourcing Service [Member]
|
|||
| Loss Contingencies [Line Items] | |||
| Incurred service fee expenses | 10.9 | 13.4 | 13.6 |
|
Original Term [Member] | Information Technology Outsourcing Service [Member]
|
|||
| Loss Contingencies [Line Items] | |||
| Annual service fee payment period | 5 years | ||
|
Original Term [Member] | Minimum [Member] | Information Technology Outsourcing Service [Member]
|
|||
| Loss Contingencies [Line Items] | |||
| Annual service fee | 10.6 | ||
|
Original Term [Member] | Maximum [Member] | Information Technology Outsourcing Service [Member]
|
|||
| Loss Contingencies [Line Items] | |||
| Annual service fee | 11.4 | ||
|
Extended Term [Member] | Information Technology Outsourcing Service [Member]
|
|||
| Loss Contingencies [Line Items] | |||
| Annual service fee | $ 10.8 | ||
| Annual service fee payment period | 2 years | ||
| X | ||||||||||
|
- Definition
The number of years over which the entity agrees to pay for an annual service fee per the service agreement. No definition available.
|
| X | ||||||||||
|
- Definition
This represents the amount of the annual fixed service fee the entity agreed to paid per the service agreement with a third party service provider. No definition available.
|
| X | ||||||||||
|
- Definition
The total amount of expense in the period, including fixed and variable portions, related to the third party service agreement. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the amount of mortgage loan commitments that remain unfunded as of the balance sheet date. No definition available.
|
| X | ||||||||||
|
- Details
|
|
Commitments And Contingencies Commitments And Contingencies (Schedule Of Future Minimum Lease Payments For Operating Leases) (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
|---|---|
| Commitments and Contingencies Disclosure [Abstract] | |
| 2015 | $ 8.3 |
| 2016 | 10.9 |
| 2017 | 12.1 |
| 2018 | 10.7 |
| 2019 | 10.8 |
| Thereafter | 61.2 |
| Total | $ 114.0 |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Dividends (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | 3 Months Ended | 12 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2013
Symetra Life Insurance Company [Member]
|
Dec. 31, 2014
Symetra Life Insurance Company [Member]
|
Dec. 31, 2015
Scenario, Forecast [Member]
|
Dec. 31, 2014
Special Dividend [Member]
|
|
| Dividends Payable [Line Items] | |||||||
| Aggregate amount of dividends limit | $ 187.0 | $ 207.8 | |||||
| Cash Dividends Paid to Parent Company by Consolidated Subsidiaries | 45.0 | 80.0 | |||||
| Cash dividends paid on common stock | $ 196.4 | $ 43.2 | $ 38.8 | $ 150.7 | |||
| X | ||||||||||
|
- Definition
This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of dividends that can be declared or paid without approval of regulatory agency. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Statutory-Basis Information (Statutory Net Income and Statutory Capital and Surplus) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
||||||
| Statutory Accounting Practices [Line Items] | ||||||||
| Risk based capital ratios exceed | 470.00% | |||||||
| Minimum statutory capital and surplus requirement | $ 501.3 | |||||||
|
Symetra Life Insurance Company [Member]
|
||||||||
| Statutory Accounting Practices [Line Items] | ||||||||
| Statutory net income (loss) | 241.0 | 183.6 | 252.3 | |||||
| Statutory capital and surplus | 2,078.3 | [1] | 1,869.7 | [1] | 1,912.6 | [1] | ||
| Percentage Of Minimum Statutory Capital And Surplus With Primary Insurance Subsidiary | 95.80% | |||||||
|
Other Subsidiaries [Member]
|
||||||||
| Statutory Accounting Practices [Line Items] | ||||||||
| Statutory net income (loss) | (64.3) | 12.4 | 12.5 | |||||
| Statutory capital and surplus | $ 136.3 | $ 106.7 | $ 95.4 | |||||
|
||||||||
| X | ||||||||||
|
- Definition
Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices attributable to the primary insurance subsidiary. No definition available.
|
| X | ||||||||||
|
- Definition
Risk based capital ratio exceeded by insurance subsidiaries. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Related Parties (Details) (USD $)
In Millions, except Share data, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Related Party Transactions [Abstract] | |||
| Company's common stock held by White Mountains Insurance Group, Ltd. | 20,048,879 | ||
| Advisory expense | $ 19.0 | $ 16.9 | $ 16.0 |
| Amounts due to WMA | $ 5.1 | $ 4.3 | |
| X | ||||||||||
|
- Definition
Total number of shares of common stock held, representing ownership interest in the entity. No definition available.
|
| X | ||||||||||
|
- Definition
Carrying amount as of the balance sheet date of obligations due all related parties. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Segment Information (Narrative) (Details)
|
12 Months Ended |
|---|---|
|
Dec. 31, 2014
segment
division
|
|
| Segment Reporting [Abstract] | |
| Segment Reporting Number Of Divisions | 3 |
| Number of reportable segments | 5 |
| X | ||||||||||
|
- Definition
Represents the number of divisions of the entity. No definition available.
|
| X | ||||||||||
|
- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. No definition available.
|
| X | ||||||||||
|
- Details
|
|
Segment Information (Schedule Of Financial Information By Segment And Reconcile Segment Pre-Tax Adjusted Operating Income (Loss)) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 12 Months Ended | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Sep. 30, 2014
|
Jun. 30, 2014
|
Mar. 31, 2014
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
||||||||
| Operating revenues: | ||||||||||||||||||
| Premiums | $ 629.1 | $ 627.2 | $ 605.0 | |||||||||||||||
| Net investment income | 1,320.5 | 1,285.0 | 1,275.2 | |||||||||||||||
| Policy fees, contract charges, and other | 190.4 | 191.7 | 189.9 | |||||||||||||||
| Benefits and expenses: | ||||||||||||||||||
| Policyholder benefits and claims | 445.9 | 462.9 | 439.0 | |||||||||||||||
| Interest credited | 953.8 | 932.0 | 932.8 | |||||||||||||||
| Other Underwriting And Operating Expenses | 367.0 | 365.1 | 360.5 | |||||||||||||||
| Interest expense | 37.7 | 33.0 | 32.8 | |||||||||||||||
| Amortization of deferred policy acquisition costs | 78.1 | 72.4 | 66.0 | |||||||||||||||
| Total benefits and expenses | 495.5 | 471.7 | 463.9 | 451.4 | 460.6 | 472.9 | 458.2 | 473.7 | 1,882.5 | 1,865.4 | 1,831.1 | |||||||
| Total revenues | 580.8 | 509.0 | 547.1 | 545.5 | 543.1 | 526.1 | 513.2 | 557.1 | 2,182.4 | 2,139.5 | 2,101.2 | |||||||
| Income from operations before income taxes | 85.3 | 37.3 | 83.2 | 94.1 | 82.5 | 53.2 | 55.0 | 83.4 | 299.9 | 274.1 | 270.1 | |||||||
| Total investments | 30,634.3 | 27,901.1 | 30,634.3 | 27,901.1 | ||||||||||||||
| Deferred policy acquisition costs | 395.1 | 322.5 | 395.1 | 322.5 | 155.8 | |||||||||||||
| Separate account assets | 949.8 | 978.4 | 949.8 | 978.4 | ||||||||||||||
| Total assets | 33,001.7 | 30,129.5 | 33,001.7 | 30,129.5 | ||||||||||||||
| Other policyholders' funds | 115.7 | 128.1 | 115.7 | 128.1 | ||||||||||||||
| Notes payable | 697.2 | 449.5 | 697.2 | 449.5 | ||||||||||||||
|
Benefits [Member]
|
||||||||||||||||||
| Operating revenues: | ||||||||||||||||||
| Premiums | 595.3 | 591.4 | 568.8 | |||||||||||||||
| Net investment income | 21.0 | 20.9 | 21.7 | |||||||||||||||
| Policy fees, contract charges, and other | 15.6 | 14.1 | 11.1 | |||||||||||||||
| Certain realized gains (losses) | 0 | 0 | 0 | |||||||||||||||
| Segment Reporting Operating Revenues | 631.9 | 626.4 | 601.6 | |||||||||||||||
| Benefits and expenses: | ||||||||||||||||||
| Policyholder benefits and claims | 365.9 | 393.4 | 370.3 | |||||||||||||||
| Interest credited | 0 | 0 | 0 | |||||||||||||||
| Other Underwriting And Operating Expenses | 175.4 | 168.8 | 160.8 | |||||||||||||||
| Interest expense | 0 | 0 | 0 | |||||||||||||||
| Amortization of deferred policy acquisition costs | 0.7 | 0 | 0 | |||||||||||||||
| Total benefits and expenses | 542.0 | 562.2 | 531.1 | |||||||||||||||
| Segment pre-tax adjusted operating income (loss) | 89.9 | 64.2 | 70.5 | |||||||||||||||
| Add: excluded realized gains (losses) | 0 | 0 | (0.1) | |||||||||||||||
| Total revenues | 631.9 | 626.4 | 601.5 | |||||||||||||||
| Income from operations before income taxes | 89.9 | 64.2 | 70.4 | |||||||||||||||
| Total investments | 4.7 | 6.5 | 4.7 | 6.5 | 16.0 | |||||||||||||
| Deferred policy acquisition costs | 2.0 | 0 | 2.0 | 0 | 0 | |||||||||||||
| Goodwill | 31.1 | 31.1 | 31.1 | 31.1 | 31.1 | |||||||||||||
| Separate account assets | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Total assets | 180.1 | 165.8 | 180.1 | 165.8 | 181.8 | |||||||||||||
| Future policy benefits, losses, claims and loss expense | 220.6 | [1] | 218.8 | [1] | 220.6 | [1] | 218.8 | [1] | 210.1 | [1] | ||||||||
| Other policyholders' funds | 20.0 | 18.8 | 20.0 | 18.8 | 21.3 | |||||||||||||
| Notes payable | 0 | 0 | 0 | 0 | 0 | |||||||||||||
|
Deferred Annuities [Member]
|
||||||||||||||||||
| Operating revenues: | ||||||||||||||||||
| Premiums | 0 | 0 | 0 | |||||||||||||||
| Net investment income | 619.7 | 565.3 | 547.2 | |||||||||||||||
| Policy fees, contract charges, and other | 23.0 | 22.2 | 20.7 | |||||||||||||||
| Certain realized gains (losses) | 0.6 | 5.1 | 0.1 | |||||||||||||||
| Segment Reporting Operating Revenues | 643.3 | 592.6 | 568.0 | |||||||||||||||
| Benefits and expenses: | ||||||||||||||||||
| Policyholder benefits and claims | 0.3 | 0.2 | 0 | |||||||||||||||
| Interest credited | 354.9 | 337.7 | 330.7 | |||||||||||||||
| Other Underwriting And Operating Expenses | 91.6 | 86.6 | 80.3 | |||||||||||||||
| Interest expense | 0 | 0 | 0 | |||||||||||||||
| Amortization of deferred policy acquisition costs | 67.4 | 60.8 | 54.3 | |||||||||||||||
| Total benefits and expenses | 514.2 | 485.3 | 465.3 | |||||||||||||||
| Segment pre-tax adjusted operating income (loss) | 129.1 | 107.3 | 102.7 | |||||||||||||||
| Add: excluded realized gains (losses) | (12.2) | (11.2) | 4.3 | |||||||||||||||
| Total revenues | 631.1 | 581.4 | 572.3 | |||||||||||||||
| Income from operations before income taxes | 116.9 | 96.1 | 107.0 | |||||||||||||||
| Total investments | 14,529.3 | 12,562.0 | 14,529.3 | 12,562.0 | 11,594.1 | |||||||||||||
| Deferred policy acquisition costs | 215.9 | 194.5 | 215.9 | 194.5 | 62.1 | |||||||||||||
| Goodwill | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Separate account assets | 794.9 | 836.2 | 794.9 | 836.2 | 723.3 | |||||||||||||
| Total assets | 15,902.5 | 13,958.9 | 15,902.5 | 13,958.9 | 12,562.4 | |||||||||||||
| Future policy benefits, losses, claims and loss expense | 14,356.7 | [1] | 12,554.0 | [1] | 14,356.7 | [1] | 12,554.0 | [1] | 11,050.3 | [1] | ||||||||
| Other policyholders' funds | 22.1 | 32.7 | 22.1 | 32.7 | 13.1 | |||||||||||||
| Notes payable | 0 | 0 | 0 | 0 | 0 | |||||||||||||
|
Income Annuities [Member]
|
||||||||||||||||||
| Operating revenues: | ||||||||||||||||||
| Premiums | 0 | 0 | 0 | |||||||||||||||
| Net investment income | 382.0 | 397.9 | 409.9 | |||||||||||||||
| Policy fees, contract charges, and other | 1.0 | 2.6 | 6.8 | |||||||||||||||
| Certain realized gains (losses) | 0 | 0 | 0 | |||||||||||||||
| Segment Reporting Operating Revenues | 383.0 | 400.5 | 416.7 | |||||||||||||||
| Benefits and expenses: | ||||||||||||||||||
| Policyholder benefits and claims | 0 | 0 | 0 | |||||||||||||||
| Interest credited | 342.1 | 343.0 | 346.0 | |||||||||||||||
| Other Underwriting And Operating Expenses | 20.3 | 21.3 | 22.6 | |||||||||||||||
| Interest expense | 0 | 0 | 0 | |||||||||||||||
| Amortization of deferred policy acquisition costs | 4.7 | 3.9 | 3.1 | |||||||||||||||
| Total benefits and expenses | 367.1 | 368.2 | 371.7 | |||||||||||||||
| Segment pre-tax adjusted operating income (loss) | 15.9 | 32.3 | 45.0 | |||||||||||||||
| Add: excluded realized gains (losses) | 63.8 | 43.5 | 9.4 | |||||||||||||||
| Total revenues | 446.8 | 444.0 | 426.1 | |||||||||||||||
| Income from operations before income taxes | 79.7 | 75.8 | 54.4 | |||||||||||||||
| Total investments | 7,420.4 | 7,079.7 | 7,420.4 | 7,079.7 | 7,476.2 | |||||||||||||
| Deferred policy acquisition costs | 58.0 | 49.2 | 58.0 | 49.2 | 45.0 | |||||||||||||
| Goodwill | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Separate account assets | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Total assets | 7,559.7 | 7,213.6 | 7,559.7 | 7,213.6 | 7,672.9 | |||||||||||||
| Future policy benefits, losses, claims and loss expense | 6,482.1 | [1] | 6,479.5 | [1] | 6,482.1 | [1] | 6,479.5 | [1] | 6,557.5 | [1] | ||||||||
| Other policyholders' funds | 5.6 | 10.4 | 5.6 | 10.4 | 9.1 | |||||||||||||
| Notes payable | 0 | 0 | 0 | 0 | 0 | |||||||||||||
|
Individual Life [Member]
|
||||||||||||||||||
| Operating revenues: | ||||||||||||||||||
| Premiums | 33.8 | 35.8 | 36.2 | |||||||||||||||
| Net investment income | 283.0 | 280.4 | 284.4 | |||||||||||||||
| Policy fees, contract charges, and other | 149.0 | 136.3 | 129.6 | |||||||||||||||
| Certain realized gains (losses) | 0 | 0 | 0 | |||||||||||||||
| Segment Reporting Operating Revenues | 465.8 | 452.5 | 450.2 | |||||||||||||||
| Benefits and expenses: | ||||||||||||||||||
| Policyholder benefits and claims | 79.7 | 69.3 | 68.7 | |||||||||||||||
| Interest credited | 258.4 | 253.0 | 258.2 | |||||||||||||||
| Other Underwriting And Operating Expenses | 76.7 | 67.2 | 67.7 | |||||||||||||||
| Interest expense | 0 | 0 | 0 | |||||||||||||||
| Amortization of deferred policy acquisition costs | 5.3 | 7.7 | 8.6 | |||||||||||||||
| Total benefits and expenses | 420.1 | 397.2 | 403.2 | |||||||||||||||
| Segment pre-tax adjusted operating income (loss) | 45.7 | 55.3 | 47.0 | |||||||||||||||
| Add: excluded realized gains (losses) | 2.7 | (7.8) | (5.9) | |||||||||||||||
| Total revenues | 468.5 | 444.7 | 444.3 | |||||||||||||||
| Income from operations before income taxes | 48.4 | 47.5 | 41.1 | |||||||||||||||
| Total investments | 6,240.0 | 5,938.7 | 6,240.0 | 5,938.7 | 6,107.3 | |||||||||||||
| Deferred policy acquisition costs | 119.2 | 78.8 | 119.2 | 78.8 | 48.7 | |||||||||||||
| Goodwill | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Separate account assets | 154.9 | 142.2 | 154.9 | 142.2 | 84.4 | |||||||||||||
| Total assets | 6,873.7 | 6,470.9 | 6,873.7 | 6,470.9 | 6,598.5 | |||||||||||||
| Future policy benefits, losses, claims and loss expense | 6,122.5 | [1] | 5,971.3 | [1] | 6,122.5 | [1] | 5,971.3 | [1] | 5,828.2 | [1] | ||||||||
| Other policyholders' funds | 58.9 | 58.3 | 58.9 | 58.3 | 63.2 | |||||||||||||
| Notes payable | 0 | 0 | 0 | 0 | 0 | |||||||||||||
|
Other [Member]
|
||||||||||||||||||
| Operating revenues: | ||||||||||||||||||
| Premiums | 0 | 0 | 0 | |||||||||||||||
| Net investment income | 14.8 | 20.5 | 12.0 | |||||||||||||||
| Policy fees, contract charges, and other | 1.8 | 16.5 | 21.7 | |||||||||||||||
| Certain realized gains (losses) | 0 | 0 | 0 | |||||||||||||||
| Segment Reporting Operating Revenues | 16.6 | 37.0 | 33.7 | |||||||||||||||
| Benefits and expenses: | ||||||||||||||||||
| Policyholder benefits and claims | 0 | 0 | 0 | |||||||||||||||
| Interest credited | (1.6) | (1.7) | (2.1) | |||||||||||||||
| Other Underwriting And Operating Expenses | 3.0 | 21.2 | 29.1 | |||||||||||||||
| Interest expense | 37.7 | 33.0 | 32.8 | |||||||||||||||
| Amortization of deferred policy acquisition costs | 0 | 0 | 0 | |||||||||||||||
| Total benefits and expenses | 39.1 | 52.5 | 59.8 | |||||||||||||||
| Segment pre-tax adjusted operating income (loss) | (22.5) | (15.5) | (26.1) | |||||||||||||||
| Add: excluded realized gains (losses) | (12.5) | 6.0 | 23.3 | |||||||||||||||
| Total revenues | 4.1 | 43.0 | 57.0 | |||||||||||||||
| Income from operations before income taxes | (35.0) | (9.5) | (2.8) | |||||||||||||||
| Total investments | 2,439.9 | 2,314.2 | 2,439.9 | 2,314.2 | 2,362.8 | |||||||||||||
| Deferred policy acquisition costs | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Goodwill | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Separate account assets | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Total assets | 2,485.7 | 2,320.3 | 2,485.7 | 2,320.3 | 2,445.3 | |||||||||||||
| Future policy benefits, losses, claims and loss expense | (21.6) | [1] | (22.9) | [1] | (21.6) | [1] | (22.9) | [1] | (24.8) | [1] | ||||||||
| Other policyholders' funds | 9.1 | 7.9 | 9.1 | 7.9 | 7.2 | |||||||||||||
| Notes payable | 697.2 | 449.5 | 697.2 | 449.5 | 449.4 | |||||||||||||
|
Consolidation [Member]
|
||||||||||||||||||
| Operating revenues: | ||||||||||||||||||
| Premiums | 629.1 | 627.2 | 605.0 | |||||||||||||||
| Net investment income | 1,320.5 | 1,285.0 | 1,275.2 | |||||||||||||||
| Policy fees, contract charges, and other | 190.4 | 191.7 | 189.9 | |||||||||||||||
| Certain realized gains (losses) | 0.6 | 5.1 | 0.1 | |||||||||||||||
| Segment Reporting Operating Revenues | 2,140.6 | 2,109.0 | 2,070.2 | |||||||||||||||
| Benefits and expenses: | ||||||||||||||||||
| Policyholder benefits and claims | 445.9 | 462.9 | 439.0 | |||||||||||||||
| Interest credited | 953.8 | 932.0 | 932.8 | |||||||||||||||
| Other Underwriting And Operating Expenses | 367.0 | 365.1 | 360.5 | |||||||||||||||
| Interest expense | 37.7 | 33.0 | 32.8 | |||||||||||||||
| Amortization of deferred policy acquisition costs | 78.1 | 72.4 | 66.0 | |||||||||||||||
| Total benefits and expenses | 1,882.5 | 1,865.4 | 1,831.1 | |||||||||||||||
| Segment pre-tax adjusted operating income (loss) | 258.1 | 243.6 | 239.1 | |||||||||||||||
| Add: excluded realized gains (losses) | 41.8 | 30.5 | 31.0 | |||||||||||||||
| Total revenues | 2,182.4 | 2,139.5 | 2,101.2 | |||||||||||||||
| Income from operations before income taxes | 299.9 | 274.1 | 270.1 | |||||||||||||||
| Total investments | 30,634.3 | 27,901.1 | 30,634.3 | 27,901.1 | 27,556.4 | |||||||||||||
| Deferred policy acquisition costs | 395.1 | 322.5 | 395.1 | 322.5 | 155.8 | |||||||||||||
| Goodwill | 31.1 | 31.1 | 31.1 | 31.1 | 31.1 | |||||||||||||
| Separate account assets | 949.8 | 978.4 | 949.8 | 978.4 | 807.7 | |||||||||||||
| Total assets | 33,001.7 | 30,129.5 | 33,001.7 | 30,129.5 | 29,460.9 | |||||||||||||
| Future policy benefits, losses, claims and loss expense | 27,160.3 | [1] | 25,200.7 | [1] | 27,160.3 | [1] | 25,200.7 | [1] | 23,621.3 | [1] | ||||||||
| Other policyholders' funds | 115.7 | 128.1 | 115.7 | 128.1 | 113.9 | |||||||||||||
| Notes payable | $ 697.2 | $ 449.5 | $ 697.2 | $ 449.5 | $ 449.4 | |||||||||||||
|
||||||||||||||||||
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Certain net realized and unrealized gains (losses) included in the entity's segment measure of profitability. No definition available.
|
| X | ||||||||||
|
- Definition
Net realized and unrealized gains excluded from the entity's segment measure of profitability. No definition available.
|
| X | ||||||||||
|
- Definition
The sum of, as of the balance sheet date, of: a) the liability to the policyholders for deposits held under the terms of insurance contracts, b) known and estimated amounts payable to policyholders pertaining to insured events for long-duration contracts, and c) the amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
This includes costs incurred during the period associated with normal operations, such as those relating to general administration and those not deferred as related to the acquisition or renewal of insurance contracts. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the entity's measure of segment profit or loss for the period, before income taxes, which excludes certain net realized gains (losses). No definition available.
|
| X | ||||||||||
|
- Definition
Segment Reporting Operating Revenues No definition available.
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of expense related to deferred policy acquisition costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net amount of deferred policy acquisition costs capitalized on contracts remaining in force as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Income from agency and brokerage operations (includes sales of annuities and supplemental contracts); service charges, commissions, and fees from the sale of insurance and related services; and management fees from separate accounts, deferred annuities, and universal life products. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Interest allocated to policyholders holding contracts under which the insurer must provide a guaranteed yield. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Liability as of the balance sheet date to the policyholders for funds held that are returnable under the terms of insurance contracts that were not separately reported. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The fair value of the assets held by the Entity for the benefit of separate account policyholders. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Quarterly Results of Operations (Schedule of Quarterly Results of Operations) (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified |
3 Months Ended | 12 Months Ended | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Sep. 30, 2014
|
Jun. 30, 2014
|
Mar. 31, 2014
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|||||||||||
| Quarterly Financial Information Disclosure [Abstract] | |||||||||||||||||||||
| Total revenues | $ 580.8 | $ 509.0 | $ 547.1 | $ 545.5 | $ 543.1 | $ 526.1 | $ 513.2 | $ 557.1 | $ 2,182.4 | $ 2,139.5 | $ 2,101.2 | ||||||||||
| Total benefits and expenses | 495.5 | 471.7 | 463.9 | 451.4 | 460.6 | 472.9 | 458.2 | 473.7 | 1,882.5 | 1,865.4 | 1,831.1 | ||||||||||
| Income from operations before income taxes | 85.3 | 37.3 | 83.2 | 94.1 | 82.5 | 53.2 | 55.0 | 83.4 | 299.9 | 274.1 | 270.1 | ||||||||||
| Net income | $ 67.6 | $ 36.0 | $ 71.5 | $ 79.3 | $ 64.4 | $ 45.3 | $ 45.0 | $ 66.0 | $ 254.4 | $ 220.7 | $ 205.4 | ||||||||||
| Basic (USD per share) | $ 0.58 | [1] | $ 0.31 | [1] | $ 0.62 | [1] | $ 0.68 | [1] | $ 0.55 | [1] | $ 0.38 | [1] | $ 0.34 | [1] | $ 0.48 | [1] | $ 2.19 | $ 1.74 | $ 1.49 | ||
| Diluted (USD per share) | $ 0.58 | [1] | $ 0.31 | [1] | $ 0.62 | [1] | $ 0.68 | [1] | $ 0.55 | [1] | $ 0.38 | [1] | $ 0.34 | [1] | $ 0.48 | [1] | $ 2.19 | $ 1.74 | $ 1.49 | ||
|
|||||||||||||||||||||
| X | ||||||||||
|
- Definition
The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Schedule I Summary Of Investments Other Than Investments In Related Parties (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | $ 28,522.8 | |||||||||
| Fair Value | 30,581.2 | |||||||||
| Amount as shown in the Balance Sheet | 30,347.3 | |||||||||
|
Mortgage Loans [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 4,138.2 | [1] | ||||||||
| Fair Value | 4,375.8 | [1] | ||||||||
| Amount as shown in the Balance Sheet | 4,130.1 | [1] | ||||||||
| Allowance for loan losses | 8.1 | |||||||||
|
Policy Loans [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 61.9 | |||||||||
| Fair Value | 61.9 | |||||||||
| Amount as shown in the Balance Sheet | 61.9 | |||||||||
|
Other Investments [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 357.6 | [2] | ||||||||
| Fair Value | 398.6 | [2] | ||||||||
| Amount as shown in the Balance Sheet | 410.4 | [2] | ||||||||
|
Fixed Maturities [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 23,402.1 | [3] | ||||||||
| Fair Value | 25,098.4 | [3] | ||||||||
| Amount as shown in the Balance Sheet | 25,098.4 | [3] | ||||||||
|
Fixed Maturities [Member] | Affiliated Entity [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 244.4 | |||||||||
| Fair Value | 281.0 | |||||||||
|
Fixed Maturities [Member] | US government and agencies [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 404.8 | |||||||||
| Fair Value | 409.9 | |||||||||
| Amount as shown in the Balance Sheet | 409.9 | |||||||||
|
Fixed Maturities [Member] | States Municipalities And Political Subdivisions [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 789.7 | |||||||||
| Fair Value | 829.2 | |||||||||
| Amount as shown in the Balance Sheet | 829.2 | |||||||||
|
Fixed Maturities [Member] | Foreign Government [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 91.4 | |||||||||
| Fair Value | 94.9 | |||||||||
| Amount as shown in the Balance Sheet | 94.9 | |||||||||
|
Fixed Maturities [Member] | Public Utilities [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 1,858.6 | |||||||||
| Fair Value | 2,081.6 | |||||||||
| Amount as shown in the Balance Sheet | 2,081.6 | |||||||||
|
Fixed Maturities [Member] | Convertible Bonds And Bonds With Warrants Attached [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 9.4 | |||||||||
| Fair Value | 10.1 | |||||||||
| Amount as shown in the Balance Sheet | 10.1 | |||||||||
|
Fixed Maturities [Member] | All Other Corporate Bonds [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 15,623.7 | |||||||||
| Fair Value | 16,796.2 | |||||||||
| Amount as shown in the Balance Sheet | 16,796.2 | |||||||||
|
Fixed Maturities [Member] | Mortgage Backed Securities [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 4,574.5 | |||||||||
| Fair Value | 4,832.6 | |||||||||
| Amount as shown in the Balance Sheet | 4,832.6 | |||||||||
|
Fixed Maturities [Member] | Redeemable Preferred Stock [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 50.0 | |||||||||
| Fair Value | 43.9 | |||||||||
| Amount as shown in the Balance Sheet | 43.9 | |||||||||
|
Equity Securities [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 563.0 | [4] | ||||||||
| Fair Value | 646.5 | [4] | ||||||||
| Amount as shown in the Balance Sheet | 646.5 | [4] | ||||||||
|
Equity Securities [Member] | Affiliated Entity [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 3.3 | |||||||||
| Fair Value | 6.0 | |||||||||
|
Equity Securities [Member] | Public Utilities [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 1.9 | |||||||||
| Fair Value | 2.4 | |||||||||
| Amount as shown in the Balance Sheet | 2.4 | |||||||||
|
Equity Securities [Member] | Banks Trusts And Insurance Companies [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 340.3 | |||||||||
| Fair Value | 392.3 | |||||||||
| Amount as shown in the Balance Sheet | 392.3 | |||||||||
|
Equity Securities [Member] | Industrial Miscellaneous And All Others [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 163.8 | |||||||||
| Fair Value | 194.1 | |||||||||
| Amount as shown in the Balance Sheet | 194.1 | |||||||||
|
Equity Securities [Member] | Nonredeemable Preferred Stock [Member]
|
||||||||||
| Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||||||||||
| Cost or Amortized Cost | 57.0 | |||||||||
| Fair Value | 57.7 | |||||||||
| Amount as shown in the Balance Sheet | $ 57.7 | |||||||||
|
||||||||||
| X | ||||||||||
|
- Definition
Amount of other addition (reduction) in allowance reserve for credit loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the carrying (reported) amount of the entity's investments as of the balance sheet date. This amount may represent the individual investment's or group of similar investments' original cost, fair value, or such other amount at which the investment is shown in the entity's balance sheet. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the original cost of the entity's investments including investments in equity securities and, as to fixed maturities, original cost reduced by repayments and adjusted for amortization of premiums or accrual of discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the reported amount of the entity's investments measured at fair value. Fair value is the price that would be received to sell an investment in an orderly transaction between market participants at the balance sheet [measurement] date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Schedule II Condensed Statement of Financial Position (Details) (USD $)
In Millions, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|---|---|---|---|---|
| Condensed Financial Statements, Captions [Line Items] | ||||
| Investments, at fair value (cost or amortized cost: $354.9 and $193.6, respectively) | $ 30,634.3 | $ 27,901.1 | ||
| Cash and cash equivalents | 158.8 | 76.0 | 130.8 | 242.3 |
| Accrued investment income | 304.9 | 298.0 | ||
| Other assets | 230.1 | 242.7 | ||
| Total assets | 33,001.7 | 30,129.5 | ||
| Notes payable | 697.2 | 449.5 | ||
| Other liabilities | 321.4 | 229.0 | ||
| Total liabilities | 29,641.1 | 27,187.6 | ||
| Common stock, $0.01 par value, 750,000,000 shares authorized; 124,850,754 shares issued and 115,797,451 outstanding as of December 31, 2014 and 124,683,023 shares issued and 117,730,757 outstanding as of December 31, 2013 | 1.2 | 1.2 | ||
| Additional paid-in capital | 1,469.5 | 1,464.6 | ||
| Treasury stock, at cost; 9,053,303 and 6,952,266 shares as of December 31, 2014 and 2013, respectively | (134.6) | (93.4) | ||
| Retained earnings | 1,033.9 | 975.9 | ||
| Accumulated other comprehensive income, net of taxes | 990.6 | 593.6 | ||
| Total stockholders’ equity | 3,360.6 | 2,941.9 | 3,630.1 | 3,114.9 |
| Total liabilities and stockholders’ equity | 33,001.7 | 30,129.5 | ||
|
Parent Company [Member]
|
||||
| Condensed Financial Statements, Captions [Line Items] | ||||
| Investments, at fair value (cost or amortized cost: $354.9 and $193.6, respectively) | 368.7 | 191.4 | ||
| Investments in subsidiaries | 3,677.2 | 3,124.4 | ||
| Cash and cash equivalents | 4.0 | 8.5 | 2.3 | 4.4 |
| Total cash and investments | 4,049.9 | 3,324.3 | ||
| Accrued investment income | 1.5 | 46.0 | ||
| Current and deferred income taxes | 31.1 | 32.8 | ||
| Receivables due from affiliates | 8.5 | 7.3 | ||
| Other assets | 7.6 | 6.2 | ||
| Total assets | 4,098.6 | 3,416.6 | ||
| Notes payable | 697.2 | 449.5 | ||
| Other liabilities | 40.8 | 25.2 | ||
| Total liabilities | 738.0 | 474.7 | ||
| Common stock, $0.01 par value, 750,000,000 shares authorized; 124,850,754 shares issued and 115,797,451 outstanding as of December 31, 2014 and 124,683,023 shares issued and 117,730,757 outstanding as of December 31, 2013 | 1.2 | 1.2 | ||
| Additional paid-in capital | 1,469.5 | 1,464.6 | ||
| Treasury stock, at cost; 9,053,303 and 6,952,266 shares as of December 31, 2014 and 2013, respectively | (134.6) | (93.4) | ||
| Retained earnings | 1,033.9 | 975.9 | ||
| Accumulated other comprehensive income, net of taxes | 990.6 | 593.6 | ||
| Total stockholders’ equity | 3,360.6 | 2,941.9 | ||
| Total liabilities and stockholders’ equity | $ 4,098.6 | $ 3,416.6 |
| X | ||||||||||
|
- Definition
Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other tax receivables expected to be realized or consumed within one year or operating cycle, if longer. No definition available.
|
| X | ||||||||||
|
- Definition
For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of investments and unrestricted cash as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate carrying amounts, as of the balance sheet date, of assets not separately disclosed in the balance sheet. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate carrying amount, as of the balance sheet date, of liabilities not separately disclosed in the balance sheet. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Schedule II Condensed Statement Of Financial Position (Parenthetical) (Details) (USD $)
In Millions, except Share data, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|---|---|---|---|---|
| Condensed Financial Statements, Captions [Line Items] | ||||
| Common stock, par value (USD per share) | $ 0.01 | $ 0.01 | ||
| Common stock, shares authorized | 750,000,000 | 750,000,000 | ||
| Common stock, shares issued | 124,850,754 | 124,683,023 | ||
| Common stock, shares outstanding | 115,797,451 | 117,730,757 | 119,087,677 | 118,637,379 |
| Treasury stock, shares | 9,053,303 | 6,952,266 | ||
|
Parent Company [Member]
|
||||
| Condensed Financial Statements, Captions [Line Items] | ||||
| Investments, at amortized cost | $ 354.9 | $ 193.6 | ||
| Common stock, par value (USD per share) | $ 0.01 | $ 0.01 | ||
| Common stock, shares authorized | 750,000,000 | 750,000,000 | ||
| Common stock, shares issued | 124,850,754 | 124,683,023 | ||
| Common stock, shares outstanding | 115,797,451 | 117,730,757 | ||
| Treasury stock, shares | 9,053,303 | 6,952,266 |
| X | ||||||||||
|
- Definition
This item represents the total of all investments, at cost. No definition available.
|
| X | ||||||||||
|
- Definition
Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Schedule II Condensed Statement Of Comprehensive Income (Loss) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2014
|
Sep. 30, 2014
|
Jun. 30, 2014
|
Mar. 31, 2014
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Revenues [Abstract] | |||||||||||
| Net investment income | $ 1,320.5 | $ 1,285.0 | $ 1,275.2 | ||||||||
| Net realized gains (losses) | 42.4 | 35.6 | 31.1 | ||||||||
| Total revenues | 580.8 | 509.0 | 547.1 | 545.5 | 543.1 | 526.1 | 513.2 | 557.1 | 2,182.4 | 2,139.5 | 2,101.2 |
| Expenses: | |||||||||||
| Interest expense | 37.7 | 33.0 | 32.8 | ||||||||
| Income from operations before income taxes | 85.3 | 37.3 | 83.2 | 94.1 | 82.5 | 53.2 | 55.0 | 83.4 | 299.9 | 274.1 | 270.1 |
| Income tax benefit | 45.5 | 53.4 | 64.7 | ||||||||
| Net income | 67.6 | 36.0 | 71.5 | 79.3 | 64.4 | 45.3 | 45.0 | 66.0 | 254.4 | 220.7 | 205.4 |
| Changes in unrealized gains (losses) on available-for-sale securities (net of taxes of $2.7, $(2.1) and $(1.6)) | 394.5 | (865.4) | 396.6 | ||||||||
| Impact of cash flow hedges (net of taxes of $0.1, $0.1 and $0.0) | 22.2 | (18.9) | (1.5) | ||||||||
| Other Comprehensive Income (Loss) | 397.0 | (777.6) | 343.9 | ||||||||
| Total comprehensive income (loss) | 651.4 | (556.9) | 549.3 | ||||||||
|
Parent Company [Member]
|
|||||||||||
| Revenues [Abstract] | |||||||||||
| Net investment income | 14.4 | 5.9 | 5.0 | ||||||||
| Net realized gains (losses) | 4.6 | 4.3 | 7.7 | ||||||||
| Total revenues | 108.5 | 274.3 | 98.5 | ||||||||
| Expenses: | |||||||||||
| Interest expense | 37.7 | 33.0 | 32.8 | ||||||||
| Operating expenses | 2.6 | 2.7 | 2.2 | ||||||||
| Total expenses | 40.3 | 35.7 | 35.0 | ||||||||
| Income from operations before income taxes | 68.2 | 238.6 | 63.5 | ||||||||
| Income tax benefit | (6.8) | (8.6) | (7.4) | ||||||||
| Income before equity in earnings of subsidiaries | 75.0 | 247.2 | 70.9 | ||||||||
| Total equity in earnings of subsidiaries | 179.4 | (26.5) | 134.5 | ||||||||
| Net income | 254.4 | 220.7 | 205.4 | ||||||||
| Changes in unrealized gains (losses) on available-for-sale securities (net of taxes of $2.7, $(2.1) and $(1.6)) | 4.9 | (3.9) | (3.0) | ||||||||
| Impact of cash flow hedges (net of taxes of $0.1, $0.1 and $0.0) | 0.1 | 0.1 | 0.1 | ||||||||
| Other comprehensive income (loss) of subsidiaries (net of taxes of $211.1, $(416.7), $186.7) | 392.0 | (773.8) | 346.8 | ||||||||
| Other Comprehensive Income (Loss) | 397.0 | (777.6) | 343.9 | ||||||||
| Total comprehensive income (loss) | 651.4 | (556.9) | 549.3 | ||||||||
|
Symetra Life Insurance Company [Member] | Parent Company [Member]
|
|||||||||||
| Revenues [Abstract] | |||||||||||
| Dividends from subsidiaries | 80.0 | 240.0 | 80.0 | ||||||||
| Expenses: | |||||||||||
| Total equity in earnings of subsidiaries | 176.2 | (11.6) | 131.0 | ||||||||
|
Other Subsidiaries [Member] | Parent Company [Member]
|
|||||||||||
| Revenues [Abstract] | |||||||||||
| Dividends from subsidiaries | 9.5 | 24.1 | 5.8 | ||||||||
| Expenses: | |||||||||||
| Total equity in earnings of subsidiaries | $ 3.2 | $ (14.9) | $ 3.5 | ||||||||
| X | ||||||||||
|
- Definition
Income (loss) before equity in undistributed net income (loss) of subsidiaries. No definition available.
|
| X | ||||||||||
|
- Definition
Net of tax amount of other comprehensive income (loss) attributable to subsidiaries. No definition available.
|
| X | ||||||||||
|
- Definition
The total amount of expense recognized during the period. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Schedule II Condensed Statement Of Comprehensive Income (Loss) (Parenthetical) (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Condensed Financial Statements, Captions [Line Items] | |||
| Changes in unrealized gains (losses) on available-for-sale securities, tax | $ 212.5 | $ (465.8) | $ 213.3 |
| Impact of cash flow hedges, tax | 12.0 | (10.2) | (0.8) |
|
Parent Company [Member]
|
|||
| Condensed Financial Statements, Captions [Line Items] | |||
| Changes in unrealized gains (losses) on available-for-sale securities, tax | 2.7 | (2.1) | (1.6) |
| Impact of cash flow hedges, tax | 0.1 | 0.1 | 0 |
| Other comprehensive income (loss) of subsidiaries, tax | $ 211.1 | $ (416.7) | $ 186.7 |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Schedule II Condensed Statement Of Cash Flows (Details) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Cash flows from operating activities | |||
| Net income | $ 254.4 | $ 220.7 | $ 205.4 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized (gains) losses | (42.4) | (35.6) | (31.1) |
| Accrued investment income | (6.9) | (21.8) | (6.8) |
| Changes in accrued items and other adjustments, net | 0.4 | 3.5 | 3.0 |
| Total adjustments | 723.9 | 798.9 | 805.8 |
| Net cash provided by (used in) operating activities | 978.3 | 1,019.6 | 1,011.2 |
| Cash flows from investing activities | |||
| Maturities, calls, paydowns, and other repayments | 1,795.0 | 1,771.3 | 1,740.4 |
| Other, net | 62.4 | 25.8 | 0 |
| Net cash provided by (used in) investing activities | (2,021.3) | (1,671.0) | (869.3) |
| Cash flows from financing activities | |||
| Net proceeds from issuance of debt | 246.0 | 0 | 0 |
| Shares repurchased | (41.2) | (93.4) | 0 |
| Proceeds from (Payments for) Other Financing Activities | (9.9) | (32.4) | (12.9) |
| Net cash provided by (used in) financing activities | 1,125.8 | 596.6 | (253.4) |
| Net increase (decrease) in cash and cash equivalents | 82.8 | (54.8) | (111.5) |
| Cash and cash equivalents at beginning of period | 76.0 | 130.8 | 242.3 |
| Cash and cash equivalents at end of period | 158.8 | 76.0 | 130.8 |
| Supplemental disclosures of cash flow information | |||
| Interest | 31.2 | 31.5 | 31.5 |
| Income taxes | 75.0 | 32.0 | 50.6 |
|
Parent Company [Member]
|
|||
| Cash flows from operating activities | |||
| Net income | 254.4 | 220.7 | 205.4 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Equity in earnings of subsidiaries | (179.4) | 26.5 | (134.5) |
| Net realized (gains) losses | (4.6) | (4.3) | (7.7) |
| Accrued investment income | 44.5 | (45.7) | 0 |
| Changes in accrued items and other adjustments, net | 2.4 | (5.8) | 0.8 |
| Total adjustments | (137.1) | (29.3) | (141.4) |
| Net cash provided by (used in) operating activities | 117.3 | 191.4 | 64.0 |
| Cash flows from investing activities | |||
| Purchases of investments | (353.5) | (138.7) | (131.9) |
| Maturities, calls, paydowns, and other repayments | 0.2 | 1.1 | 1.1 |
| Proceeds from Sale, Maturity and Collection of Investments | 196.2 | 47.3 | 157.6 |
| Return of capital (capital contributed) | 26.8 | 34.4 | (52.8) |
| Acquisitions | 0 | 0 | (2.0) |
| Other, net | (1.2) | 5.6 | (1.0) |
| Net cash provided by (used in) investing activities | (131.5) | (50.3) | (29.0) |
| Cash flows from financing activities | |||
| Net proceeds from issuance of debt | 246.0 | 0 | 0 |
| Cash dividends paid on common stock | (196.4) | (43.2) | (38.8) |
| Shares repurchased | (41.2) | (93.4) | 0 |
| Proceeds from (Payments for) Other Financing Activities | 1.3 | 1.7 | 1.7 |
| Net cash provided by (used in) financing activities | 9.7 | (134.9) | (37.1) |
| Net increase (decrease) in cash and cash equivalents | (4.5) | 6.2 | (2.1) |
| Cash and cash equivalents at beginning of period | 8.5 | 2.3 | 4.4 |
| Cash and cash equivalents at end of period | 4.0 | 8.5 | 2.3 |
| Supplemental disclosures of cash flow information | |||
| Interest | 31.2 | 31.5 | 31.5 |
| Income taxes | $ (6.0) | $ (3.9) | $ (6.1) |
| X | ||||||||||
|
- Definition
The cash inflow associated with maturities, calls, paydowns and other repayments of investments. No definition available.
|
| X | ||||||||||
|
- Definition
This item includes: (a) cash dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations that are returns of capital. Excludes dividends or distributions from equity method investments classified as operating activities; and (b) the cash outflow associated with the acquisition of or advances to an unconsolidated subsidiary, affiliate, and joint venture or equity method investment, or the acquisition of an additional interest in a subsidiary (controlled entity). No definition available.
|
| X | ||||||||||
|
- Definition
The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The increase (decrease) during the reporting period in investment income that has been earned but not yet received in cash. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of cash paid for interest during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net cash outflow or inflow from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow to reacquire common stock during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. No definition available.
|
| X | ||||||||||
|
- Definition
The net cash inflow or outflow from other financing activities. This element is used when there is not a more specific and appropriate element in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Schedule II Condensed Statement Of Financial Information [Schedule] Schedule II Notes to Condensed Financial Statements (Details) (Parent Company [Member], USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
|
Parent Company [Member]
|
|||
| Condensed Financial Statements, Captions [Line Items] | |||
| Cash Dividends Paid to Parent Company | $ 134.5 | $ 219.1 | $ 85.8 |
| Dividends Receivable | $ 45.0 | ||
| X | ||||||||||
|
- Definition
This element represents disclosure of the total aggregate cash dividends paid to the entity by consolidated subsidiaries, by unconsolidated subsidiaries, and by 50% or less owned persons accounted for using the equity method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Carrying amount as of the balance sheet date of dividends declared but not received. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|